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Background: Multiple imputation is a widely used approach to handling missing 
data. Despite a growing evidence base for its use, implementation in practical 
settings remains challenging. This thesis considers knowledge gaps in the 
application of multiple imputation for handling missing outcome data. 
 
Research has shown that deleting observations with multiply imputed outcomes 
before analysis can be beneficial when imputation and analysis models are the 
same. However, it is unclear how this approach performs with auxiliary variables, 
which are often available in practice. Another challenge arises when the outcome 
of interest is binary. The use of log binomial regression to produce relative risks is 
common, yet standard methods for imputing binary outcomes involve logistic 
regression or a multivariate normal assumption. It is uncertain whether 
inconsistencies between imputation and analysis models in this setting lead to 
biased or inefficient estimation. Questions also remain concerning the utility of 
multiple imputation in randomised trials. Unlike observational studies, the key 
exposure in randomised trials (randomised group) is always observed and 
independent of covariates for adjustment. If extended follow-up beyond 
completion of a randomised trial is planned, there may be more missing outcome 
data than in the original trial, and the use of eligibility restrictions and separate 
consent processes for participation in extended follow-up may complicate the use 
of multiple imputation. Unfortunately little is known about the extent of missing 
outcome data in this setting. 
 
Aims: Specific aims are to: 
  
1. Evaluate the effect of deleting imputed outcomes prior to analysis in the 
presence of auxiliary variables; 




3. Assess the utility of multiple imputation in randomised trials; 
4. Summarise the extent of missing outcome data and provide guidance on the 
implementation of multiple imputation in extended follow-up studies. 
 
Methods: The performance of multiple imputation was evaluated using data 
simulation and application to a real clinical trial. To summarise the extent of 
missing outcome data in extended follow-up studies, a systematic review of 
published follow-up studies was undertaken. 
 
Results: Deleting imputed outcomes prior to analysis can lead to bias when the 
imputation model contains auxiliary variables associated with missingness in the 
outcome. For relative risk estimation, standard multiple imputation methods 
introduce bias and tend to produce confidence intervals that are too wide. Multiple 
imputation performs well in randomised trials, but simpler unbiased alternative 
methods for handling missing data are often slightly more efficient. Missing 
outcome data are a considerable threat to the validity of conclusions from 
extended follow-up studies. Eligibility restrictions and separate consent processes 
for participation are commonly employed in this setting, making the 
implementation of multiple imputation more challenging. 
 
Conclusions: This thesis demonstrates the pitfalls of deleting imputed outcomes 
prior to analysis, the need for new methods of imputation when estimating the 
relative risk, and the limitations of multiple imputation for handling missing 
outcome data in randomised trials and extended follow-up studies. These findings 
will help to guide researchers on the appropriate use of multiple imputation for 
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Missing data are a widespread problem in medical research. Defined as values 
that are not available but would have been meaningful for analysis had they been 
observed (1), missing data can result in biased and/or inefficient parameter 
estimates if inadequately handled in the statistical analysis. The validity of any 
statistical approach for handling missing data depends on the process that led to 
the data being missing, termed the "missing data mechanism". Rubin (2) 
introduced three classes of missing data mechanisms: missing completely at 
random (MCAR), missing at random (MAR), and missing not at random 
(MNAR). Data are said to be MCAR if the probability of missing data is unrelated 
to observed or unobserved data. Data are MAR if the probability of missing data 
is unrelated to unobserved data, conditional on observed data. Lastly, MNAR 
occurs when the probability of missing data depends on unobserved data, even 
after taking observed data into account. Although MCAR can be ruled out from 
the observed data, it is not possible to distinguish between MAR and MNAR 
without knowing the missing values. Hence any analysis in the presence of 
missing data relies on untestable assumptions about the missing data mechanism. 
 
1.1. Multiple imputation 
 
Introduced by Rubin (3, 4), multiple imputation (MI) is a flexible and increasingly 
popular statistical approach for handling missing data. The method involves two 
distinct stages. In the first stage, each missing value is replaced by multiple draws 
( > 1) from the posterior predictive distribution of the missing data conditional 
on the observed data, resulting in  complete datasets. In the second stage, the  
complete datasets are analysed identically using standard complete-data 
techniques, with resulting estimates combined across datasets using rules that 
account for the uncertainty due to missing data. Standard implementations of MI 
assume that data are MAR, although the method can also be applied under an 
assumption that data are MNAR. Provided the assumption about the missing data 
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mechanism is satisfied and models used for imputation and analysis are correctly 
specified, MI produces consistent and asymptotically efficient parameter 
estimates (4).  
 
A key task in applying MI is the specification of an appropriate method for 
generating the imputed datasets. To avoid bias, the model for imputing missing 
values should include all variables involved in the intended analysis in the 
appropriate functional form, accommodating non-linear and interaction terms as 
required (5). It can also be beneficial to include auxiliary variables, which are 
variables not involved in analysis models but added to the imputation model to 
improve estimation. Candidate auxiliary variables are correlates of analysis model 
variables that have missing data, correlates of missingness in those variables, or 
both (6). As well as decisions around the inclusion of variables in the imputation 
model, a general method for implementing MI must be chosen; a variety of 
methods are now available, each with their own strengths and weaknesses. In the 
case of missing outcome data, a choice must also be made about whether to retain 
or delete observations with imputed outcomes from imputed datasets. In the 
complex settings in which MI is typically applied, there is often no consensus in 
the literature to inform these decisions. 
 
1.2. Multiple imputation and missing outcome data 
 
Many of the challenges in implementing MI vary according to the nature of the 
missing data problem. The focus of this thesis is on the practical use of MI to 
handle missing data in outcome variables for analysis, which may or may not be 
accompanied by missing data in exposure variables. Missing outcome data are a 
common problem, particularly in randomised trials and observational studies 
involving longitudinal follow-up of participants. Indeed, in a recent systematic 
review on the use of MI in high impact medical journals, 72% of articles that 
stated which variables were included in the imputation model reported imputing 




In settings where both outcome and exposure variables are subject to missing data 
and interest concerns the estimation of regression coefficients from a generalised 
linear model, a popular alternative to the standard implementation of MI is the 
“multiple imputation, then deletion” (MID) method, proposed by von Hippel (8). 
MID entails imputing missing outcome and exposure values in the conventional 
manner, but then deleting observations with imputed outcomes prior to analysis. 
Provided imputation and analysis models are equivalent and correctly specified, 
MID can offer efficiency advantages over standard MI under a MAR assumption, 
particularly when the number of imputations is small (8). Another argument for 
MID is that it can help to minimise the bias introduced by a misspecified model 
for imputing missing outcomes, although this claim is yet to be supported by 
empirical evidence. A potential limitation of MID is its inability to incorporate 
information from auxiliary variables for the outcome. For a small number of 
imputations, von Hippel showed that the correlation between a single auxiliary 
variable and an incomplete outcome had to be fairly strong for standard MI to 
demonstrate efficiency advantages over MID (8). Unfortunately von Hippel only 
considered the efficiency of estimates in his evaluation of MID, ignoring the use 
of auxiliary variables for bias reduction. Importantly, it was unclear from this 
research whether MID could introduce bias when auxiliary variables associated 
with missing data in the outcome are included in the imputation model. 
 
Another challenge arises when MI is applied in settings where the intended 
analysis has a functional form that is difficult to replicate in the imputation model. 
An important example of this problem is the use of MI for handling missing data 
in a binary outcome when the effect measure of interest is the relative risk. For 
missing data in both outcome and exposure variables, the two standard model-
based methods of MI are fully conditional specification (FCS) (5, 9, 10), also 
known as chained equations or regression switching, and multivariate normal 
imputation (MVNI) (11). FCS involves specifying a series of univariate 
imputation models, one for each variable with missing data, with incomplete 
binary variables typically imputed using logistic regression. MVNI on the other 
hand assumes that all variables in the imputation model follow a multivariate 
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normal distribution. For analysis, the standard approach to estimating the relative 
risk is to fit a generalised linear model with a binomial error distribution and a log 
link, known as the log binomial model. This model assumes a different functional 
form for the relationship between the outcome and exposure variables than that 
involved in imputing outcomes using logistic regression in FCS, or under a 
multivariate normal assumption in MVNI. It is unknown whether inconsistencies 
between imputation and analysis models in this setting could lead to biased or 
inefficient estimation. 
  
As well as challenges in implementing MI in general settings, this thesis considers 
the use of MI in randomised trials, where missing outcome data are often a major 
threat to the validity of group comparisons (12). Unlike observational studies, the 
key exposure in randomised trials (randomised group) is always observed and 
known to be independent of baseline covariates. In addition, missing data tend to 
be restricted to outcome variables in randomised trials, although baseline 
covariates may also be subject to missing data. Under these conditions, other 
methods for handling missing data may be preferable to MI. Should MI be 
adopted, an important consideration in handling missing outcome data is whether 
imputation should be carried out across all randomised participants or whether a 
separate but identical imputation model should be fitted to each randomised 
group. If subgroup analyses are of interest, interaction terms involving 
randomised group should be accounted for during the imputation process to avoid 
biasing interaction tests towards the null (5). In this case, performing imputation 
separately by randomised group can be appealing since it avoids the need to 
specify interaction terms in the imputation model (13-15). Often, though, 
subgroup analyses are not of interest, and it is unclear whether there is any merit 
in undertaking imputation separately by randomised group in this setting. 
 
After the protocol defined completion of a randomised trial, investigators may 
choose to initiate an extended follow-up period to study longer-term impacts of 
the intervention (16). This type of study design is referred to as an “extended 
follow-up study” throughout this thesis. Missing outcome data can be a 
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considerable threat to the validity of group comparisons in this setting. As well as 
increased attrition over time, extended follow-up studies often involve additional 
eligibility restrictions and consent processes for inclusion in follow-up, which can 
further reduce participation rates. An important consideration in applying MI in 
extended follow-up studies is whether ineligible and non-consenting participants 
(where applicable) should be included in the imputation model. This decision 
could depend on the availability of auxiliary variables in the original trial to aid in 
the imputation of outcomes collected during extended follow-up, and the ability to 
satisfy an assumption about the missing data mechanism with the inclusion of 
ineligible and non-consenting participants in the analysis. The population for 
which the parameter of interest is defined (e.g. all randomised versus only those 
satisfying additional eligibility criteria) should also be taken into account when 
implementing MI in extended follow-up studies. Unfortunately discussion of these 
issues is lacking in the current literature and it is unclear how missing data are 
being handled in practice in this context. 
 
1.3. Thesis aim 
 
The overarching aim of this thesis is to address knowledge gaps in the practical 
application of MI for handling missing outcome data. Specific aims are to: 
 
1. Contrast the performance of standard MI and MID when auxiliary variables 
associated with the incomplete outcome are included in the imputation 
model. 
2. Evaluate the use of standard model-based methods of MI for handling 
missing outcome data when the analysis involves the estimation of relative 
risks. 
3. Compare MI with alternative methods for handling missing data in 
randomised trials and explore the merits of imputing separately by 
randomised group in this context. 
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4. Summarise the extent and sources of missing outcome data in extended 
follow-up studies and provide guidance on the implementation of MI in this 
setting. 
 
1.4. Thesis outline 
 
The remainder of this thesis is structured as follows. Chapter 2 provides 
background material on missing data and MI in order to introduce key concepts 
and terminology that will be used throughout the thesis. In Chapter 3, literature on 
the practical use of MI for handling missing outcome data is reviewed to identify 
knowledge gaps and motivate the four specific aims of the thesis, as described 
above. A general description of the methods used to address the thesis aims is also 
provided in this chapter. The four thesis aims are then addressed in sequence 
through Chapters 4 to 7, with publications arising from the research included in 
each chapter. Lastly, a general discussion of results, limitations, suggestions for 







2. Missing data and multiple imputation 
 
In this chapter, introductory material on missing data and the MI method is 
presented in order to introduce concepts and terminology that will be used 
throughout the thesis. Section 2.1 provides a background to missing data,   
focusing on key concepts such as the missing data mechanism and the pattern of 
missing data. The MI procedure and its underlying assumptions are then described 
in Section 2.2. 
 
2.1. Missing data 
 
Missing data are defined as values that, for one reason or another, are not 
available, but would have been meaningful for analysis had they been observed 
(1). Despite the best efforts of researchers to collect complete data, missing data 
remain a common problem in medical research. In randomised trials, missing data 
can arise from participants withdrawing from the study, perhaps due to worsening 
of their disease, an adverse reaction to study procedures, or relocating to a new 
area. In longitudinal settings, participants may be lost to follow-up during the 
course of the study, preventing the collection of data at subsequent assessments. 
Individual measures could also be missing, possibly because measuring 
equipment was unavailable or not working correctly, a question was missed, or 
the participant skipped or refused a subtest. These are of course just a few of 
many reasons why missing data arise.  
 
The major concern with missing data is the threat it poses to the validity of study 
findings. In most statistical packages, the default approach for handling missing 
data is to restrict the analysis to participants with complete data on all variables in 
the analysis model, which is known as a complete case analysis. There are two 
major statistical drawbacks with this approach. First, discarding information from 
partially observed cases can lead to a loss of precision in comparison to methods 
that can incorporate this information. Second, a complete case analysis can 
introduce bias if participants with complete data systematically differ from those 
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with incomplete data (14). Statistical drawbacks aside, discarding information 
from partially observed cases is wasteful of the resources devoted to collecting 
that information in the first instance (17, 18). 
 
Given the problems associated with a complete case analysis, a broad range of 
statistical approaches have been developed to more adequately handle missing 
data. These approaches aim to provide valid inference in the presence of missing 
data, that is, to produce consistent estimates with standard errors and confidence 
intervals that appropriately account for sampling variability and uncertainty due to 
missing data (1). The validity of any statistical approach for handling missing data 
depends primarily on the process that led to the data being missing, referred to as 
the missing data mechanism, and the resulting pattern of missing data. These two 
important characteristics for describing missing data are introduced in the 
following sections. 
 
2.1.1. Missing data mechanisms 
 
Broadly, the missing data mechanism describes the process by which data become 
missing. Suppose in a study involving  participants that data are intended to be 
collected on  different variables, all of which will feature in the substantive 
analysis model. Let = ( , … , ) be a matrix comprising of the complete data 
(i.e. what would be observed in the absence of missing data). Note that some of 
the  variables could be outcome variables and others exposure variables, 
although no distinction is made between variable types at this stage. If some 
observations are missing,  can be partitioned into observed and missing 
components, denoted by  and , respectively. Finally, let  represent a 
matrix of missing data indicators for , with = 1 if  is missing and 0 
otherwise (for participant = 1	to	 , and variable	 = 1	to	 ). The missing data 
mechanism is formally defined as the conditional probability distribution of the 
missing data indicators given the data that were intended to be collected, i.e. 
( | ). Alternatively, to emphasise that this distribution can depend on both 
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observed and missing values of , the missing data mechanism can also be 
expressed as ( | , ).  
 
Following the framework introduced by Rubin (2), missing data mechanisms can 
be classified into three broad categories, as described below. 
 
1. Missing completely at random (MCAR). The missing data mechanism is 
MCAR, or equivalently data are said to be MCAR, if the probability of 
missing data is unrelated to observed or unobserved data, i.e. ( | ) = 
( ). Under this mechanism, participants with complete data are 
representative of those with incomplete data, and so a complete case 
analysis will result in unbiased estimates. Assuming that data are MCAR is 
a strong assumption to make, however, and one that rarely holds in practice 
(1, 6, 19). 
 
2. Missing at random (MAR). The missing data mechanism is MAR if the 
probability of missing data is unrelated to unobserved data, conditional on 
observed data, i.e. ( | ) = ( | ). MAR is a considerably less 
restrictive and more realistic mechanism than MCAR. Should an analysis 
approach be valid under an assumption that data are MAR, it will also 
produce valid inference when data are MCAR.  
 
3. Missing not at random (MNAR). The missing data mechanism is MNAR if 
the probability of missing data depends on unobserved data, even after 
taking observed data into account. Unlike MCAR and MAR, the missing 
data mechanism ( | ) needs to be explicitly incorporated into the 
analysis to ensure valid inference when data are MNAR.  
 
It is important to note that the missing data mechanism relates to both the data 
collected and the analysis undertaken. To illustrate, suppose that the probability of 
missing data in  is unrelated to unobserved data, conditional on observed data in 
. Thus data in  would be considered to be MAR in an analysis incorporating 
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all observed data on  and . However, should  be omitted from the analysis, 
data in  would instead be MNAR. 
 
Provided missing data are unplanned rather than by design, as is assumed 
throughout this thesis, any analysis in the presence of missing data relies on 
untestable assumptions about the missing data mechanism. Although MCAR can 
be ruled out using observed data, for example by identifying predictors of missing 
data using logistic regression, it is not possible to distinguish between MAR and 
MNAR without knowing the values of the missing data. As a result, researchers 
are strongly encouraged to undertake sensitivity analyses to assess the robustness 
of findings to the assumption made about the missing data mechanism in the main 
analysis (1, 13, 17, 19-21). 
 
2.1.2. Missing data patterns 
 
The missing data pattern describes which values in the data are observed and 
which are missing, as defined by the matrix of missing data indicators . Within 
the missing data literature, a distinction is often made between univariate, 
monotone and arbitrary patterns of missing data (14, 22). Data are said to be 
missing in a univariate pattern when missing data are confined to a single 
variable. A monotone pattern of missing data occurs when the  variables 
intended for collection can be ordered in such a way that, when  is missing for a 
participant, then ( , … , ) are also missing. The monotone pattern tends to 
arise in longitudinal settings, where drop-out at a given time-point entails missing 
data on variables collected at subsequent assessments. Lastly, if data are missing 
in more than one variable, and these variables cannot be ordered to produce a 
monotone pattern, then they are said to be missing in an arbitrary pattern. 
 
The missing data pattern is important to consider for two reasons. First, it 
determines which statistical approaches may be used, as some approaches for 
handling missing data are only applicable to certain missing data patterns. Second, 
the validity of some statistical approaches can depend both on the broad type of 
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missing data mechanism (i.e. MCAR, MAR, or MNAR) and the missing data 
pattern. For example, a complete case analysis can lead to bias and a loss of 
precision when data are MAR in an arbitrary pattern. However, when data are 
MAR in a univariate pattern in the outcome variable for analysis, a complete case 
analysis is both unbiased and fully efficient (18, 23, 24). 
 
2.1.3. Statistical approaches to handling missing data 
 
A range of alternative statistical approaches to complete case analysis have been 
developed to handle missing data, including single imputation methods, inverse 
probability weighting, likelihood-based methods, and MI. A very brief overview 
of these approaches is provided below (with the exception of MI, which is 
covered in Section 2.2). 
 
Single imputation methods describe any procedure in which missing values are 
replaced with a single imputed value. Widely used methods include mean 
imputation, hot deck imputation, and the baseline or last observation carried 
forward for longitudinal data. Although single imputation methods are easy to 
understand and allow end users to proceed with the analysis as if all data were 
observed, their validity often depends on unrealistic assumptions about the 
missing data mechanism. For example, the last observation carried forward can 
introduce bias when outcome values change following the last observed 
measurement (13). Another concern with single imputation methods is that 
analyses are often conducted as if all data were observed (i.e. by employing 
variance estimators that are only appropriate for complete data), which can lead to 
overstated precision (13, 25).  
 
Inverse probability weighting (IPW) is a modification of complete case analysis 
whereby complete cases are weighted in the analysis according to the inverse of 
the probability of being a complete case. Similar to the use of probability weights 
in the survey sample setting, the basic idea of IPW is to reweight complete 
observations so that they are representative of the entire sample. Provided the 
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model for assigning probability weights is correctly specified, IPW produces valid 
inference when data are MAR (26). However, in its standard implementation, 
IPW can be inefficient, as it discards information from partially observed cases. In 
addition, the method is difficult to apply to arbitrary missing data patterns (26).  
 
Another option for valid inference under a MAR assumption is to use an 
estimation procedure based on the likelihood function of the observed data, for 
example maximum likelihood estimation or Bayesian posterior inference. Rubin 
(2) showed that the missing data mechanism ( | ) drops out of the likelihood 
function, and hence can be ignored during estimation, provided that data are MAR 
(see (2) for technical details). Although this simplifies the estimation a great deal, 
the likelihood function may remain complex in the presence of incomplete 
observations (6), and so special computational techniques are often required (e.g. 
the expectation-maximisation algorithm for maximum likelihood estimation). As 
well as providing valid inference under a MAR assumption, likelihood-based 
methods are highly efficient (6). Despite their attractive statistical properties, 
likelihood-based methods can be difficult to implement in standard statistical 
software packages, particularly when incorporating information from auxiliary 
variables. Hence they are not as widely used as other approaches to handling 
missing data, most notably MI. 
 
2.2. Multiple imputation 
 
First introduced in the survey sample setting in 1978 (3), MI now has a very large 
bibliography in the medical research literature, including numerous review papers 
and texts (e.g. (4, 11, 27-29)). The popular approach involves two distinct stages. 
In the first stage, each missing value is replaced by > 1 values drawn from an 
imputation model, a process which results in the generation of  complete 
datasets. The rationale for using > 1 imputations is to propagate missing data 
uncertainty, a key shortcoming of single imputation methods (without appropriate 
variance correction). In the second stage of MI, the analysis of interest is 
conducted on each complete dataset, with results appropriately combined across 
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datasets to give a single MI estimate. Standard implementations of MI provide 
valid inference when data are MAR, although the approach can also be applied 
under MNAR mechanisms (4). 
 
MI has many appealing features. Arguably the most important is the considerable 
flexibility of the method. As well as its ability to be validly implemented under 
both MAR and MNAR mechanisms for any pattern of missing data, MI enables 
end users to employ virtually any statistical technique appropriate for complete 
data, which makes it widely applicable. Another appealing feature of MI is its 
ability to incorporate information from auxiliary variables, which in the context of 
MI are defined as variables not involved in analysis models but added to the 
imputation model to improve estimation of the missing values. In practice, 
auxiliary variables can lead to noticeable gains in terms of bias reduction and 
increased efficiency (6). Finally, MI procedures are now widely available in most 
major statistical packages, including SAS, Stata and R. 
 
2.2.1. The imputation model 
 
The validity of MI depends primarily on how the imputed values are generated. 
Very broadly, an imputation method should, on average, provide reasonable 
predictions for the missing data and reflect all relevant sources of uncertainty. An 
imputation method that satisfies these conditions and leads to valid inference is 
said to be “proper” (see (4) for technical details). In practice, proper imputations 
tend to be created using Bayesian arguments. Under a MAR assumption, this 
entails drawing imputed values from the posterior predictive distribution of the 
missing data given the observed data. Let ( | ) denote a parametric model for 
the complete data with population parameters , and ( ) a prior distribution for 
 (typically a non-informative prior is specified). Independently for = 1	to	 , 
Bayesian proper MI proceeds by first drawing ( )	from its posterior distribution 
( | ) (where ( | ) ∝ ( )∫ ( , | ) , see (29)), then 
drawing imputed values for ( )  from its posterior predictive distribution 
( | , ( )). As well as reflecting uncertainty in the imputed values due to 
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prediction error, this process also importantly acknowledges the uncertainty in the 
estimated model parameters. 
 
To ensure valid inference, the method for generating imputed values should also 
preserve associations among variables that will be the subject of subsequent 
analyses. In particular, the imputation model should be “compatible” with the 
analysis model, where compatibility is defined in statistical terms as the existence 
of a joint model that contains both the imputation and analysis models as 
conditionals (30, 31). Effectively this means that the imputation model should 
include all variables in the intended analysis in the appropriate functional form, 
accommodating non-linear and interaction terms as required (5, 11, 30). To 
illustrate the problem of incompatibility, consider an analysis involving the simple 
linear regression of an incomplete exposure on a complete outcome. Failing to 
include the outcome in the imputation model would result in imputed values in the 
exposure bearing no relationship with the outcome, which in the subsequent 
analysis would lead to the regression coefficient being biased towards the null 
(excepting the case where there truly was no association between variables). 
Although compatibility is simple to achieve in some settings (as in the example 
above with the inclusion of the outcome in the imputation model), in others it can 
be quite complex, for example in analyses involving interaction or quadratic terms 
for incomplete exposures (5, 30, 32, 33), survival outcomes (30, 34), or fractional 
polynomials (35). 
 
While the imputation model should include all variables in the intended analysis 
model, it should be noted that the converse is not required (36). As previously 
described, one of the appealing features of MI is the ability to include auxiliary 
variables in the imputation model to assist with the prediction of missing values. 
In this case incompatibility can be beneficial for estimation, both in terms of bias 
reduction and increased efficiency. Hence a general strategy when specifying an 
imputation model is that it should be at least as complex as the intended analysis 




2.2.2. Multiple imputation inference and Rubin’s rules 
 
Having multiply imputed the missing values from an appropriate imputation 
model, the analysis is then conducted on each of the  complete datasets. Let  
denote the population parameter of interest,  the estimate of  from the th 
complete dataset and  the corresponding variance estimate for . Note that 
parameter and variance estimates will differ across the  complete datasets due to 
differences in imputed values. Using Rubin's rules (4), the combined MI estimate 
 is calculated as the mean of the m estimates, i.e. = 1⁄ ∑ . The 
estimated variance is given by var = + (1 + 1⁄ ), where =
	1⁄ ∑  is the average within-imputation variance and = ( −
1) ∑ ( − )  the between imputation variance. Assuming  is a scalar 
quantity, for example a regression coefficient, Wald-type significance tests and 
confidence intervals can be obtained using a t-distribution with = ( −
1)[1 + (1 + )⁄ ]  degrees of freedom. Wald-tests can also be extended to 
handle multivariate  (11). Provided imputation and analysis models are correctly 
specified, estimates derived using Rubin’s rules are both consistent and 
asymptotically efficient (4). 
 
As outlined in White et al. (5), Rubin’s rules can be used to combine any statistic 
that is an estimator of a population parameter, although in some cases a 
transformation may be required to ensure the statistic is approximately normally 
distributed (e.g. for an odds ratio or a standard deviation). In contrast, statistics 
that are not estimators of a population parameter, for example p-values, cannot be 
combined using Rubin’s rules.  
 
2.2.3. Methods for conducting multiple imputation 
 
Following a decision to use MI, a method of imputation needs to be chosen. When 
data are missing in a single variable, a univariate imputation model can be applied 
with the model tailored to the variable being imputed, for example linear 
regression for a continuous variable or logistic regression for a binary variable. If 
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data are missing in a monotone pattern, imputations can be generated using a 
sequence of univariate imputation models, starting from the variable with the least 
missing data and proceeding through to the variable with the most missing data, 
conditioning at each stage on variables imputed earlier in the sequence (4). Again, 
the univariate imputation models can be tailored to the variables being imputed. 
When data are missing in an arbitrary pattern, as is typically the case in practice, 
variables need to be imputed simultaneously using iterative methods. The two 




Joint modelling involves specifying a parametric joint model for . Available 
joint models include the multivariate normal model for continuous variables, the 
log-linear model for categorical variables and the general location model for a 
mixture of continuous and categorical variables. Due to the limited applicability 
of alternative joint models, the multivariate normal model is indisputably the most 
popular joint model in practice, with the MVNI procedure now available in most 
major statistical packages. First implemented by Schafer (11), MVNI uses a 
Markov chain Monte Carlo algorithm (known as data augmentation) for 
imputation. Initially, missing values are imputed based on assumed starting 
parameter values for the multivariate normal distribution. These are typically 
obtained from available data using the expectation-maximisation algorithm. Next, 
updated parameter values for the multivariate normal distribution are drawn from 
their posterior distribution based on the observed and imputed data. This iterative 
process of imputing missing values and drawing updated parameter values 
continues until these values converge to a stationary distribution (11, 36). 
Following these “burn-in” iterations, a set of imputed values is taken. In order to 
reduce dependence between imputations, additional iterations are performed 
before the next set of imputed values is obtained. 
 
Due to the strong theoretical underpinnings of joint modelling and the ease of 
specifying imputation models, MVNI is an appealing method when multivariate 
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normality is reasonable. Clearly such an assumption is not always realistic, 
particularly when the imputation model contains skewed or binary variables. For 
skewed data, several authors have recommended transforming variables to better 
approximate normality prior to implementing MVNI (14, 17, 36). In contrast, 
others have found that transformations have little effect on estimation (37) or can 
even increase bias (38). Recent evidence suggests that the linearity of 
relationships between variables, rather than the skewness of marginal 
distributions, is the more important factor to consider before applying a 
transformation (39). In the case of binary variables, continuous imputed values 
obtained through MVNI often need to be classified into categories so that 
statistical methods appropriate for binary data can be applied (e.g. logistic 
regression for a binary outcome). Bernaards et al. (40) investigated several 
classification methods for binary variables and found that MVNI performed well 
in most settings, particularly when an adaptive rounding threshold1 was used to 
classify imputed values. Several other authors have also reported good 
performance with MVNI for binary variables (11, 37, 41). Despite these and other 
promising findings, it remains difficult to make global statements about the 
robustness of MVNI to violations of multivariate normality, whether in the 
specific cases of skewed and binary variables or more generally. 
 
Fully conditional specification 
 
Rather than defining a full joint model for the data, FCS involves specifying a 
series of univariate models, one for each variable with missing data (5, 9, 10). The 
most appealing feature of FCS is the ability to tailor univariate models according 
to the distribution of the variable being imputed. For example, linear regression 
can be used to impute continuous variables, logistic regression to impute binary 
variables, and Poisson regression to impute count variables. Other appealing 
features of FCS include its ability to handle skip questions and, where appropriate, 
                                               
1 The adaptive rounding threshold is based on a normal approximation to the binomial distribution. 
Letting 	denote the mean of a binary (0/1) variable in the th complete dataset and -1 the 
quantile function of the normal distribution, the threshold is given by  −-1( ) (1− ).  
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impose bounds on imputed values by drawing them from truncated predictive 
distributions (9). It is also easy to accommodate non-linear and interaction terms 
within the univariate imputation models. 
 
For each variable with missing data, the FCS algorithm begins by replacing 
missing values with “place holder” values (42), often by way of mean imputation 
or simple random sampling from the observed data. The first variable with 
missing data,  say, is then regressed on other variables according to its specified 
univariate model, restricted to participants with observed values of  and using 
place holder values for other variables. Missing values in  are then replaced by 
simulated draws from their posterior predictive distribution (allowing for 
uncertainty in model parameters). The process is then repeated for the next 
variable with missing data, for example , but this time incorporating imputed 
rather than place holder values for  into the estimation. This process continues 
until all incomplete variables have been imputed, which signals the completion of 
a “cycle”. Further cycles are then performed using the most recent imputed values 
in order to stabilise the distribution of parameters governing the imputations, after 
which a single imputed dataset is generated. Additional imputed datasets are 
obtained by independently repeating this process. 
 
Despite being extremely flexible, FCS is not without limitations. One concern 
with the approach is the possibility of specifying univariate models where the 
conditional distributions implied do not correspond to a valid joint distribution. A 
potential consequence is that results could vary according to the ordering of 
regression models within the FCS procedure, which is clearly undesirable. 
Fortunately this issue seems to have little impact on results in practice (9, 10, 41, 
43). Another drawback of FCS is the modelling effort required to generate 
imputed datasets. Since regression models need to be specified for each 
incomplete variable in the imputation model, FCS can become quite time 
consuming, particularly in datasets containing a large number of variables (41). 
Finally, like MVNI, FCS can produce biased results when assumptions of the 
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imputation model are incorrect, for example when skewed variables are imputed 





3. Multiple imputation of missing outcomes and 
thesis aims 
 
Many of the practical challenges in applying MI vary according to the nature of 
the missing data problem. Having provided a general outline of the MI procedure 
in Chapter 2, the thesis now turns to specific challenges in applying MI when 
handling missing outcome data. In this chapter, literature on the practical use of 
MI for handling missing outcome data is reviewed to identify knowledge gaps and 
motivate the four specific aims of the thesis. A brief overview of the methods to 
be used to address the thesis aims is also provided. 
 
3.1. Multiple imputation, then deletion  
 
When missing data are evident in exposure as well as outcome variables, it is well 
known that the outcome should be included in the imputation model to avoid 
biasing associations towards the null (11, 14, 44). Whether imputed outcome 
values should be retained in subsequent analyses is less clear. In an influential 
article, von Hippel (8) proposed a modification to the standard implementation of 
MI that involved deleting imputed outcomes prior to analysis, an approach he 
termed “multiple imputation, then deletion” (MID). Suppose data are collected on 
an outcome variable  and exposure variables = ( , … , ); note the change 
in notation from previous sections in order to now distinguish between outcomes 
and exposures. MID involves generating imputed values in the usual manner, that 
is, by including both  and  in the imputation model, then discarding 
observations where  has been imputed prior to analysis. The resulting modified 
datasets are then analysed as intended, with parameter estimates and standard 
errors combined across datasets using Rubin’s rules.  
 
von Hippel advocated MID primarily on the grounds of efficiency. Provided that 
the imputation and analysis models are compatible and correctly specified, and 
assuming data are MAR, MID produces unbiased estimates of regression 
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coefficients with a greater precision than that of MI (8) (albeit efficiency gains 
tend to be minor unless the number of imputations is small). von Hippel also 
argued that MID can help to minimise the bias introduced by a misspecified 
model for imputing the missing outcomes, as problematic imputed values are 
removed from the analysis (8). Unfortunately this claimed advantage has not yet 
been supported by empirical evidence. 
 
The rationale for MID is that, following imputation, observations with missing 
outcomes only add noise to the estimation procedure (8, 18). Although this 
assertion is valid when imputation and analysis models are compatible and 
correctly specified, it does not hold when the imputation model contains auxiliary 
variables for improving the prediction of missing outcome values. Importantly, 
while both MI and MID benefit equally from the inclusion of auxiliary variables 
for predicting missing values in , only MI benefits from auxiliary variables for 
predicting missing values in  (8). The additional information provided by 
auxiliary variables for  may need to be fairly substantial, however, for MI to 
demonstrate efficiency advantages over MID. Using a simulation study, von 
Hippel found that MID was more efficient than MI, provided the correlation 
between a single completely observed auxiliary variable and an incomplete 
outcome did not exceed 0.7, 0.6, and 0.5 for 2, 5, and 10 imputations, respectively 
(8). Based on these results, and noting that auxiliary variables may be less useful 
in practice when they too are subject to missing data, von Hippel concluded that 
MID will typically be a superior strategy relative to MI. 
 
There are two major limitations with von Hippel’s investigation of MID and 
auxiliary variables. First, it is unclear whether MID would maintain similar 
efficiency advantages over MI with a larger number of imputations. Although 
early texts on MI suggest that 10 or fewer imputations are often adequate (11, 25, 
36), more recent texts recommend performing many more (5, 45), and it is not 
uncommon for 50 or more imputations to be used in practice (7). Second, von 
Hippel only considered the use of auxiliary variables for efficiency gains, ignoring 
settings where they might be used instead for reducing bias. In developing high 
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quality imputations, numerous experts have recommended incorporating auxiliary 
variables that are associated with the incomplete variables to be imputed, the 
probability of missing data, or both (5, 6, 11, 46, 47). It is the inclusion of 
auxiliary variables related to the probability of missing data that is important for 
satisfying a MAR assumption and hence for minimising bias; such auxiliary 
variables were not considered in von Hippel’s research. Consequently, it remains 
unclear whether MID could introduce bias not seen with a conventional MI 
approach when auxiliary variables associated with missing data in  are included 
in the imputation model. 
 
The extent to which auxiliary variables in MI can minimise bias has been studied 
extensively. In a landmark study, Collins et al. (6) demonstrated via simulation 
that failure to incorporate information from an auxiliary variable correlated with 
an incomplete variable and with missingness in that variable led to biased 
estimates of regression coefficients following MI. Conversely, adding several 
“junk” auxiliary variables to the imputation model (that were unrelated to the 
incomplete variable) did not adversely impact estimation. Based on these results, 
Collins et al. recommended researchers adopt inclusive strategies when selecting 
auxiliary variables for imputation models. Extending this work, Graham (48) 
observed that the magnitude of bias introduced by omitting an auxiliary variable 
for an incomplete variable depended on a number of factors: the proportion of 
missing data in the incomplete variable, the proportion of missing data in the 
auxiliary variable, the strength of the association between the auxiliary variable 
and the incomplete variable, and the strength of the association between the 
auxiliary variable and missingness in the incomplete variable. As a simple rule of 
thumb, Graham suggested that overlooking an auxiliary variable would lead to 
practically meaningful bias if its correlation with the incomplete variable and with 
missingness in the incomplete variable both exceeded 0.40. Similar results have 
been observed in other studies, with the effects of auxiliary variables ranging from 
little impact on inference (37, 49) through to noticeable reductions in bias and/or 
gains in efficiency (50-53). Of course, one should take care not to incorporate too 
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many auxiliary variables, as an overfit imputation model can result in unstable 
and biased estimates (50, 51). 
 
Assuming a sensible imputation model, the literature indicates that auxiliary 
variables in MI at worst do little harm, and at best can be greatly beneficial for 
estimation. Consequently, a more thorough assessment of the relative merits of 
MID in settings where auxiliary variables for an incomplete outcome are available 
is of practical importance. 
 
Thesis aim 1 
 
The first aim of this thesis is to contrast the performance of MI and MID in 
settings where missing data are evident in both outcome and exposure variables, 
and where auxiliary variables associated with the outcome are included in the 
imputation model. Two types of auxiliary variables will be considered: those 
associated just with the outcome, and those associated with both the outcome and 
missingness in the outcome. The impact of using a large number of imputations 
on the comparison between MI and MID will also be explored. Thesis aim 1 is 
addressed in Chapter 4. 
 
3.2. Multiple imputation for estimating the relative risk 
 
As described previously, the imputation model should include all variables to be 
included in the intended analysis in the functional form required for analysis. 
Although considerable research has focused on the correct specification of 
imputation models when handling missing data restricted to exposure variables, 
for example in analyses involving interaction or quadratic terms for incomplete 
exposures (5, 30, 32, 33), less attention has been paid to challenges associated 
with imputing missing outcome data. A somewhat neglected problem is the use of 
MI for handling missing outcome data when the analysis involves a generalised 
linear model with a non-canonical link function. In this case, it may be difficult to 
replicate the functional form of the analysis model using standard model-based 
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methods of MI, particularly when exposure variables are also subject to missing 
data. An important example of this problem, and the focus of Chapter 5 of this 
thesis, is the use of MI for handling missing data in a binary outcome when 
estimating the relative risk. 
 
The relative risk is a summary measure of effect for binary outcome data that is 
often of interest in medical research (54-57). Formally, the relative risk describes 
the probability (or risk) of experiencing an outcome of interest in one group 
relative to the probability in another. Letting  and  denote outcome 
probabilities in two groups for comparison, the relative risk is given by / . 
Unlike the standard metric for binary outcome data, the odds ratio, defined as 
[ /(1− )] [ /(1− )]⁄ , the relative risk is simple to interpret and has the 
attractive statistical property of being collapsible across covariate strata (58). 
Another appealing feature of the relative risk is that, for clustered and longitudinal 
data, marginal (population-averaged) and conditional (subject-specific) parameter 
values are identical (59). 
 
The main drawback of the relative risk is that it can be difficult to estimate. The 
standard approach to estimating the relative risk is to fit a generalised linear 
model with a binomial error distribution and a log link, known as the log binomial 
model (60, 61). Since the log link allows predicted probabilities greater than one, 
convergence problems with this model are not uncommon, particularly for models 
containing continuous covariates or outcomes with high prevalence (60, 61). To 
address failed convergence with the log binomial model, several alternative 
approaches to relative risk estimation have been proposed, including modified 
Poisson regression using a log link and a robust error variance (62), and Cox 
regression with constant time at risk (63). For rare outcomes, where the odds ratio 
approximates the relative risk, another possibility is to estimate relative risks from 
logistic regression models (i.e. by treating the odds ratio as a relative risk). In 
cases where the log binomial model is deemed inappropriate due to apparent 
model misspecification, relative risks can also be estimated by applying marginal 
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or conditional standardisation to predicted probabilities obtained using logistic 
regression (64). 
 
Despite the popularity of the relative risk and the widespread use of MI for 
handling missing data, there has been little research on the application of MI when 
estimating the relative risk. The primary challenge in this setting is replicating the 
functional form of an appropriately specified log binomial model (or equivalent, 
in the event of failed convergence with this model) within the imputation model. 
Suppose data are missing in an arbitrary pattern in outcome and exposure 
variables. Here the use of MI would typically entail a choice between MVNI and 
FCS. As described in Section 2.2.3, MVNI assumes that all variables in the 
imputation model follow a multivariate normal distribution, which for a binary 
outcome variable implies a linear relationship between the risk and other variables 
in the imputation model. Following imputation, continuous imputed values in the 
outcome need to be classified back into categories to facilitate analysis via a log 
binomial model. For FCS, standard software uses logistic regression to impute 
binary variables, which for a binary outcome assumes a linear relationship 
between the log odds of the risk and other variables in the imputation model. 
Clearly, both MVNI and FCS employ different assumptions than the intended 
analysis, where the log of the risk is assumed to be linearly related to exposure 
variables. It is unclear whether these differences could lead to biased or inefficient 
estimation. 
 
von Hippel’s MID approach could also be beneficial for relative risk estimation. 
Potential limitations with auxiliary variables aside, a promising feature of MID is 
that it may help to minimise bias introduced by a misspecified model for imputing 
missing outcomes (8). Should the imputation of incomplete binary outcomes 
using FCS or MVNI lead to biased estimation of the relative risk, this claimed 
strength of MID could lessen the bias. Unfortunately, little is known about the 
performance of MID when imputation and analysis models are incompatible, as in 




Thesis aim 2 
 
The second aim of this thesis is to evaluate the performance of FCS and MVNI 
for handling missing outcome data when estimating the relative risk. Should these 
methods lead to biased estimates of the relative risk, a further aim is to investigate 
the relative merits of MID in this setting. Thesis aim 2 is addressed in Chapter 5. 
 
3.3. Multiple imputation in randomised trials 
 
The randomised controlled trial (RCT) is widely regarded as the gold standard 
design for assessing the effectiveness of health interventions. Randomisation 
eliminates differential selection bias by approximately balancing prognostic 
factors between groups, which means that a direct causal link between 
intervention and health outcome may be established (19). Of course, as with other 
study designs, the validity of causal conclusions from RCTs can be severely 
affected by missing outcome data.  
 
Given the influence of evidence from RCTs on decisions concerning health policy 
and clinical practice, the topic of missing outcome data in RCTs has received 
considerable attention in the medical literature. Documents of considerable 
importance to biostatisticians include the International Conference on 
Harmonization (ICH) E9 guideline (65) and the National Research Council report 
on the prevention and treatment of missing data in clinical trials (1). Key 
recommendations in these and other guidance documents for RCTs include the 
need to pre-specify statistical methods for handling missing data, to state and 
justify the missing data mechanism assumed in the primary analysis, and to assess 
the robustness of findings to assumptions about the missing data mechanism in 
sensitivity analyses. Researchers should also detail the population parameter of 
interest, otherwise known as the estimand, by carefully defining both the outcome 





This thesis focuses on the performance of MI for estimating treatment effects 
according to the intention to treat (ITT) principle, or equivalently, estimating the 
ITT estimand. For a given outcome, the ITT estimand is defined as the average 
effect of randomisation, irrespective of treatment received, over all randomised 
individuals (68). The objective of ITT is to maintain the balance in prognostic 
factors achieved by randomisation, which is essential for avoiding selection bias 
and establishing causation (69, 70). Analysis under the ITT principle is generally 
recommended as the preferred approach for evaluating the effectiveness of health 
interventions. According to the 2010 CONSORT statement, “to preserve fully the 
huge benefits of randomisation we should include all randomised participants in 
the analysis, all retained in the group to which they were allocated” (70). In a 
similar vein, the European Medicines Agency states that the ITT principle “is of 
critical importance as confirmatory clinical trials should estimate the effect of the 
experimental intervention in the population of patients with greatest external 
validity and not the effect in the unrealistic scenario where all patients receive 
treatment with full compliance to the treatment schedule and with a complete 
follow-up as per protocol” (71). 
 
In evaluating the utility of MI for an ITT analysis, it is important to first consider 
whether missing outcomes should be imputed under ITT. Although some 
researchers have argued that imputation is necessary in order to include all 
randomised participants in the analysis (70, 72, 73), others have argued that an 
ITT analysis need only provide a valid estimate of the ITT estimand (1, 20, 74); 
whether or not such an analysis involves the imputation of missing outcomes is 
inconsequential. Given recent commentary on the importance of defining and 
validly estimating the estimand of interest (1), and noting that current guidance 
documents for RCTs do not strictly recommend imputing missing outcomes, it 
seems the prevailing view is that an ITT analysis need only provide a valid 
estimate of the ITT estimand. This is important as it means that the utility of MI 
must be judged solely on its ability to estimate the ITT estimand. Equivalently, 
statistical approaches that do not involve imputation, for example likelihood-
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based methods, can be recommended over MI should they demonstrate superior 
statistical properties in estimating the ITT estimand. 
 
The considerable flexibility of MI makes it an attractive option for handling 
missing outcome data in an ITT analysis. It is not uncommon for trialists to 
collect data on a large number of outcome variables. One of the key strengths of 
MI is its ability to handle missing data on a range of different variable types (e.g. 
continuous, binary, count), whether for univariate or multivariate outcomes. An 
added benefit of including all outcomes in a single imputation model is that 
observed associations between related outcomes can aid imputation. Another 
strength of MI is the ease with which auxiliary variables can be added to the 
imputation model. In RCTs, potentially useful auxiliary variables include 
measures of treatment compliance, proxy measures of the outcome, and even 
measures of the intent of participants to attend further follow-up (75). Finally, the 
ability of MI to be implemented under an assumption that data are MNAR makes 
it well suited to undertaking sensitivity analyses around a primary assumption that 
data are MAR (76), and as a primary method of analysis in RCTs where data are 
believed to be MNAR. Given the substantial flexibility of MI, it is not surprising 
that numerous research articles and guidance documents have advocated for its 
use in RCTs (e.g. (1, 12, 13, 47, 71, 77)). 
 
Conversely, some authors have expressed a preference for the use of simpler 
likelihood-based approaches in RCTs (19, 24, 78). Since missing data are more 
likely to be restricted to the outcome in RCTs, specification of an appropriate 
likelihood-based method can be more straightforward than in other research 
settings. For missing data in a continuous multivariate outcome, likelihood-based 
estimation of a linear mixed model is a popular alternative to MI for estimating 
treatment effects under a MAR assumption (79). Although not widely known, 
auxiliary variables can also be incorporated into linear mixed models through 
joint modelling with the outcome (19, 80). For missing data restricted to a 
univariate outcome, the complete case likelihood is equivalent to the likelihood 
function of the observed data, and so a complete case analysis can be viewed as a 
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likelihood-based approach in this case (81). If data in the univariate outcome are 
MAR, the complete case analysis of this outcome is unbiased and fully efficient 
(18, 23, 24). Compared to MI, likelihood-based approaches offer a number of 
advantages: they are quicker to run, more efficient, involve fewer judgements 
during model-fitting, and yield a single unique estimate for a given dataset (19, 
82). In addition, the issue of incompatibility between imputation and analysis 
models is clearly not a concern for analysis with a likelihood-based approach (82). 
 
With the use of MI in RCTs rising dramatically in recent years (7), editors and 
journal reviewers are increasingly requesting to see MI used to handle missing 
data. For missing data restricted to a univariate outcome, there may be a 
reluctance to accept results from a complete case analysis given the shortcomings 
of this approach in general regression settings. Similarly, there is sometimes a 
perception that MI is the only valid option for incorporating information from 
auxiliary variables. However, whether it is reasonable for MI to be viewed as the 
gold standard approach for handling missing outcome data in RCTs is 
questionable. Importantly, results derived in general regression settings supporting 
the use of MI may not be applicable to RCTs, where missing data tend to occur 
primarily in the outcome and where the key exposure (randomised group) is 
always observed and expected to be independent of baseline covariates. With 
limited comparisons between MI and alternatives such as likelihood-based 
methods available in the literature, particularly in the estimation of treatment 
effects according to the ITT principle, a more rigorous investigation of the utility 
of MI in RCTs is needed. 
 
Another uncertainty around the use of MI in RCTs is whether imputation should 
be carried out across all randomised participants or whether a separate but 
identical imputation model should be fitted to each randomised group. If there is 
interest in estimating the effect of treatment within a subgroup, the ICH E9 
guideline recommends the inclusion of an interaction term between the subgroup 
variable and randomised group in the analysis model (65). To avoid biasing the 
interaction test towards the null due to incompatibility between imputation and 
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analysis models, the interaction term needs to be accounted for during the 
imputation process. Rather than specifying an interaction term within the 
imputation model, several authors have recommended fitting separate but 
identical imputation models to each randomised group (13-15). Assuming the 
sample size is large enough to fit separate imputation models, this strategy is 
appealing due to both its simplicity and its ability to facilitate subgroup analyses 
for any baseline covariate included in the imputation model. Often, though, 
subgroup analyses are not of interest, and it is unclear whether there is any merit 
in undertaking imputation separately by randomised group in such settings. Of 
particular interest is the implementation of MI in settings where interaction effects 
are overlooked in the analysis model in favour of producing an estimate of the 
average effect of treatment across subgroups. 
 
Thesis aim 3 
 
The third aim of this thesis is to evaluate the performance of MI for handling 
missing outcome data in the RCT setting and to explore the merits of imputing 
overall and separately by randomised group. For feasibility, the research will 
focus on scenarios that are commonly encountered in practice, in particular for 
handling missing data in a continuous or binary outcome variable measured once 
or repeatedly over time, and for analysis implemented under a MAR assumption. 
Thesis aim 3 is addressed in Chapter 6. 
 
3.4. Multiple imputation in extended follow-up studies 
 
Extended follow-up studies based on RCTs play an important role in assessing the 
longer term impacts of health interventions. Depending on the research setting, 
investigators may choose to initiate an extended follow-up period to learn more 
about disease progression, long term safety, the maintenance of early effects, or 
effects on longer-term, more clinically meaningful endpoints (16, 83, 84). A key 
benefit of initiating an extended follow-up study after the completion of an RCT 
is the cost saving associated with using an already established cohort. Given the 
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substantial investment involved in setting up a trial cohort and providing 
treatment, it is not surprising that many RCTs do eventually transition to extended 
follow-up studies (16). 
 
Missing outcome data can pose a considerable threat to the validity of findings 
from extended follow-up studies. Compared to standard RCTs, the longer duration 
of time between randomisation and final outcome assessment in extended follow-
up studies is likely to be associated with higher levels of participant attrition. In 
addition, investigators could choose to impose extra eligibility restrictions for 
inclusion into extended follow-up, for example by only recruiting participants that 
adhered to the protocol in the original RCT, further reducing participation rates. 
Depending on the information provided to participants in the original RCT, a 
separate consent form for entry into extended follow-up may also be required. 
Some participants may be unwilling to consent at this stage. Finally, participants 
may simply fail to provide information about a particular measure during 
extended follow-up. These varied sources of missing data (attrition over time, 
ineligibility, non-consent, and item non-response) could result in a large 
proportion of the original randomised cohort having missing outcome data. 
 
An important consideration in applying MI in extended follow-up studies is 
whether ineligible and non-consenting participants (where applicable) should be 
included in the imputation model. Incorporating the full randomised cohort in the 
analysis preserves the benefits of randomisation, but this is likely to mean a large 
amount of missing data to account for and a possible mixture of missing data 
mechanisms at play, since reasons for missing data could differ between ineligible 
participants, non-consenters, and consenters. Conversely, satisfying an 
assumption about the missing data mechanism might be more feasible if the 
imputation model only included consenting participants, but then the benefits of 
randomisation would be diminished. In choosing a participant group to 
incorporate in the imputation model, important factors to consider might include 
the target population for the chosen estimand (e.g. all randomised for an ITT 
analysis) and the availability of auxiliary variables in the original RCT to aid with 
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the imputation of outcomes collected during extended follow-up. Whether other 
factors might also influence the choice of MI approach is hard to judge as there 
have been no published reports outlining the full scope of the missing data 
problem in this setting. 
 
An informal review of published extended follow-up studies shows differences 
between researchers in how MI is being implemented in this setting. Two studies 
identified in a preliminary search of PubMed (conducted in September 2014) 
failed to indicate whether eligibility restrictions or separate consent processes 
were used (85, 86), making it difficult to understand the reasons for missing data 
during extended follow-up. Among studies that detailed both eligibility 
restrictions and separate consent processes for entry into extended follow-up, MI 
approaches included imputation for consenting participants in a primary analysis 
(87), imputation for all randomised participants in a sensitivity analysis (88), and 
imputation in a sensitivity analysis without any indication of the group for which 
results were imputed (89). In the absence of guidance documents on handling 
missing outcome data in extended follow-up studies, it is possible that other 
imputation strategies would be identified in a more thorough search of the 
literature.  
 
In order to provide recommendations around the use of MI in extended follow-up 
studies, clearly a first step is to gain a better understanding of the missing data 
problem in this setting, particularly in relation to the extent and key sources of 
missing outcome data in this setting. 
 
Thesis aim 4 
 
The fourth aim of this thesis is to review the extent and common sources of 
missing outcome data in recently published extended follow-up studies. Based on 
the findings of this review, a further aim is to provide general recommendations 




3.5. Methods for addressing thesis aims 
 
For thesis aims 1 to 3, the performance of MI is evaluated primarily using 
simulation studies. In these studies, model parameters and missing data 
mechanisms are specified by the researcher, which means that the performance of 
statistical methods can be judged in relation to the known truth (90). Key 
statistical properties evaluated in the simulation studies include bias, measures of 
precision, power, and the coverage of estimated confidence intervals. For thesis 
aims 3 and 4, the performance of MI is also explored through application to data 
from the Docosahexaenoic Acid for the Improvement of Neurodevelopmental 
Outcome in Preterm Infants (DINO) trial (91). In DINO, n=657 preterm infants 
born < 33 weeks gestation were randomised between April 2001 and October 
2005 to receive a high docosahexaenoic acid (DHA) or a standard DHA diet from 
within 5 days of commencing enteral feeds through to term. The initial DINO trial 
concluded following the assessment of neurodevelopmental outcomes in the 
children at 18 months corrected age; later an extended follow-up period was 
initiated to assess neurodevelopmental and growth outcomes in the children at 7 
years corrected age. Ethics approval to use DINO data in this thesis was granted 
by the University of Adelaide Human Research Ethics Committee (approval 
number H-2014-239). Lastly, for thesis aim 4, the extent and common sources of 
missing outcome data in recently published extended follow-up studies, and 
statistical approaches used to handle missing outcome data in this setting, are 
summarised using a systematic review. 
 
Further details on the methods for addressing the thesis aims, including 
descriptions of simulation parameters, additional background information on the 












This chapter presents the first of four articles contributing to this thesis. The 
article, published in the American Journal of Epidemiology, contrasts the 
performance of MI and MID when auxiliary variables associated with an 
incomplete outcome are included in the imputation model. Previous research on 
MID only considered the use of auxiliary variables for efficiency gains, whereas 
in practice, auxiliary variables are often used to reduce bias. Another limitation of 
previous work is that comparisons between MI and MID only involved a small 
number of imputations. The purpose of this article is to provide a more 
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Multiple imputation (MI) is increasingly being used to handle missing data in 
epidemiologic research. When data on both the exposure and the outcome are 
missing, an alternative to standard MI is the “multiple imputation, then deletion” 
(MID) method, which involves deleting imputed outcomes prior to analysis. 
While MID has been shown to provide efficiency gains over standard MI when 
analysis and imputation models are the same, the performance of MID in the 
presence of auxiliary variables for the incomplete outcome is not well understood. 
Using simulated data, we evaluated the performance of standard MI and MID in 
regression settings where data were missing on both the outcome and the exposure 
and where an auxiliary variable associated with the incomplete outcome was 
included in the imputation model. When the auxiliary variable was unrelated to 
missingness in the outcome, both standard MI and MID produced negligible bias 
when estimating regression parameters, with standard MI being more efficient in 
most settings. However, when the auxiliary variable was also associated with 
missingness in the outcome, alarmingly MID produced markedly biased 
parameter estimates. On the basis of these results, we recommend that researchers 
use standard MI rather than MID in the presence of auxiliary variables associated 




Missing data are a widespread problem in experimental and observational 
research, leading to biased and inefficient parameter estimates if they are 
inadequately handled during the analysis. Among the more rigorous statistical 
approaches to handling missing data, multiple imputation (MI) has been widely 
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adopted due to its flexibility and relative ease of implementation (17, 29). First 
introduced by Rubin (4), MI uses a statistical model fitted to the observed data to 
estimate (impute) values for the missing data. The imputation process is repeated 
many times to generate multiple complete datasets, which are then analysed 
separately using standard statistical techniques. Finally, results from the multiple 
analyses are combined using Rubin's rules, which appropriately account for the 
uncertainty in the missing data by combining variability within and between 
imputed datasets (4). In its standard implementation, MI provides valid inference 
when data are missing at random (MAR)―that is, when the probability of 
missingness depends only on observed values (2). 
 
Missing data are often evident in the outcome(s) for analysis, especially in studies 
involving participant follow-up. Although MI can be applied when missing data 
are confined to the outcome, it is most valuable when data on exposure variables 
are also missing (18, 92, 93). In addition to standard MI as proposed by Rubin (4), 
a popular method for handling missing data in outcome and exposure variables 
within the MI framework is von Hippel's "multiple imputation, then deletion" 
(MID) approach (8). As of February 11, 2015, there were 232 citations of von 
Hippel’s article in Scopus (Elsevier B.V., Amsterdam, the Netherlands), the 
majority from empirical studies (e.g. (94-101)). As an illustration of the difference 
between standard MI and MID, consider a generalised linear model with 
univariate outcome  and predictors = ( , … , ), where data are missing in 
both  and . Suppose also that interest lies only in estimating the parameters 
|  that govern the conditional distribution of  given  (e.g. regression 
coefficients). In both standard MI and MID, an imputation model is generated 
including  and all components of . To ensure that imputation and analysis 
models are consistent and to avoid biasing associations towards independence, 
observed and imputed values of  are used to impute missing values for all 
components of  and vice versa (14, 27, 44). Following imputation, in standard 
MI all of the observed and imputed data for  and  are used in the analysis of 
each of the completed datasets. In contrast, MID excludes (or deletes) cases with 
imputed ’s from the analysis of each of the completed datasets. In other words, 
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analysis using standard MI involves all participants in the study, whereas analysis 
under MID is restricted to participants with observed outcome data. Provided that 
the MAR assumption is valid, the deletion of observations with imputed outcomes 
in MID offers two practical advantages. Firstly, for a finite number of 
imputations, MID has been shown to produce more precise estimates of |  than 
standard MI (i.e. smaller standard errors, narrower confidence intervals), although 
efficiency gains tend to be minor unless the number of imputations is small and 
the proportion of missing data is high (8). Secondly, removing observations with 
imputed outcomes from the analysis can help to minimise the bias introduced by a 
misspecified model for imputing the missing outcomes (8). 
 
The rationale behind MID is that following imputation, cases with missing 
outcome data do not contribute any further information about the parameters | ; 
hence, retaining these cases in the analysis only adds noise to the estimation 
process (8, 18). While this assertion is correct when the imputation and analysis 
models include the same variables (in an appropriate form), in practice these 
models often differ. Indeed, one of the appealing features of the MI framework is 
the ability to incorporate additional "auxiliary" variables into the imputation 
model that are not part of the substantive analysis to improve the prediction of 
missing values (14). In clinical trials, for example, post-randomisation measures 
such as treatment compliance are often used as auxiliary variables. Importantly, 
while both standard MI and MID benefit equally from the inclusion of auxiliary 
variables to improve the prediction of missing values in , only standard MI 
benefits from the inclusion of auxiliary variables to predict missing values in  
(8). However, depending on the number of imputations used, the additional 
information provided by an auxiliary variable for  needs to be fairly substantial 
for standard MI to demonstrate efficiency advantages over MID. On the basis of a 
simulation study involving normally distributed variables, von Hippel found that 
MID was more efficient than standard MI when the correlation between a single 
auxiliary variable and the incomplete outcome did not exceed 0.7, 0.6, and 0.5 for 
2, 5, and 10 imputations, respectively (8). It is unclear whether MID would 
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maintain similar efficiency advantages over standard MI with a larger number of 
imputations.  
 
While important, efficiency gains are not the only consideration when identifying 
auxiliary variables for inclusion in imputation models. Arguably the more 
essential role of auxiliary variables is in helping to make the MAR assumption 
which underlies MI more plausible. In developing high quality imputations, 
numerous experts have recommended the inclusion in the imputation model of 
auxiliary variables that are associated with the incomplete variables to be imputed, 
the probability of missing data, or both (e.g.(5, 6, 11, 46, 47)). It is the inclusion 
of auxiliary variables related to the probability of missing data that is important 
for satisfying the MAR assumption. Auxiliary variables related to the probability 
of missing data were not considered in von Hippel's original paper proposing MID 
(8). In a landmark study, Collins et al. (6) demonstrated via simulation that failure 
to incorporate information from auxiliary variables that are correlated with an 
incomplete outcome and with missingness in the outcome leads to biased 
inference in estimating regression coefficients from linear regression models 
following MI. Given the potential for auxiliary variables to reduce bias and 
improve efficiency, they recommended that researchers adopt inclusive strategies 
for selecting auxiliary variables to include in imputation models. These findings 
have important implications for the use of MID in studies where auxiliary 
information is available. Since MID is unable to take advantage of auxiliary 
information for an incomplete outcome, it can be argued that the approach is not 
entirely consistent with the inclusive strategy for variable selection when setting 
up an imputation model. Further, if auxiliary variables are required to satisfy a 
MAR assumption for the outcome, it is unclear whether including these variables 
in the imputation model and then deleting imputed outcomes prior to analysis 
could introduce bias. To our knowledge, these issues have not been investigated in 
the comparison of standard MI and MID. 
 
Our aim in this paper was to evaluate the performance of standard MI and MID in 
regression settings where data are missing for both the outcome and the exposure 
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and where auxiliary variables associated with the outcome are included in the 
imputation model. We hypothesised that the efficiency advantages of MID would 
be less pronounced with a larger number of imputations, and that this approach 
would introduce bias in the estimation of |  when the imputation model 
contained auxiliary variables that were additionally associated with the probability 






We evaluated the performance of standard MI and MID in the presence of an 
auxiliary variable associated with an incomplete outcome by extending the earlier 
simulation study of von Hippel. Using the same data generation procedure, we 
investigated the consequences of using a larger number of imputations and 
allowing for missingness in the outcome to depend on an auxiliary variable. 
 
For each simulation scenario, 1,000 complete datasets of size  = 200 were 
created. Initially, two predictor variables  and  were generated from a 
bivariate standard normal distribution with correlation . An outcome  was 
then produced according to the linear regression model = + + +
, where  was a normally distributed error term with mean 0 and variance , 
and where the regression parameters ( , , ) were set to (1,1,1). The proportion 
of the variance in  explained by the linear regression model ( ) was fixed by 
setting the variance as = 2(1− )(1 + )/ . Next, a standard normal 
auxiliary variable  was generated according to the equation = +
/var( ), where  was the correlation between  and  and where  was 
normally distributed with mean 0 and variance 1− . In generating complete 
datasets,	 ,  and  were independently varied. Following the simulation 
study of von Hippel (8), we allowed  and  to take the values 0.2, 0.5, and 
0.8, while  was set to either 0.1, 0.5, or 0.9. Collectively this resulted in 27 




Following the generation of complete datasets, values of  and  were 
independently set to missing according to one of two MAR mechanisms. In one 
setting, we replicated the "coordinated missingness" mechanism previously 
considered by von Hippel in which   and  were set to missing independently 
with probability 2 ( ), where  is the cumulative distribution function of the 
standard normal distribution. Hereafter we refer to this missing data mechanism as 
"auxiliary independent missingness", since missingness in the outcome is 
conditionally independent of the auxiliary variable . The motivation for 
investigating this missing data mechanism was to evaluate the efficiency of 
standard MI and MID when a larger number of imputations was used; only 2, 5, 
and 10 imputations were considered previously. In a second setting, we 
considered a new missing data mechanism in which values of  were set to 
missing with probability 2 ([ + ]/var[ + ]).  was again set to 
missing with probability 2 ( ). Throughout the remainder of the paper, we 
refer to this second missing data mechanism as "auxiliary dependent 
missingness". When setting values to missing, we allowed the overall proportion 
 of missing data in both  and  to equal 0.2 or 0.5. Together this resulted in 4 
missing data patterns and 108 simulation scenarios overall. 
 
Imputation and analysis methods 
 
For each simulation scenario, missing values in  and  were imputed using a 
Markov chain Monte Carlo algorithm assuming multivariate normality (11). , 
, , and  were all included in the imputation model. Under auxiliary 
independent missingness, the expected percentage of incomplete cases was 34.7% 
and 66.7% when the proportion of missing data in  and  was equal to 0.2 and 
0.5, respectively. Based on the rule of thumb that Monte Carlo error should be 
acceptably small when the number of imputations equals the percentage of 
incomplete cases (5), the use of approximately 70 imputations is recommended 
for standard MI. However, since the efficiency advantages of MID are greater 
when the number of imputations is lower (8) and since fewer imputations are 
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common in practice, we chose 50 imputations as a reasonable compromise. 
Following imputation, the 50 complete datasets were analysed directly for 
standard MI and analysed following the deletion of observations with imputed 
outcomes for MID. Thus, for each scenario, standard MI and MID estimates were 
based on the same underlying imputed data. Each imputed dataset was analysed 
by fitting a linear regression model of the form = + + + . Of 
interest were the standard MI and MID estimates and 95% confidence intervals 
for the parameters ,  and . Inference on individual parameters was obtained 




For each simulation scenario, standard MI and MID parameter estimates across 
the 1,000 simulated datasets were summarised. The performance of the two 
approaches was assessed in terms of the bias (defined as the average difference 
between the parameter estimate and the true underlying value used to generate the 
data ( = 	 = = 1)) and the average estimated standard error of the 
parameter estimates. We also report the coverage of the estimated 95% confidence 
intervals, defined as the proportion of 95% confidence intervals that contained the 
true value. Based on 1,000 simulated datasets and a normal approximation to the 
binomial distribution, on 95% of occasions we would expect the coverage to lie 
between 0.936 and 0.964 for a nominal level of 0.95. In addition to summaries for 
each individual simulation scenario, mean values for the bias, average standard 
error, and coverage were also calculated across simulation scenarios for the two 
missing data mechanisms to obtain an overall measure of performance. 
 
All statistical calculations were performed using SAS, version 9.3 (SAS Institute, 
Inc., Cary, North Carolina). Multiple imputation was carried out using the MI 
procedure, while analysis was performed using the GENMOD and MIANALYZE 
procedures. Starting seeds for generating variables, inducing missing data, and 
performing MI were varied across simulation scenarios and recorded so that 





To investigate whether the performance of MID depends on variable type, we also 
performed a limited simulation study involving a binary outcome, a binary 
auxiliary variable, and two binary covariates. Details of this additional simulation 
study are outlined in the web appendix (see Section 4.3.6; also available online at 




Table 4.1 summarises the performance of standard MI and MID under the 
auxiliary independent mechanism. Across the 54 simulation scenarios, both 
standard MI and MID exhibited negligible bias (i.e. the range of biases were 
consistent with Monte Carlo error), with coverage probabilities close to nominal 
levels throughout. In most settings, standard MI demonstrated moderate efficiency 
advantages over MID, with overall average standard errors (i.e. averaged across 
the 54 scenarios × 1,000 datasets) for the estimated parameters ,  and  being 
at least 3% smaller with standard MI.  
 
Table 4.1. Mean values for performance measures across 54 scenarios where 
missing data were induced under the auxiliary independent mechanism. 
Imputation method Parameter Biasa Range SE Coverage Range
Standard MI  0.001  -0.016 to 0.020 0.199 0.946  0.930 to 0.962
  0.005  -0.023 to 0.042 0.259 0.946  0.926 to 0.963
  -0.006  -0.054 to 0.023 0.260 0.946  0.925 to 0.959
MID  0.000  -0.020 to 0.017 0.213 0.946  0.931 to 0.964
  0.004  -0.027 to 0.036 0.274 0.948  0.931 to 0.964
  -0.006  -0.056 to 0.025 0.269 0.947  0.931 to 0.966
Abbreviations: MI, multiple imputation; MID, multiple imputation, then deletion; SE, standard error. 
a Monte Carlo error for bias in ( , , )   (0.015, 0.025, 0.025) for standard MI and MID across the 54 
scenarios. 
 
The efficiency advantages of standard MI under the auxiliary independent 
mechanism depended most strongly on the correlation between the auxiliary 
variable and the outcome ( ), and on the proportion of missing values in  and 
 ( ). Table 4.2 compares the performance of the two imputation approaches for 
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different values of  when  = 0.2,  = 0.2, and  = 0.5. For  = 0.1, the 
average estimated standard errors across the 1,000 imputations for the 3 
parameters were approximately 1% larger using standard MI compared to MID. 
When the correlation  was increased to 0.5, standard MI began exhibiting 
efficiency advantages over MID, particularly in estimating  and . In this 
setting, the average estimated standard errors for  and  were approximately 6% 
smaller using MI, and they were 2% smaller for . Finally, for  = 0.9, the 
average estimated standard errors were noticeably reduced with standard MI. 
Compared with MID, standard errors for , , and  were 28%, 27%, and 13% 
smaller using standard MI, respectively. A similar pattern of results was observed 
when the proportion of missing values in  and  was 0.2; however, absolute 
differences in precision were less pronounced (results not shown). 
 
Table 4.2. Performance in scenarios where missing data were induced under the 
auxiliary independent mechanism for  = 0.2,  = 0.2, and  = 0.5a. 
        Standard MI           MID 
 Parameter Bias SE Coverage Bias SE Coverage 
0.1  -0.014 0.398 0.954 -0.013 0.393 0.958 
0.1  0.018 0.401 0.957 0.019 0.396 0.960 
0.1  -0.007 0.388 0.943 -0.007 0.384 0.946 
0.5  0.020 0.371 0.948 0.017 0.393 0.946 
0.5  0.012 0.375 0.954 0.009 0.398 0.955 
0.5  -0.017 0.371 0.942 -0.015 0.380 0.940 
0.9  0.003 0.283 0.951 0.001 0.392 0.956 
0.9  0.008 0.290 0.951 0.005 0.395 0.957 
0.9  -0.011 0.325 0.925 -0.012 0.374 0.948 
Abbreviations: MI, multiple imputation; MID, multiple imputation, then deletion; SE, standard error. 
a Average values across the 1,000 simulations for each scenario. 
 
As demonstrated in Table 4.3, standard MI also performed well under the 
auxiliary dependent mechanism. The absolute bias of standard MI was at most 
0.023 across the 54 simulation scenarios for all three parameters, and the coverage 
probabilities remained close to nominal levels throughout. In contrast, MID 
showed deficiencies when the probability of missing data in the outcome variable 
depended on the auxiliary variable. The average bias and coverage for ( , , ) 
across the 54 simulation scenarios was (-0.207, -0.074, -0.017) and (0.812, 0.928, 
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0.947), respectively. The performance of MID suffered most when the proportion 
of missing data in  and  was high (0.5), when the correlation between the 
auxiliary variable and the outcome was high (0.9), and when the proportion of 
variance in  explained by the regression model was low (0.2). Table 4.4 shows 
the performance of standard MI and MID under auxiliary dependent missingness 
for different values of  when  = 0.2,  = 0.2, and  = 0.5. The bias 
associated with MID was relatively small when  = 0.1, although there was 
some evidence of undercoverage in the estimation of  and . For  = 0.5, the 
bias in MID estimates was larger, particularly for  and . Finally for  = 0.9, 
MID produced substantially biased estimates for  and , with coverage 
dropping to just 0.114 for . 
 
Table 4.3. Mean values for performance measures across 54 scenarios where 
missing data were induced under the auxiliary dependent mechanism. 
Imputation method Parameter Biasa Range SE Coverage Range
Standard MI  -0.001 -0.014 to 0.023 0.199 0.948 0.937 to 0.962
  0.002 -0.020 to 0.017 0.255 0.947 0.932 to 0.962
  -0.004 -0.023 to 0.021 0.264 0.945 0.933 to 0.957
MID  -0.207 -1.329 to -0.002 0.202 0.812 0.114 to 0.961
  -0.074 -0.544 to 0.008 0.264 0.928 0.713 to 0.956
  -0.017 -0.114 to 0.012 0.271 0.947 0.932 to 0.960
Abbreviations: MI, multiple imputation; MID, multiple imputation, then deletion; SE, standard error. 
a Monte Carlo error for bias in ( , , )   (0.015, 0.025, 0.026) for standard MI and MID across the 54 
scenarios. 
 
Table 4.4. Performance in scenarios where missing data were induced under the 
auxiliary dependent mechanism for  = 0.2,  = 0.2, and  = 0.5a. 
        Standard MI           MID 
 Parameter Bias SE Coverage Bias SE Coverage 
0.1  -0.004 0.400 0.945 -0.137 0.360 0.935 
0.1  -0.020 0.376 0.943 -0.076 0.365 0.941 
0.1  -0.006 0.399 0.937 -0.008 0.395 0.934 
0.5  0.001 0.374 0.957 -0.622 0.360 0.585 
0.5  -0.009 0.357 0.952 -0.277 0.362 0.883 
0.5  0.001 0.384 0.945 -0.026 0.385 0.935 
0.9  -0.012 0.283 0.954 -1.111 0.350 0.114 
0.9  -0.001 0.282 0.948 -0.478 0.346 0.713 
0.9  -0.023 0.330 0.949 -0.114 0.362 0.955 
Abbreviations: MI, multiple imputation; MID, multiple imputation, then deletion; SE, standard error. 
a Average values across the 1,000 simulations for each scenario. 
47 
 
To more accurately demonstrate the bias introduced by MID in the presence of an 
auxiliary variable associated with the outcome and with missingness in the 
outcome, we performed additional simulations for  = 0.2 and  = 0.2, where 
we varied the correlation between the auxiliary variable and the outcome ( ) in 
increments of 0.1. The performance of standard MI and MID in estimating  and 
 are plotted in Figure 4.1. As shown in Figure 4.1A, estimates of  were close 
to the true value for both standard MI and MID when the proportion of missing 
data in  and  was 0.2. However, when the proportion of missing data in  and 
 was increased to 0.5, MID exhibited bias, even for small values of , with 
the magnitude of the bias increasing linearly with the correlation . A similar 
pattern of results was observed for  (Figure 4.1B), although for this parameter 
MID also exhibited some bias when the proportion of missing data in  and  
was 0.2. 
 
In line with results for continuous outcomes, standard MI performed well when 
missing data in a binary outcome depended on an auxiliary variable, but 
coefficient estimates in a logistic regression model were biased with MID (see 
web appendix, Table 4.5). Once again the magnitude of the bias of MID depended 






Figure 4.1. Bias under the auxiliary dependent mechanism in the estimation of  
(A) and  (B) for  = 0.2 and  = 0.2. Correlation on the x-axis represents the 
correlation between the outcome  and the auxiliary variable . Results are for 
multiple imputation with  = 0.2 (white squares), multiple imputation with  = 0.5 
(black squares), “multiple imputation, then deletion” (MID) with  = 0.2 (white 






























In this study, we evaluated the performance of standard MI and MID when the 
imputation model was enriched by auxiliary information for the incomplete 
outcome. In line with previous results, both standard MI and MID exhibited 
negligible bias in estimating regression parameters when an auxiliary variable 
associated with the incomplete outcome, but not with missingness in the outcome, 
was added to the imputation model. We have now demonstrated that when the 
auxiliary variable is also related to missingness in the outcome and hence is 
required in the imputation model to satisfy the MAR assumption, MID produces 
biased estimates of regression parameters, whereas standard MI does not. These 
results have important implications for the use of MID in applied research. 
 
When the auxiliary variable was unrelated to missingness in the outcome, results 
demonstrated that the precision of MID was only marginally better than that of 
standard MI for a weak correlation between the auxiliary variable and the 
outcome. Conversely, standard MI was noticeably more efficient for moderate-to-
strong correlations between the auxiliary variable and the outcome. The results are 
in line with those observed previously for 10 or fewer imputations (8), however, 
in our study, the efficiency advantages of standard MI were greater with 50 
imputations. This suggests that the intended number of imputations is an 
important factor to take into account when choosing between standard MI and 
MID based solely on efficiency considerations. Although early texts on MI 
suggested that 10 or fewer imputations are usually adequate (25, 27, 36), more 
recent recommendations state that the number of imputations should be much 
larger (i.e. 20 to 100) (5, 45). Since increasing the number of imputations entails 
greater precision, standard MI with a large number of imputations should be 
preferred over MID if the primary goal is to maximise efficiency. In light of 
continuing improvements in computational power and analytical software, 
standard MI with a large number of imputations should be feasible in most 




When missingness in the outcome depended on the auxiliary variable, MID 
produced biased estimates of regression parameters, with the magnitude of the 
bias being positively associated with the amount of missing data and the 
correlation between the auxiliary variable and the outcome. Effectively, MID 
discarded the information about the outcome provided by the auxiliary variable, 
leading to the violation of a MAR assumption that was otherwise satisfied under 
standard MI. The results suggest that MID is not an optimal strategy in the 
presence of auxiliary variables that are associated with missingness in the 
outcome. In our view, failing to exploit the information offered by auxiliary 
variables and potentially introducing serious bias into the analysis for small 
potential gains (or possible losses) in precision is a poor trade-off. This leaves 
researchers with two choices for implementing MI when auxiliary information for 
an incomplete outcome is available: 1) imputing using a model that excludes 
auxiliary variables associated with the incomplete outcome and proceeding with 
MID or 2) incorporating these auxiliary variables into the imputation model and 
employing a standard MI analysis. Given the potential value of auxiliary variables 
for bias reduction and efficiency gains, we believe the latter option is preferable in 
most settings. 
 
Clearly, results based on a restricted simulation study such as this cannot be 
generalised to all applied settings. For example, in this study we did not consider 
scenarios with missingness in auxiliary variables, multiple auxiliary variables, or 
more complex regression models, all of which are common in practice. Further, in 
all simulation scenarios the association between the auxiliary variable and the 
probability of missing data in the outcome was fixed; previous research has shown 
that the strength of this association is an important determinant of the bias 
associated with failing to include an auxiliary variable in the imputation model 
(48). While the simulation study illustrates the potential for introducing bias using 
MID, the extent of this bias will depend on specific characteristics of the 
individual study. Associations involving auxiliary variables may be weaker than 
those considered in this study, and hence the bias introduced by MID may not be 
of practical importance in many settings (6, 48, 49). Alternatively, researchers 
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may have access to a large number of auxiliary variables, which collectively could 
have a dramatic influence on bias and efficiency. Thus, while the bias in 
estimating regression coefficients with 20% missing data was moderate in the 
current study, it could be larger in other settings with similar amounts of missing 
data. 
 
A further limitation of this study is that it only considered a MAR mechanism and 
a correctly specified imputation model. Both conditions may not be met in 
practice. Although a MAR assumption is often plausible, data may instead be 
missing not at random, which occurs when the probability of missingness depends 
on unobserved values (2). Unless missingness occurs by design, it is impossible to 
tell whether data are truly MAR or missing not at random based only on observed 
values. If imputation is performed under a MAR assumption when data are in fact 
missing not at random, in general this will lead to biased inference, although 
auxiliary variables can help to mitigate this bias (6). Since MID is unable to 
incorporate information about an incomplete outcome from auxiliary variables, it 
may be that this approach would produce more biased estimates than standard MI 
when data are missing not at random, although this remains to be investigated. In 
choosing between standard MI and MID, another important consideration is the 
ability to adequately specify the imputation model. One argument for using MID 
is that removing imputed outcomes from the analysis will reduce the bias 
introduced by a misspecified model for imputing outcomes. Whether this is 
important in practice is unclear. Popular methods of imputation such as 
multivariate normal imputation and fully conditional specification are known to 
be fairly robust to model misspecification (e.g.(5, 11, 40, 43)), while ad hoc 
approaches such as predictive mean matching can be used when there is 
uncertainty surrounding relationships between variables in the imputation model 
(5, 41). Thus, even in settings where there is considerable uncertainty in 
specifying an appropriate imputation model, we would still recommend 
proceeding with standard MI when auxiliary information for an incomplete 




In summary, MID can lead to biased estimation when auxiliary variables that are 
associated with missingness in an incomplete outcome are included in the 
imputation model. Once a decision has been made to include auxiliary variables in 
the imputation model, whether to satisfy a MAR assumption or to improve 
precision, we recommend retaining this information in the analysis and using a 
standard MI approach.  
 




For each simulation scenario, 1,000 complete datasets of size  = 500 were 
created. A larger sample size was considered for binary outcomes to reduce the 
likelihood of observing zero-cells in cross-tabulations involving the outcome. 
Initially, two dependent binary variables  and  were generated with success 
probability 0.5 and with an odds ratio for their association (i.e. odds[  = 1|  = 
1]/odds[  = 1|  = 0]) of 2.25. A binary outcome  was then generated 
according to the logistic regression model logit ( = 1) = + + , 
where the regression parameters ( , , ) were set to (-1, 1, 1). Next, a binary 
auxiliary variable  was generated according to the equation ( = 1) =  + , 
with values of  and  chosen to give  an overall success probability of 0.5 and 
an odds ratio for the association with  (i.e. odds[  = 1|	  = 1]/odds[  = 1|	  = 0]) 
of either 2, 5, or 10 (three scenarios). Following the generation of complete 
datasets, values of  were set to missing with probability 0.2 + 0.6 . 
Independently values of  were set to missing with probability 0.2 + 0.3  + 0.3  
(i.e. missing data in  depended on the auxiliary variable ). The missing data 
mechanism resulted in 50% missing data for both  and .  
 
For each of the three simulation scenarios, missing values in  and  were 
imputed using fully conditional specification (9, 10) with 50 cycles and 50 
imputations. , ,  and  were specified as binary variables in the imputation 
model, with  and  imputed using logistic regression models. Following 
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imputation, the 50 complete datasets were analysed directly for standard multiple 
imputation (MI) and analysed following the deletion of observations with imputed 
outcomes for multiple imputation, then deletion (MID). Each imputed dataset was 
analysed by fitting a logistic regression model of the form logit ( = 1) = +
+ . Of interest were the standard MI and MID estimates and 95% 
confidence intervals for the parameters , , and . Inference on individual 
parameters was obtained by combining estimates over the 50 imputed datasets 
using Rubin's rules (4). Performance across the 1,000 simulated datasets for each 
parameter was summarised using the bias, average estimated standard error and 
coverage. All statistical calculations were performed using SAS version 9.3 (SAS 




Table 4.5 summarises the performance of standard MI and MID for the 3 
simulation scenarios for binary outcomes. In line with results for continuous 
outcomes, standard MI performed well when missing data in the binary outcome 
depended on the auxiliary variable. Bias was negligible for all parameters across 
all scenarios, and coverage probabilities remained close to nominal levels 
throughout. In contrast, MID produced biased parameter estimates of  and , 
with the magnitude of bias increasing with the strength of the association between 
the auxiliary variable and the outcome. Coverage probabilities and standard errors 
for these parameters also suffered with MID. Of note, MID exhibited negligible 
bias in estimating . This finding is not unexpected given the symmetrical 
properties of the odds ratio and the missing data mechanism considered. Since the 
probability of missing data in our example depended on  and  (via the 
auxiliary variable ) but not , an analysis restricted to cases with complete data 
would be expected to provide an unbiased estimate of  (102). In terms of 
precision, average standard errors for  were larger with MID than with standard 





Table 4.5. Performance in scenarios for a binary outcomea. 
       Standard MI          MID 
 Parameter Biasb SE Coverage Biasb SE Coverage 
2  -0.012 0.242 0.955 -0.094 0.242 0.944 
2 β1 0.013 0.304 0.946 -0.055 0.305 0.942 
2 β2 -0.004 0.362 0.955 -0.002 0.364 0.957 
5  -0.018 0.241 0.954 -0.199 0.246 0.908 
5 β1 0.017 0.294 0.956 -0.130 0.306 0.922 
5 β2 0.005 0.357 0.951 0.007 0.367 0.957 
10  -0.007 0.235 0.949 -0.252 0.246 0.868 
10 β1 0.005 0.283 0.948 -0.208 0.307 0.894 
10 β2 0.009 0.346 0.955 0.011 0.365 0.956 
Abbreviations: , odds ratio for the association between  and ; MI, multiple imputation; MID, multiple 
imputation, then deletion; SE, standard error. 
a Average values across the 1,000 simulations for each scenario. 
b Monte Carlo error for bias in ( , , )   (0.008, 0.010, 0.011) for standard MI and MID across the 3 scenarios. 
 
*** End of published article *** 
 
4.4. Additional discussion 
 
Another possible method for handling missing outcome data within the MI 
framework that was not mentioned in the published article is to delete 
observations with missing outcomes prior to fitting the imputation model, an 
approach termed “deletion, then multiple imputation” (DMI) (8). In the absence of 
auxiliary variables, von Hippel found that DMI was marginally more biased and 
less efficient than MID across a range of simulation scenarios where data were 
MAR in the outcome and exposure variables. However, in settings where 
participants with missing outcome data tended to have complete data on exposure 
variables, and vice versa, DMI performed considerably worse than MID in terms 
of bias and precision (8). Based on these results, von Hippel discouraged the use 
of DMI in practice, and subsequently this approach was not considered when the 
article in this chapter was conceived. More recently, Kontopantelis et al. (103) 
evaluated imputation strategies for handling missing outcome data and observed 
little difference in performance between DMI, MID, and MI, both in the absence 
of auxiliary variables and in settings where a single auxiliary variable was used 
for efficiency gains (but not bias reduction). Based on these results, the authors 
concluded that the choice of imputation approach makes little difference in 
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practice; the important thing is that the outcome is included in the imputation 
model. In light of this recent recommendation, an additional investigation into the 
performance of DMI in the presence of auxiliary variables for the outcome seems 
warranted. 
 
The statistical properties of DMI were evaluated via simulation using the data 
generation procedures and missing data mechanisms from the main article (see 
Section 4.3.3). Results obtained for DMI were then compared with findings for 
MID and standard MI. Under the auxiliary independent mechanism, DMI 
produced unbiased parameter estimates that were slightly less efficient than 
corresponding MID estimates (which were also unbiased). Compared to MID, 
average estimated standard errors for , , and  were approximately 2.1%, 
1.0%, and 0.4% larger with DMI, respectively. However, like MID, DMI was at 
times substantially less precise than standard MI. As illustrated in Figure 4.2 for 
the parameter , where  = 0.2,  = 0.2, and  = 0.5, standard MI exhibited 
noticeable efficiency advantages over DMI (and MID) as the correlation between 
the outcome and the auxiliary variable ( ) increased to 0.9. Interestingly, 
average estimated standard errors for DMI and MID appeared invariant to , 
suggesting that these approaches were not incorporating any of the information 






Figure 4.2. Average estimated standard errors for  under the auxiliary 
independent mechanism where  = 0.2,  = 0.2, and  = 0.5. Correlation on 
the x-axis represents the correlation between the outcome  and the auxiliary 
variable . Results are for MI (black squares), MID (black circles), and DMI 
(white triangles). 
 
Similarities in performance between DMI and MID also extended to settings 
where the probability of missing data in the outcome depended on the auxiliary 
variable, albeit with DMI marginally more biased and less efficient than MID. 
Importantly, both DMI and MID were inferior to standard MI. As evident in 
Figure 4.3 for the parameter , where  = 0.2,  = 0.2, and  = 0.5, the bias of 
both DMI and MID became progressively more pronounced as  increased, 
while standard MI remained unbiased. A similar pattern of results was observed 

























Figure 4.3. Bias for  under the auxiliary dependent mechanism where  = 
0.2,  = 0.2, and  = 0.5. Correlation on the x-axis represents the correlation 
between the outcome  and the auxiliary variable . Results are for MI (black 
squares), MID (black circles), and DMI (white triangles). 
 
Collectively, the results from this additional simulation study do not alter the main 
message from the published article, which is that it is preferable to employ 
standard MI when the imputation model contains auxiliary variables for the 




















This chapter presents the second article contributing to this thesis, published in 
BMC Medical Research Methodology. The primary aim of the article is to 
evaluate the performance of standard model-based methods of MI for handling 
missing outcome data when estimating the relative risk. Given the potential for 
bias due to a misspecified imputation model, a further aim is to investigate 
whether removing imputed outcome values using MID improves estimation. 
Given the findings of Chapter 4, any potential benefits of MID for relative risk 
estimation should be weighed against the limitations of this approach in the 
presence of auxiliary variables. 
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Background: Multiple imputation is a popular approach to handling missing data 
in medical research, yet little is known about its applicability for estimating the 
relative risk. Standard methods for imputing incomplete binary outcomes involve 
logistic regression or an assumption of multivariate normality, whereas relative 
risks are typically estimated using log binomial models. It is unclear whether 
misspecification of the imputation model in this setting could lead to biased 
parameter estimates.  
 
Methods: Using simulated data, we evaluated the performance of multiple 
imputation for handling missing data prior to estimating adjusted relative risks 
from a correctly specified multivariable log binomial model. We considered an 
arbitrary pattern of missing data in both outcome and exposure variables, with 
missing data induced under missing at random mechanisms. Focusing on standard 
model-based methods of multiple imputation, missing data were imputed using 
multivariate normal imputation or fully conditional specification with a logistic 
imputation model for the outcome.  
 
Results: Multivariate normal imputation performed poorly in the simulation 
study, consistently producing estimates of the relative risk that were biased 
towards the null. Despite outperforming multivariate normal imputation, fully 
conditional specification also produced somewhat biased estimates, with greater 
bias observed for higher outcome prevalences and larger relative risks. Deleting 
imputed outcomes from analysis datasets did not improve the performance of 




Conclusions: Both multivariate normal imputation and fully conditional 
specification produced biased estimates of the relative risk, presumably since both 
use a misspecified imputation model. Based on simulation results, we recommend 
researchers use fully conditional specification rather than multivariate normal 
imputation and retain imputed outcomes in the analysis when estimating relative 
risks. However fully conditional specification is not without its shortcomings, and 
so further research is needed to identify optimal approaches for relative risk 




The relative risk is a summary measure of effect for binary outcomes that is often 
of interest in medical research (54-57). Unlike the odds ratio, the relative risk is 
simple to interpret and collapsible across covariate strata (58). For rare outcomes, 
relative risks may be estimated from logistic regression models, since the odds 
ratio approximates the relative risk in this case (57). For more common outcomes, 
the odds ratio overestimates the relative risk and so alternatives to logistic 
regression are required to estimate the relative risk. A standard approach to 
estimating the relative risk directly is to fit a generalised linear model with a 
binomial error distribution and a log link, known as the log binomial model (60, 
61). Since the log link allows predicted probabilities greater than one, 
convergence problems with this model are not uncommon, particularly for models 
containing continuous covariates or outcomes with high prevalence (60, 61). 
Several alternative approaches to relative risk estimation have been proposed to 
address failed convergence with the log binomial model, with modified Poisson 
regression using a log link and a robust error variance (62) one of the more 
commonly used methods. 
 
A common feature of epidemiologic investigations is the occurrence of missing 
data, which can result in biased and inefficient parameter estimates if inadequately 
handled during the statistical analysis. Among the more rigorous approaches to 
handling missing data, multiple imputation (MI) (4) has been widely adopted due 
63 
 
to its flexibility and availability in statistical software packages (7). MI involves 
fitting a statistical model to the observed data to estimate values for the missing 
data. To incorporate missing data uncertainty, multiple values are imputed for 
each missing observation, producing multiple complete datasets. Following 
analysis, parameter estimates from the multiple datasets are appropriately 
combined to give a single MI estimate. Standard implementations of MI assume 
that data are missing at random (MAR), which occurs when the probability of 
missing data depends only on observed data (2). Provided this assumption is met 
and statistical models used for imputation and analysis are correctly specified, MI 
produces consistent and asymptotically efficient parameter estimates (4). 
  
For arbitrary patterns of missing data (i.e. missing data occurring in any variable, 
in any pattern across variables), the two standard model-based methods of MI are 
fully conditional specification (FCS) (5, 9, 10), also known as chained equations, 
and multivariate normal imputation (MVNI) (11). FCS involves specifying a 
series of univariate imputation models, one for each variable with missing data. 
Standard software uses logistic regression to impute incomplete binary outcomes, 
which assumes a linear relationship between the log odds of the risk and other 
variables in the imputation model. Incomplete covariates can similarly be imputed 
using appropriate univariate models (e.g. linear regression for continuous 
covariates). In contrast, MVNI assumes that all variables in the imputation model 
follow a multivariate normal distribution. For incomplete binary outcomes, an 
additional rounding step is also required following MVNI to convert continuous 
imputed values to binary values suitable for analysis (40). Although FCS and 
MVNI have been evaluated in settings where the goal is to estimate the odds ratio 
using logistic regression (9, 40, 43), little is known about their performance when 
the aim is to estimate the relative risk. Importantly, it is unclear whether imputing 
outcomes using logistic regression in FCS or under a multivariate normal 
assumption in MVNI could lead to biased or inefficient estimation when the 




A popular alternative to the standard implementation of MI for handling missing 
data in both outcome and exposure variables is the “multiple imputation, then 
deletion” approach (MID), where observations with imputed outcomes are 
excluded from the analysis (8). Although MID is not advisable when the 
imputation model contains auxiliary variables for the outcome (i.e. variables that 
are not part of the analysis but which help to predict missing outcome values) 
(104), the approach can offer small efficiency gains over standard MI when 
imputation and analysis models are the same. Of relevance to the estimation of 
relative risks, it has been argued that removing imputed outcomes prior to analysis 
can help to minimise the bias introduced by a misspecified imputation model for 
the outcome (8). Should the imputation of incomplete binary outcomes using FCS 
or MVNI lead to biased estimation of the relative risk, this claimed strength of 
MID could lessen this bias. 
 
This article aims to (i) evaluate the performance of FCS and MVNI for handling 
missing outcome data when estimating the relative risk, and (ii) investigate 
whether deleting imputed outcomes prior to analysis improves the performance of 
FCS and MVNI in this setting. The rest of the article is set out as follows. In the 
next section, we describe the methods of FCS and MVNI in more detail, drawing 
attention to potential limitations. This is followed by an outline of the simulation 
methods used to address the article aims, and a summary of the simulation results. 
Finally, we conclude the article by discussing key findings and providing 




Fully conditional specification 
 
FCS involves specifying a series of univariate imputation models, one for each 
variable with missing data (5, 9, 10), with models tailored according to the 
distribution of the variable being imputed. For each variable with missing data, 
the FCS algorithm begins by replacing missing values with randomly selected 
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observed values or the mean value for the same variable. Imputations are then 
generated by estimating each univariate model in turn, restricted to participants 
with observed values for the variable being considered and using imputed values 
for other variables; at each stage missing values are replaced by draws from their 
posterior predictive distribution. This process continues until all incomplete 
variables have been imputed and is repeated several times in order to stabilise the 
results, leading to the generation of a single imputed dataset. Additional imputed 
datasets are obtained by independently repeating this process. 
 
Despite its flexibility, FCS is not without limitations. One concern with the 
approach is the possibility of specifying univariate imputation models where the 
conditional distributions implied do not correspond to a valid joint distribution. A 
potential consequence of this is that results could vary according to the ordering 
of univariate imputation models within the FCS procedure. Fortunately this issue 
appears to have little impact on results in practice (9, 10, 41, 43). Another 
drawback of FCS is that it can be time consuming to implement in settings 
containing a large number of incomplete variables, since univariate imputation 
models need to be specified for each incomplete variable in the imputation model.  
 
Multivariate normal imputation 
 
MVNI is a joint modelling approach to imputation where all variables in the 
imputation model are assumed to follow a multivariate normal distribution. First 
implemented by Schafer (11), MVNI uses a Markov chain Monte Carlo algorithm 
(known as data augmentation) for imputation. Initially, missing values are 
imputed based on assumed starting parameter values for the multivariate normal 
distribution. These are typically obtained from available data using the 
expectation-maximisation algorithm. Next, updated parameter values for the 
multivariate normal distribution are drawn from their posterior distribution based 
on the observed and imputed data. This iterative process of imputing missing 
values and drawing updated parameter values continues until these values 
converge to a stationary distribution (11, 36). Following these “burn-in” 
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iterations, a set of imputed values is taken. In order to reduce dependence between 
imputations, additional iterations are performed before the next set of imputed 
values is obtained. 
 
Due to its strong theoretical underpinnings, MVNI is an appealing method when 
multivariate normality holds, but such an assumption is not always realistic, 
particularly when the imputation model contains binary variables. Although 
several authors have reported good performance with MVNI for binary variables 
(11, 37, 40, 41), it remains difficult to make global statements about the 
robustness of this approach to violations of multivariate normality, whether in the 




The performance of FCS and MVNI for handling missing outcome data when 
estimating the relative risk was evaluated using data simulation. In order to 
attribute any deficiencies in performance to the method of MI, rather than getting 
caught up in complexities of the data, we focused on relatively simple simulation 
scenarios. 
 
In each simulation scenario, 2000 datasets of size n = 1000 were generated from 
the log binomial model log ( = 1) = + + , where  and  
were binary or normally distributed exposure variables and  was the binary 
outcome. A relatively large sample size was chosen to avoid zero cells in cross-
tabulations involving the outcome. Following generation of complete datasets, 
values in  and  were set to missing according to a specified MAR mechanism 
to produce an arbitrary pattern of missing data in these two variables. Missing 
values were then multiply imputed using FCS or MVNI with = 20 
imputations. For FCS, missing values in  were imputed using a logistic 
regression model, while imputations for binary or normally distributed  were 
generated from a logistic or linear regression model respectively. A total of 20 
cycles were used for each imputation, with the outcome imputed last. For MVNI, 
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missing values were imputed using a Markov chain Monte Carlo algorithm with a 
burn-in of 200 iterations. Following imputation with MVNI, imputed values in the 
outcome were rounded to binary values using adaptive rounding, which has been 
recommended over alternative rounding techniques (40). Finally, complete 
datasets either retaining or deleting imputed outcomes were analysed using log 
binomial models (or modified Poisson regression as appropriate), with parameter 
estimates for  and  combined across datasets using Rubin’s rules (4). Since 
the outcome  was generated under the analysis model, any deficiencies in 
performance could be attributed to the method of MI. For reference, a complete 
case analysis (CCA) restricted to participants with complete data on both  and 
 was also performed in each simulation scenario. 
 
Simulation study 1: categorical exposures 
 
In simulation study 1,  and  were generated as binary variables with a 
prevalence of 0.50 and a relative risk for their association (RR( , )) of 2 or 3, 
to induce moderate or strong confounding respectively. In simulating values for 
the outcome ,  and  were both set to log(2) or log(3) to give conditional 
relative risks (i.e. RR( , | ) and RR( , | )) of 2 or 3. Lastly the intercept 
 was chosen to give an overall outcome prevalence of 0.10 or 0.30. Following 
generation of complete datasets, values in  and  were set to missing according 
to one of two MAR mechanisms: 
 
1) Coordinated: logit	 ( 	missing) = logit	 ( 	missing) = + . 
2) Opposite: logit	 ( 	missing) = + , logit	 ( 	missing) = + (1 −
). 
 
Under the coordinated mechanism, participants with missing data were often 
missing both  and , whereas under the opposite mechanism, participants with 
missing data tended to be missing either  or  (but not both). For both 
mechanisms, the parameter  was set to 1 or 2 to indicate a moderate or strong 
missing data mechanism respectively, while  was chosen to produce 30% 
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missing data in  and . Collectively this resulted in 4 missing data patterns and 
32 simulation scenarios. Following imputation, complete datasets were analysed 
using log binomial models. Provided MVNI was applied with adaptive rounding 
for imputed values in  (in addition to ), there were no convergence issues with 
the log binomial model in this setting. 
 
Simulation study 2: continuous exposures 
 
For simulation study 2,  and  were generated from a bivariate normal 
distribution with mean 0, variance 0.20 and correlation (corr( , )) 0.30 or 
0.70. Again  and  were set to log(2) or log(3) to give conditional relative risks 
of 2 or 3, while  was chosen to give an outcome prevalence of 0.10 or 0.30. One 
concern when simulating data under a log binomial model with unbounded 
continuous covariates is the possibility of generating ‘success’ probabilities 
greater than one. In choosing the variance for  and , we sought to maximise 
the size of standardised conditional relative risks while minimising the occurrence 
of invalid success probabilities. With a variance of 0.20, invalid success 
probabilities were rare, except in settings involving an outcome prevalence of 
0.30 and conditional relative risks of 3 (where 5.4% of success probabilities 
exceeded one). Following previous simulation studies exploring the relative risk 
(e.g. (105)),  and  were resampled in these instances to ensure valid success 
probabilities. 
  
Letting = / var( ), the coordinated and opposite missing data 
mechanisms were adapted for the continuous setting as follows:  
 
1) Coordinated: logit	 ( 	missing) = logit	 ( 	missing) = + 	 . 
2) Opposite: logit	 ( 	missing) = + 	 , logit	 ( 	missing) = − 	 . 
 
In line with simulation study 1,  was set to 1 or 2 and  was chosen to produce 
30% missing data in  and . Again this resulted in 4 missing data patterns and 
32 simulation scenarios. As non-convergence with the log binomial model was a 
69 
 
considerable problem in this setting, often occurring for some but not all imputed 
datasets within a single simulation, we elected to analyse all complete datasets 




The performance of the MI approaches in estimating parameters  and  was 
evaluated in terms of bias (average difference between estimate and true value) 
and the coverage of estimated 95% confidence intervals (proportion of 95% 
confidence intervals containing the true value). With 2000 simulated datasets per 
simulation scenario, on 95% of occasions the coverage is expected to lie between 
0.94 and 0.96 for a true coverage of 0.95. For each parameter, the average within-
simulation estimated standard error (denoted the average standard error), the 
standard error of parameter estimates across simulated datasets (denoted the 
empirical standard error), and the mean square error (average squared difference 
between the estimate and the true value) were also derived. All analyses were 
performed in SAS version 9.4 (SAS Institute, Inc., Cary, North Carolina). 
Multiple imputation was carried out using the MI procedure, while analysis was 
performed using the GENMOD and MIANALYZE procedures. The SAS code for 





Simulation study 1: categorical exposures 
 
Table 5.1 displays results for the categorical exposure setting in scenarios with a 
strong missing data mechanism ( = 2), where RR( , ) = 2 and = =
log(3). Similar results were observed for RR( , ) = 3, while absolute biases 
of the imputation approaches were smaller in magnitude when = 1 and =
= log(2). Full results for all simulation scenarios are available in web 
appendix B (see Section 5.3.6). MVNI performed poorly across the 32 simulation 
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scenarios, consistently producing estimates of  that were biased towards the null 
(bias range -0.32 to -0.10). The bias of -0.32 shown in Table 5.1 for an outcome 
prevalence of 0.30 under the coordinated mechanism equates to a relative risk 
estimate of 2.19 compared with the true value of 3; coverage was just 0.55 in this 
scenario. Bias was less of a concern for  (bias range -0.08 to 0.07). Deleting 
imputed outcomes following MVNI led to some reduction in absolute bias for , 
although estimates for  were moderately biased away from the null with this 
approach (bias range 0.02 to 0.11). Interestingly, average and empirical standard 
errors were noticeably increased by the deletion of imputed outcomes following 
MVNI. Compared to MVNI (without deletion), MVNI with deletion led to small 
increases in the mean square error for , but tended to decrease the mean square 
error for . 
 
In contrast to MVNI, FCS performed fairly well for categorical exposures, with 
absolute bias only exceeding 0.10 for the coefficient  in scenarios involving a 
strong coordinated mechanism, an outcome prevalence of 0.30 and where =
= log(3). Excluding simulation scenarios where the bias for  exceeded 0.10, 
the coverage of estimated 95% confidence intervals for  and  remained close 
to nominal levels (range 0.93 to 0.96). Compared to FCS (without deletion), FCS 
with deletion led to small reductions in absolute bias for  under the coordinated 
mechanism for an outcome prevalence of 0.30, but slight increases in absolute 
bias under the opposite mechanism for the same outcome prevalence. There was 
little difference in average standard errors, empirical standard errors, and mean 
square errors between FCS and FCS with deletion, although both approaches were 
less precise than MVNI.  
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Coordinated 0.10 MVNI  -0.08 0.30 0.28 0.951 0.08
 -0.28 0.35 0.28 0.896 0.15
MVNI + deletion  0.06 0.30 0.31 0.955 0.10
 -0.09 0.39 0.35 0.956 0.13
FCS  0.02 0.30 0.31 0.955 0.10
 0.00 0.40 0.40 0.962 0.16
FCS + deletion  0.02 0.30 0.31 0.948 0.09
 0.01 0.40 0.40 0.962 0.16
CCA  0.01 0.34 0.34 0.953 0.12
 0.03 0.40 0.40 0.964 0.16
Coordinated 0.30 MVNI  0.03 0.16 0.15 0.952 0.02
 -0.32 0.17 0.16 0.547 0.13
MVNI + deletion  0.05 0.16 0.16 0.948 0.03
 -0.15 0.20 0.19 0.872 0.06
FCS  0.03 0.16 0.16 0.951 0.03
 -0.11 0.20 0.21 0.893 0.05
FCS + deletion  0.02 0.16 0.16 0.955 0.02
 -0.06 0.21 0.21 0.932 0.05
CCA  0.01 0.17 0.17 0.953 0.03
 0.01 0.21 0.22 0.949 0.05
Opposite 0.10 MVNI  -0.08 0.29 0.28 0.949 0.08
 -0.26 0.34 0.26 0.908 0.13
MVNI + deletion  0.05 0.30 0.30 0.955 0.09
 -0.07 0.37 0.33 0.964 0.11
FCS  0.01 0.30 0.31 0.952 0.10
 0.03 0.39 0.39 0.963 0.16
FCS + deletion  0.01 0.30 0.31 0.950 0.09
 0.05 0.39 0.40 0.964 0.16
CCA  0.03 0.39 0.41 0.956 0.17
 0.03 0.39 0.39 0.965 0.15
Opposite 0.30 MVNI  0.00 0.16 0.15 0.961 0.02
 -0.20 0.18 0.16 0.805 0.06
MVNI + deletion  0.03 0.16 0.15 0.961 0.02
 -0.02 0.20 0.19 0.952 0.03
FCS  0.00 0.16 0.16 0.951 0.02
 0.01 0.20 0.20 0.948 0.04
FCS + deletion  -0.02 0.16 0.15 0.949 0.02
 0.07 0.21 0.21 0.947 0.05
CCA  0.01 0.20 0.20 0.952 0.04
 0.02 0.20 0.20 0.952 0.04
Abbreviations: MVNI, multivariate normal imputation; FCS, fully conditional specification; CCA, complete case 




Interestingly, CCA exhibited little bias in simulation scenarios involving 
categorical exposures, with a maximum absolute bias of 0.06 for both  and . 
As expected, in discarding information from partially observed cases, CCA was 
noticeably less efficient than the MI approaches, especially for the coefficient  
for the fully observed exposure . 
 
Simulation study 2: continuous exposures 
 
To ensure that any deficiencies in performance in the continuous exposure setting 
could be attributed to the method of MI and not the use of modified Poisson 
regression for estimating relative risks, the accuracy of this method was first 
verified in complete datasets (i.e. before values in  and  were set to missing). 
Reassuringly, unbiased estimates for  and  were observed across all 
simulation scenarios (absolute bias ≤ 0.01), with estimated 95% confidence 
intervals demonstrating appropriate coverage (i.e. within the range 0.94 to 0.96) 
(results not shown). 
 
The performance deficits of MI were more pronounced in the presence of 
continuous exposures than categorical exposures. Table 5.2 shows results for 
scenarios with a strong missing data mechanism ( = 2), where corr( , ) =
0.70 and = = log(3). A similar pattern of results was observed in other 
simulation scenarios, although absolute biases were smaller in magnitude for =
1 and = = log(2). As shown in Table 5.2, MVNI produced estimates for  
and  that were biased towards the null, with the largest absolute bias observed 
for  under the opposite mechanism with an outcome prevalence of 0.10 (relative 
risk estimate of 1.68 compared with the true value of 3). Across all 32 simulation 
scenarios, the median bias of MVNI was -0.21 for  (range -0.58 to -0.10) and -
0.12 for  (range -0.27 to -0.06). Deleting imputed outcomes following MVNI 
reduced the bias of this imputation method, although moderate bias remained for 
 in scenarios with an outcome prevalence of 0.30. The cost of this bias 
reduction was substantially larger average standard errors in comparison to 
MVNI. In terms of accuracy, deleting imputed outcomes following MVNI led to 
73 
 
reductions in the mean square error relative to MVNI without deletion in 26/32 
and 12/32 simulation scenarios for  and  respectively. 
 
FCS also produced estimates of  and  that were biased towards the null, albeit 
to a lesser degree than MVNI. The bias of -0.24 shown in Table 5.2 for an 
outcome prevalence of 0.30 under the coordinated mechanism translates to a 
relative risk estimate of just 2.37 versus the true value of 3. In addition to the 
more extreme simulation scenarios, noticeable bias for  (absolute bias > 0.10) 
was apparent in simulation scenarios with an outcome prevalence of 0.10, a 
moderate missing data mechanism or where = = log(2). Deleting imputed 
outcomes following FCS tended to decrease the bias of this imputation approach, 
with absolute bias reduced in 28/32 and 26/32 simulation scenarios for  and  
respectively. The trade-off for this bias reduction was a substantial loss in 
precision. Across the 32 simulation scenarios, average standard errors were 14.4% 
larger for  and 8.1% larger for  with the deletion of imputed outcomes 
following FCS compared to FCS alone. A consequence of the substantial loss in 
precision with the deletion of imputed outcomes following FCS was a loss in 
overall accuracy, with the mean square error increased relative to FCS without 
deletion in 30/32 and 26/32 simulation scenarios for  and  respectively. 
 
Another noteworthy result from the continuous exposure setting was that average 
standard errors were consistently larger than empirical standard errors. Averaged 
across the 32 simulation scenarios, average standard errors for  and  were 
25.8% and 17.9% larger than empirical standard errors respectively for MVNI, 
14.4% and 11.9% larger for MVNI with deletion, 10.4% and 9.5% larger for FCS, 
and 14.3% and 12.1% larger for FCS with deletion. Discrepancies were most 
prominent in simulation scenarios with an outcome prevalence of 0.30. In 
scenarios where  and  were estimated with little bias, coverage probabilities 
also tended to be much higher than the nominal level of 0.95. Collectively these 
















Coordinated 0.10 MVNI  -0.56 0.48 0.39 0.838 0.47
 -0.22 0.50 0.43 0.958 0.24
MVNI + deletion  0.01 0.58 0.55 0.965 0.30
 -0.03 0.55 0.53 0.959 0.28
FCS  -0.08 0.51 0.49 0.961 0.25
 -0.14 0.50 0.48 0.950 0.25
FCS + deletion  0.02 0.58 0.55 0.964 0.30
 -0.04 0.55 0.53 0.961 0.28
CCA  0.01 0.66 0.67 0.943 0.45
 0.01 0.53 0.55 0.936 0.30
Coordinated 0.30 MVNI  -0.26 0.26 0.20 0.890 0.11
 -0.27 0.25 0.20 0.859 0.11
MVNI + deletion  0.01 0.31 0.26 0.978 0.07
 -0.11 0.28 0.23 0.963 0.07
FCS  -0.09 0.26 0.22 0.962 0.06
 -0.24 0.24 0.21 0.878 0.10
FCS + deletion  0.02 0.31 0.26 0.980 0.07
 -0.12 0.28 0.23 0.963 0.07
CCA  0.02 0.32 0.32 0.951 0.11
 0.00 0.25 0.26 0.950 0.07
Opposite 0.10 MVNI  -0.58 0.47 0.37 0.830 0.47
 -0.17 0.48 0.42 0.961 0.21
MVNI + deletion  0.00 0.56 0.52 0.966 0.28
 0.02 0.53 0.51 0.959 0.26
FCS  -0.08 0.48 0.46 0.961 0.22
 -0.07 0.49 0.47 0.959 0.22
FCS + deletion  0.01 0.56 0.52 0.971 0.27
 0.01 0.53 0.51 0.962 0.26
CCA  0.00 0.60 0.62 0.939 0.39
 0.01 0.48 0.50 0.938 0.25
Opposite 0.30 MVNI  -0.25 0.24 0.19 0.886 0.10
 -0.07 0.26 0.20 0.981 0.05
MVNI + deletion  0.01 0.30 0.25 0.983 0.06
 0.06 0.29 0.23 0.980 0.06
FCS  -0.07 0.24 0.21 0.974 0.05
 -0.02 0.26 0.22 0.980 0.05
FCS + deletion  0.02 0.29 0.25 0.983 0.06
 0.05 0.29 0.23 0.982 0.06
CCA  0.00 0.29 0.29 0.945 0.08
 0.01 0.23 0.22 0.949 0.05
Abbreviations: MVNI, multivariate normal imputation; FCS, fully conditional specification; CCA, complete case 
analysis; Avg SE, average standard error; Emp SE, empirical standard error; MSE, mean square error. 
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As observed for categorical exposures, CCA exhibited little bias but tended to 
produce inefficient estimates of  in scenarios involving continuous exposures. 
Interestingly, CCA produced more precise estimates of  than the two MID 
approaches; across the 32 simulation scenarios, average standard errors for 




In light of the relatively poor performance of the MI approaches for relative risk 
estimation, we undertook additional analyses to explore whether findings were 
sensitive to choices made during the fitting of imputation models or to the 
simulation parameters considered. First, we investigated the performance of 
simple rounding following MVNI as an alternative to adaptive rounding. While 
differences were minimal in most scenarios, MVNI introduced slightly more bias 
in both categorical and continuous exposure settings when simple rounding was 
used in place of adaptive rounding (results not shown). Next, we investigated the 
performance of FCS with the outcome imputed before rather than after the 
incomplete covariate . This modification made little difference to results (also 
not shown). We then explored the performance of the four MI approaches in 
scenarios involving n = 250 rather than n = 1000 observations. Excluding 
simulation scenarios with binary  and  where the reduced sample size 
resulted in zero cells in cross-tabulations involving the outcome (i.e. where log 
binomial analysis models would not converge), this change made little difference 
to the bias and coverage of parameter estimates (results not shown). 
 
To investigate whether biased estimation would persist if the exposures were 
independent of one another, if the outcome was unrelated to one or both 
exposures, or if data were missing completely at random (i.e. probability of 
missing data unrelated to observed or unobserved data), several “null-case” 
simulation settings were considered. Table 5.3 shows results for continuous  
and  under the coordinated missing data mechanism for an outcome prevalence 
of 0.30. The reference case for comparisons in this table was the previously 
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considered simulation scenario involving a strong missing data mechanism ( =
2), where corr( , ) = 0.70 and = = log(3). As shown in the table, the 
four MI approaches continued to produce biased parameter estimates when the 
exposures were independent of one another (i.e. corr( , ) = 0). When the 
outcome was unrelated to one of the exposures, parameter estimates remained 
biased only for the exposure that was predictive of the outcome; little bias was 
observed with any of the MI approaches when both exposures were unrelated to 
the outcome. Lastly, bias was reduced but still evident when data were missing 
completely at random. A similar pattern of results was observed with binary  
and , and for an outcome prevalence of 0.10. Full results for these sensitivity 
analyses are available in web appendix C (see Section 5.3.6).  
 
Table 5.3. Bias in scenarios with  and  continuous, coordinated missing data 
mechanism, and outcome prevalence = 0.30. 
Simulation scenario Parameter MVNI  MVNI + 
deletion  
FCS FCS + 
deletion 
1. Corr( , ) = 0.70, 	 = = log	(3), = 2  -0.26 0.01 -0.09 0.02 
 -0.27 -0.11 -0.24 -0.12 
2. As in (1.), but with Corr( , ) = 0  -0.27 -0.05 -0.15 -0.05 
 -0.21 -0.06 -0.16 -0.06 
3. As in (1.), but with 	 = 0  -0.04 0.02 0.01 0.02 
  -0.17 -0.03 -0.10 -0.03 
4. As in (1.), but with 	 = 0  -0.24 0.00 -0.10 0.00 
  0.00 0.00 0.00 0.00 
5. As in (1.), but with 	 = = 0  -0.01 -0.01 -0.01 -0.01 
  0.01 0.01 0.01 0.01 
6. As in (1.), but with 	 = 0 (MCAR)  -0.11 0.00 0.00 0.00 
  -0.17 -0.08 -0.08 -0.08 
Abbreviations: Corr, correlation; MCAR, missing completely at random; MVNI, multivariate normal imputation; 
FCS, fully conditional specification. 
 
Lastly, to evaluate whether the performance deficiencies of FCS could be 
attributed solely to the misspecified logistic imputation model for the outcome, we 
considered additional simulation scenarios where missing data were restricted to 
either  or  only (with logit	 (missing) = + ). Since data were missing 
in a single variable, missing values were imputed 20 times using logistic or linear 
regression as appropriate. Table 5.4 shows results for an outcome prevalence of 
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0.30, = 2 and = = log(3) for categorical exposures with RR( , ) = 2 
or continuous exposures with corr( , ) = 0.70. The results for the original 
simulation scenario for FCS under the coordinated mechanism are also presented 
for comparison. As shown in the table, estimation remained biased when missing 
data were restricted to . Indeed for continuous exposures, the bias for  was 
larger when missing data were restricted to  compared to when missing data 
were restricted to . Thus it seems that the shortcomings of FCS were at least 
partly attributable to the choice of conditional imputation model for the 
incomplete covariate . It is worth noting that the bias following the imputation 
of continuous  with a univariate linear model, as shown in Table 5.4, also 
suggests that the performance deficits seen with MVNI in the continuous 
exposure setting were partly due to inappropriate imputed values in the exposure 
(and not just the outcome). 
 
Table 5.4. Bias in scenarios with = 2, outcome prevalence = 0.30, and = =
log	(3). 
Simulation scenario Parameter Coordinated missing 
data in  and  (FCS)  
Missing data in  
only  
Missing data in   
only 
Categorical  and , 
RR( , ) = 2 
 0.03 0.02 0.02 
 -0.11 -0.06 -0.05 
Continuous  and , 
Corr( , ) = 0.70 
 -0.09 -0.08 -0.03 
 -0.24 -0.07 -0.22 




Given the widespread use of MI and the popularity of the relative risk, the lack of 
research on the application of MI for estimating the relative risk is surprising. In 
this study we demonstrated that standard model-based methods of MI can produce 
biased estimates of the relative risk with overly wide confidence intervals when 
data are MAR. Performance deficits were particularly evident when the analysis 
included continuous exposures, and in settings with larger relative risks, stronger 
missing data mechanisms and higher outcome prevalences. These findings raise 




The primary aim of this study was to contrast the performance of MVNI and FCS 
for handling missing outcome data when estimating the relative risk. MVNI 
performed more poorly than FCS, producing relative risk estimates that were 
often substantially biased towards the null, both for categorical and continuous 
exposures. Although MVNI has been shown to be robust to violations of the 
multivariate normal assumption across a range of other settings, for example in 
estimating odds ratios or dealing with non-normal exposure variables (40, 41), 
such robustness to imputation model misspecification was not evident here. In 
contrast, FCS performed well when the analysis involved categorical exposures, 
only introducing noticeable bias for an outcome prevalence of 0.30, a strong 
missing data mechanism and large relative risks. Performance was less 
satisfactory in the presence of continuous exposures, with noticeable bias towards 
the null also evident in settings involving moderate relative risks or an outcome 
prevalence of 0.10. Even when relative risks for continuous exposures were 
estimated with little bias, FCS produced confidence intervals that were too wide. 
While we would recommend FCS over MVNI for relative risk estimation based 
on the simulation results presented here, clearly the approach is not without its 
shortcomings. 
 
The secondary aim of this study was to evaluate whether deleting imputed 
outcomes improves the performance of MI for relative risk estimation. Focusing 
on FCS as the better performed method of MI, we observed little difference 
between FCS with and without deletion of imputed outcomes for analysis models 
involving categorical exposures. In the presence of continuous exposures, deleting 
imputed outcomes following FCS was associated with partial decreases in 
absolute bias at the expense of large increases in average standard errors; an 
interesting finding given that deletion improves the precision of estimation in 
settings where analysis and imputation models are the same (8). The lost precision 
with MID in the continuous exposure settings suggests that imputed values in the 
outcome contained information that was useful for analysis, which may be due to 
inconsistencies between the imputation and analysis models. Of course, since the 
imputation model was misspecified, this additional information could also result 
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in increased bias in a conventional MI analysis. In any case, we find it difficult to 
recommend MID for relative risk estimation based on these results, particularly 
since the approach is only advisable in settings where auxiliary variables for the 
outcome are unavailable (104). 
 
Although logistic regression is the standard choice for imputing binary outcomes 
in software for implementing FCS, evidently this model is not optimal for relative 
risk estimation. Since controlling for confounding differs between the odds ratio 
and the relative risk (106), it is perhaps unsurprising that performance deficits 
were observed with FCS in this simulation study. This raises the question of 
whether an alternative conditional imputation model for the outcome should be 
adopted with FCS when relative risk estimation of interest. Assuming the analysis 
model is appropriately specified, an obvious candidate to minimise the problems 
of imputation model misspecification is the log binomial model, however issues 
with non-convergence could be a significant limitation in the context of FCS. As 
relative risks are often estimated using modified Poisson regression, another 
possibility would be to impute outcomes using Poisson regression. One difficulty 
with this approach is that imputed outcome values would be counts and would 
thus entail the use of modified Poisson regression in the analysis or the use of a 
rounding method prior to analysis with a log binomial model. Rounding methods 
have not been developed for this purpose. Another important challenge would be 
to incorporate a robust estimate of the error variance within the imputation model, 
since ordinary Poisson regression tends to overestimate the standard error for the 
relative risk (62). Although other approaches have been proposed to estimate 
relative risks (e.g. Cox regression with constant time at risk (63)), like Poisson 
regression, they typically require the use of a robust error variance which would 
need to be accounted for during imputation. This is difficult to achieve with 
current MI software. 
 
In addition to the misspecified logistic model for imputing the outcome, 
sensitivity analyses revealed that the bias introduced by FCS could also be 
attributed to the conditional models used to impute the covariates. Imputing the 
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continuous covariate using linear regression in FCS assumed a linear relationship 
between the covariate and the outcome, which was inconsistent with the data 
generation model. A similar argument applies for the imputation of binary 
covariates using logistic regression. In a recent article, Bartlett and colleagues 
(30) proposed a modification to the standard FCS algorithm such that incomplete 
covariates are imputed from models that are compatible with the intended analysis 
model. While the approach seems promising in this context, further research is 
needed to understand its properties and suitability for relative risk estimation. 
 
Due to convergence problems with the log binomial model in the continuous 
exposure setting, we elected to analyse all imputed datasets using the popular 
modified Poisson regression approach. Simulation results demonstrated that this 
method performed well in the absence of missing data, which is consistent with 
previous investigations of the method (62, 63, 105). An interesting consideration 
that arose following imputation was whether to use modified Poisson regression 
to analyse all imputed datasets or only those datasets where the log binomial 
model failed to converge. We chose the former approach, as this was simpler to 
implement and seemed more in keeping with Rubin’s rules, however the latter 
could also be considered in future work.  
 
Given the missing data mechanisms considered in the simulation study, it is not 
surprising that CCA produced parameter estimates with little bias. For missing 
data in a univariate outcome, CCA is known to produce unbiased and fully 
efficient of regression coefficients when the probability of missing data depends 
only on fully observed covariates (18, 23, 24). For missing data restricted to a 
covariate , CCA is known to be unbiased (but not fully efficient) if the probability 
of missing data is independent of the outcome conditional on the other covariates 
in the model (92). Both of these conditions were satisfied in the simulation study, 
where the probability of missing data in  and  depended only on the fully 
observed covariate . Clearly these conditions do not always hold in more 
complex practical settings, and CCA can introduce considerable bias when data 
are MAR. Taking into account the potential bias and inefficiency of CCA, we do 
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not advocate its use over MI for handling arbitrary patterns of missing data when 
estimating the relative risk.  
 
Although we anticipate similar deficits with MVNI and FCS in more complex 
practical settings, it is difficult to draw definitive conclusions from a restricted set 
of simulation scenarios. Further exploration of the performance of these MI 
methods in real datasets (where the missing data mechanism is unknown) and in 
simulation scenarios with different covariate characteristics, outcome prevalences 
and missing data mechanisms would certainly be useful. A further limitation of 
the current study is that we did not evaluate alternatives to standard model-based 
methods of MI for handling missing data. Most notably we did not consider 
inverse probability weighting, a method that involves weighting complete cases in 
the analysis according to the inverse of the probability of being a complete case 
(26). We chose to focus on MI as it known to be more efficient than inverse 
probability weighting, particularly in the presence of auxiliary variables and for 
arbitrary patterns of missing data. However in light of the performance deficits of 
MI, further research could explore the use of inverse probability weighting in this 
setting. Within the MI framework, we did not consider less widely used model-
based methods such as the general location model for mixtures of continuous and 
categorical variables, or non-parametric methods such as hot deck imputation. 





In summary, standard model-based methods of MI can produce biased and 
inefficient estimates of the relative risk due to misspecification of the imputation 
model. Should MI be chosen to handle missing data, we recommend researchers 
avoid MVNI and instead use FCS without deletion for estimating relative risks. 
However, further research is needed to identify optimal approaches for relative 




5.3.6. Web appendix 
 
Web appendix A. SAS code used in simulation studies. 
 
Simulation study 1: categorical exposures 
 
%macro categorical(seed, mvni_seed, fcs_seed, rrx, rry, intercept, 
mechanism); 
 
*see note 1 for macro variable definitions; 
 
 *1. Generate x1, x2 and y; 
 
 data temp; 
  length simulation id 5.; 
  do simulation = 1 to 2000; *number of simulations = 2000; 
   do id = 1 to 1000; *sample size = 1000; 
    output; 
   end; 
  end; 
 run; 
 
 data temp; 
  set temp; 
  uniform1 = ranuni(&seed.); 
  uniform2 = ranuni(&seed.); 
  uniform3 = ranuni(&seed.); 
  uniform4 = ranuni(&seed.); 
  uniform5 = ranuni(&seed.); 
 run; 
 
 data temp; 
  set temp; 
  if uniform1 < 0.5 then x1 = 0; 
  else x1 = 1; 
 run; 
 
 %if &rrx. = 2 %then %do; 
 
  data temp; 
   set temp; 
   prob_x2 = (1/3) + (1/3)*x1; 




 %else %if &rrx. = 3 %then %do; 
 
  data temp; 
   set temp; 
   prob_x2 = (1/4) + (2/4)*x1; 




 data temp; 
  set temp; 
  if uniform2 < prob_x2 then x2 = 1; 
  else x2 = 0; 
 run; 
 
 data temp; 
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  set temp; 
  prob_y = exp(&intercept. + log(&rry.)*x1 + log(&rry.)*x2); 
  *solve intercept computationally to give desired outcome  
  prevalence, see note 2 after macro; 
 run; 
 
 data temp; 
  set temp; 
  if uniform3 <= prob_y then y = 1; 
  else y = 0; 
 run; 
 
 *2. Induce missing data in y and x2; 
 
 data temp; 
  set temp; 
  prob_y_strong = exp(-2.05 + 2*x1)/(1 + exp(-2.05 + 2*x1));  
  *intercepts produce 30% missing data in y and 2; 
  prob_y_mod = exp(-1.40 + 1*x1)/(1 + exp(-1.40 + 1*x1)); 
  prob_x2_strong = exp(-2.05 + 2*x1)/(1 + exp(-2.05 + 2*x1)); 
  prob_x2_mod = exp(-1.40 + 1*x1)/(1 + exp(-1.40 + 1*x1)); 
  prob_x2_opp_strong = exp(-0.05 - 2*x1)/(1 + exp(-0.05 - 2*x1)); 
  prob_x2_opp_mod = exp(-0.40 - 1*x1)/(1 + exp(-0.40 - 1*x1));  
 run; 
 
 %if &mechanism. = "Coordinated_strong" %then %do; 
 
  data temp; 
   set temp; 
   if uniform4 <= prob_y_strong then missing_y = 1; 
   else missing_y = 0; 
   if uniform5 <= prob_x2_strong then missing_x2 = 1; 
   else missing_x2 = 0; 




 %else %if &mechanism. = "Coordinated_mod" %then %do; 
 
  data temp; 
   set temp; 
   if uniform4 <= prob_y_mod then missing_y = 1; 
   else missing_y = 0; 
   if uniform5 <= prob_x2_mod then missing_x2 = 1; 
   else missing_x2 = 0; 




 %else %if &mechanism. = "Opposite_strong" %then %do; 
 
  data temp; 
   set temp; 
   if uniform4 <= prob_y_strong then missing_y = 1; 
   else missing_y = 0; 
   if uniform5 <= prob_x2_opp_strong then missing_x2 = 1; 
   else missing_x2 = 0; 




 %else %if &mechanism. = "Opposite_mod" %then %do; 
 
  data temp; 
   set temp; 
   if uniform4 <= prob_y_mod then missing_y = 1; 
   else missing_y = 0; 
   if uniform5 <= prob_x2_opp_mod then missing_x2 = 1; 
   else missing_x2 = 0; 
84 
 




 data temp; 
  set temp; 
  observed_y = y; 
  if missing_y = 1 then observed_y = .; 
  observed_x2 = x2; 
  if missing_x2 = 1 then observed_x2 = .; 
  keep simulation id x1 x2 y missing_y missing_x2 observed_y  
  observed_x2; 
 run; 
 
 *3. Impute data; 
 
 *MVNI with adaptive rounding; 
 
 proc mi data=temp seed=&mvni_seed. nimpute=20 out=mvni; 
  by simulation; 
  mcmc chain=single initial=em; 
  var observed_y observed_x2 x1; 
 run; 
 
 proc univariate data = mvni; 
  by simulation _imputation_; 
  var observed_y observed_x2; 
  ods output BasicMeasures = bm; 
 run; 
 
 data temp1; 
  set bm; 
  where varname = 'observed_y' and locmeasure = 'Mean'; 
  rename locvalue = w_y; 
  keep simulation _imputation_ locvalue; 
 run; 
 
 data temp2; 
  set bm; 
  where varname = 'observed_x2' and locmeasure = 'Mean'; 
  rename locvalue = w_x2; 
  keep simulation _imputation_ locvalue; 
 run; 
 
 data mvni; 
  merge mvni temp1 temp2; 
  by simulation _imputation_; 
  threshold_y = w_y - (quantile('NORMAL', w_y)*sqrt(w_y*(1- 
  w_y))); 
  threshold_x2 = w_x2 - (quantile('NORMAL', w_x2)*sqrt(w_x2*(1- 
  w_x2))); 
 run; 
 
 data mvni; 
  set mvni; 
  if observed_y > threshold_y then observed_y = 1; 
  else if observed_y <= threshold_y then observed_y = 0; 
  if observed_x2 > threshold_x2 then observed_x2 = 1; 





 proc mi data=temp seed=&fcs_seed. nimpute=20 out=fcs; 
  by simulation; 
  class observed_x2 observed_y x1; 
  fcs logistic(observed_x2) logistic(observed_y) logistic(x1); 










Note 1: macro variable definitions 
 
seed: starting seed for random number generation 
mvni_seed: starting seed for multivariate normal imputation 
fcs_seed: starting seed for fully conditional specification 
rrx: relative risk for association between X1 and X2 
rry: relative risk for association between Y and X1, and Y and X2 
intercept: intercept value for generating P(Y=1) (see note 2 below) 
mechanism: missing data mechanism, takes values "Coordinated_strong", 
"Coordinated_mod", "Opposite_strong", "Opposite_mod" (see article for 
mechanism definitions) 
  
Note 2: values for macro variable <intercept> used in simulation study: 
 
rry = 2, rrx = 2, prevalence = 0.10, intercept = -3.15 
rry = 2, rrx = 3, prevalence = 0.10, intercept = -3.17 
rry = 2, rrx = 2, prevalence = 0.30, intercept = -2.05 
rry = 2, rrx = 3, prevalence = 0.30, intercept = -2.07 
rry = 3, rrx = 2, prevalence = 0.10, intercept = -3.77 
rry = 3, rrx = 3, prevalence = 0.10, intercept = -3.81 
rry = 3, rrx = 2, prevalence = 0.30, intercept = -2.67 





*Example call of macro for rrx = 2, rry = 3, prevalence = 0.30, strong 
coordinated mechanism; 
 
%categorical(seed=1501, mvni_seed=1502, fcs_seed=1503, rrx=2, rry=3, 
intercept=-2.67, mechanism = "Coordinated_strong"); 
 
  
*Example analysis with MVNI;  
 
proc genmod data=mvni descending; 
 class observed_y; 
 by simulation _imputation_; 
 model observed_y = observed_x2 x1 / link=log dist=binomial type3 wald 
 covb; 
 ods output parameterestimates = _estimates covb = _cov 




 length parameter $11; 
 set _cov; 
 if rowname = 'Prm1' then Parameter = 'Intercept'; 
 if rowname = 'Prm2' then Parameter = 'observed_x2'; 
 if rowname = 'Prm3' then Parameter = 'x1'; 
 drop rowname; 
 rename prm1 = Intercept prm2 = observed_x2 prm3 = x1; 
run; 
 
proc mianalyze parms=_estimates covb=_cov; 
 by simulation; 
 modeleffects Intercept observed_x2 x1; 






Simulation study 2: continuous exposures 
 
%macro continuous(seed, mvni_seed, fcs_seed, corrx, rry, intercept, 
intercept_miss_y, intercept_miss_x2, mechanism); 
 
*see note 1 for macro variable definitions; 
 
 *1. Generate x1, x2 and y; 
 
 data temp; 
  length simulation id 5.; 
  do simulation = 1 to 2000; *number of simulations = 2000; 
   do id = 1 to 1200;  
   *sample size = 1000, allowing extra observations so that 
   out of range values for P(Y=1) can be replaced; 
    output; 
   end; 
  end; 
 run; 
 
 data temp; 
  set temp; 
  uniform1 = ranuni(&seed.); 
  uniform2 = ranuni(&seed.); 
  uniform3 = ranuni(&seed.); 
  normal1 = rannor(&seed.); 
  normal2 = rannor(&seed.); 
 run; 
 
 data temp; 
  set temp; 
  x1 = sqrt(0.2)*normal1; 
 run; 
 
 data temp; 
  set temp; 
  x2 = &corrx.*x1 + sqrt(0.2*(1-&corrx.*&corrx.))*normal2; 
  x1_std = x1/sqrt(0.2); 
 run; 
 
 data temp; 
  set temp; 
  prob_y = exp(&intercept. + log(&rry.)*x1 + log(&rry.)*x2);  
  *solve intercept computationally to give desired outcome  
  prevalence, see note 2 after macro; 
 run; 
 
 data out_of_range; 
  set temp; 
  where prob_y > 1; 
 run; 
  
 data out_of_range; 
  set out_of_range; 
  count = _n_; 
  indicator = 1; 
 run; 
 
 data out_of_range; 
  set out_of_range; 
  by indicator; 
  if last.indicator; 
  percent_out_range = 100*count/(1200*2000);  
  *calculate percentage simulated values outside of range; 





 data temp; 
  set temp; 
  if prob_y > 1 then delete; *exclude observations where   
  probability out of range; 
 run; 
 
 data temp; 
  retain counter; 
  set temp; 
  by simulation; 
  if first.simulation then counter = 1; 
  else counter = counter + 1; 
 run; 
 
 data temp; 
  set temp; 
  where counter <= 1000; 
  if uniform1 <= prob_y then y = 1; 
  else y = 0; 
 run; 
 
 *2. Induce missing data in y and x2; 
 
 %if &mechanism. = "Coordinated" %then %do; 
 
  data temp; 
   set temp; 
   prob_y_miss = exp(&intercept_miss_y. + 2*x1_std)/(1 +  
   exp(&intercept_miss_y. + 2*x1_std));  
   prob_x2_miss = exp(&intercept_miss_x2. + 2*x1_std)/(1 +  
   exp(&intercept_miss_x2. + 2*x1_std)); 
   *solve intercept computationally to produce 30% missing  
   data in y and x2, see note 3 after macro; 




 %if &mechanism. = "Coordinated_mod" %then %do; 
 
  data temp; 
   set temp; 
   prob_y_miss = exp(&intercept_miss_y. + 1*x1_std)/(1 +  
   exp(&intercept_miss_y. + 1*x1_std)); 
   prob_x2_miss = exp(&intercept_miss_x2. + 1*x1_std)/(1 +  
   exp(&intercept_miss_x2. + 1*x1_std)); 




 %if &mechanism. = "Opposite" %then %do; 
 
  data temp; 
   set temp; 
   prob_y_miss = exp(&intercept_miss_y. + 2*x1_std)/(1 +  
   exp(&intercept_miss_y. + 2*x1_std)); 
   prob_x2_miss = exp(&intercept_miss_x2. - 2*x1_std)/(1 +  
   exp(&intercept_miss_x2. - 2*x1_std)); 




 %if &mechanism. = "Opposite_mod" %then %do; 
 
  data temp; 
   set temp; 
   prob_y_miss = exp(&intercept_miss_y. + 1*x1_std)/(1 +  
   exp(&intercept_miss_y. + 1*x1_std)); 
   prob_x2_miss = exp(&intercept_miss_x2. - 1*x1_std)/(1 +  
   exp(&intercept_miss_x2. - 1*x1_std)); 
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 data temp; 
  set temp; 
  if uniform2 <= prob_y_miss then missing_y = 1; 
  else missing_y = 0; 
  if uniform3 <= prob_x2_miss then missing_x2 = 1; 
  else missing_x2 = 0; 
 run; 
 
 data temp; 
  set temp; 
  observed_y = y; 
  if missing_y = 1 then observed_y = .; 
  observed_x2 = x2; 
  if missing_x2 = 1 then observed_x2 = .; 
  keep simulation id x1 x2 y missing_y missing_x2 observed_y  
  observed_x2;  
 run; 
 
 *3. Impute data; 
 
 *MVNI with adaptive rounding; 
 
 proc mi data=temp seed=&mvni_seed. nimpute=20 out=mvni; 
  by simulation; 
  mcmc chain=single initial=em; 
  var observed_y observed_x2 x1; 
 run; 
 
 proc univariate data = mvni; 
  by simulation _imputation_; 
  var observed_y; 
  ods output BasicMeasures = bm; 
 run; 
 
 data temp1; 
  set bm; 
  where varname = 'observed_y' and locmeasure = 'Mean'; 
  rename locvalue = w_y; 
  keep simulation _imputation_ locvalue; 
 run; 
 
 data mvni; 
  merge mvni temp1; 
  by simulation _imputation_; 
  threshold_y = w_y - (quantile('NORMAL', w_y)*sqrt(w_y*(1- 
  w_y))); 
 run; 
 
 data mvni; 
  set mvni; 
  if observed_y > threshold_y then observed_y = 1; 





 proc mi data=temp seed=&fcs_seed. nimpute=20 out=fcs; 
  by simulation; 
  class observed_y; 
  fcs reg(observed_x2) logistic(observed_y) reg(x1); 










Note 1: macro variable definitions 
 
seed: starting seed for random number generation 
mvni_seed: starting seed for multivariate normal imputation 
fcs_seed: starting seed for fully conditional specification 
corrx: correlation for association between X1 and X2 
rry: relative risk for association between Y and X1, and Y and X2 
intercept: intercept value for generating P(Y=1) (see note 2 below) 
intercept_miss_y: intercept value for generating 30% missing data in Y (see 
note 3 below) 
intercept_miss_x2: intercept value for generating 30% missing data in X2 (see 
note 3 below) 
mechanism: missing data mechanism, takes values "Coordinated_strong", 
"Coordinated_mod", "Opposite_strong", "Opposite_mod" (see article for 
mechanism definitions) 
  
Note 2: values for macro variable <intercept> used in simulation study: 
 
rry = 2, corrx = 0.30, prevalence = 0.10, intercept = -2.43 
rry = 2, corrx = 0.70, prevalence = 0.10, intercept = -2.46 
rry = 2, corrx = 0.30, prevalence = 0.30, intercept = -1.32 
rry = 2, corrx = 0.70, prevalence = 0.30, intercept = -1.34 
rry = 3, corrx = 0.30, prevalence = 0.10, intercept = -2.61 
rry = 3, corrx = 0.70, prevalence = 0.10, intercept = -2.69 
rry = 3, corrx = 0.30, prevalence = 0.30, intercept = -1.37 
rry = 3, corrx = 0.70, prevalence = 0.30, intercept = -1.36 
 
Note 3: values for macro variables <intercept_miss_y> and <intercept_miss_x2> 
used in simulation study: 
 
Moderate mechanism, intercept_miss_y = intercept_miss_x2 = -1.02 
Strong mechanism, intercept_miss_y = intercept_miss_x2 = -1.39 
 
-> Note intercept values adjusted in scenarios with an outcome prevalence of 






*Example call of macro for corrx = 0.70, rry = 2, prevalence = 0.10, moderate 
coordinated mechanism; 
 
%continuous (seed=12601, mvni_seed=12602, fcs_seed=12603, corrx=0.70, rry=2, 
intercept=-2.46, intercept_miss_y = -1.02, intercept_miss_x2 = -1.02, 
mechanism = "Coordinated_mod"); 
 
 
*Example analysis with FCS (using log Poisson GEE to estimate the relative 
risk);  
 
proc genmod data=fcs; 
 class id; 
 by simulation _imputation_; 
 model observed_y = observed_x2 x1 / link=log dist=poisson type3 wald 
 covb; 
 repeated subject = id /type=ind;  




 set _estimates; 
 rename parm = parameter; 






 length parameter $11; 
 set _cov; 
 if rowname = 'Prm1' then Parameter = 'Intercept'; 
 if rowname = 'Prm2' then Parameter = 'observed_x2'; 
 if rowname = 'Prm3' then Parameter = 'x1'; 
 drop rowname; 
 rename prm1 = Intercept prm2 = observed_x2 prm3 = x1; 
run; 
 
proc mianalyze parms=_estimates covb=_cov; 
 by simulation; 
 modeleffects Intercept observed_x2 x1; 








Web appendix B. Full results from simulation studies 1 and 2. 
 
Table 5.5. Simulation results for  and  binary, coordinated mechanism, = 1. 
Outcome 
prevalence 





0.10 Log(2) 2 MVNI -0.04 0.26 0.24 0.961 0.06 
    -0.14 0.30 0.26 0.941 0.09 
   MVNI + deletion 0.05 0.27 0.27 0.948 0.08 
    -0.05 0.32 0.30 0.960 0.10 
   FCS 0.02 0.27 0.28 0.945 0.08 
    0.00 0.33 0.34 0.957 0.11 
   FCS + deletion 0.02 0.27 0.28 0.947 0.08 
    0.01 0.33 0.34 0.957 0.11 
   CCA 0.02 0.31 0.32 0.954 0.10 
    0.01 0.33 0.33 0.957 0.11 
0.10 Log(2) 3 MVNI -0.04 0.29 0.27 0.968 0.07 
    -0.14 0.33 0.28 0.957 0.10 
   MVNI + deletion 0.05 0.30 0.30 0.958 0.09 
    -0.05 0.36 0.33 0.962 0.11 
   FCS 0.02 0.31 0.31 0.955 0.10 
    0.01 0.37 0.37 0.947 0.14 
   FCS + deletion 0.01 0.30 0.31 0.952 0.10 
    0.02 0.37 0.37 0.951 0.14 
   CCA 0.00 0.34 0.34 0.953 0.12 
    0.03 0.36 0.37 0.948 0.14 
0.10 Log(3) 2 MVNI -0.07 0.30 0.27 0.958 0.08 
    -0.27 0.34 0.27 0.895 0.15 
   MVNI + deletion 0.08 0.30 0.32 0.951 0.11 
    -0.10 0.38 0.35 0.944 0.13 
   FCS 0.04 0.31 0.32 0.953 0.10 
    0.02 0.40 0.41 0.954 0.17 
   FCS + deletion 0.03 0.30 0.32 0.953 0.10 
    0.03 0.40 0.41 0.958 0.17 
   CCA 0.04 0.35 0.36 0.953 0.13 
    0.03 0.39 0.41 0.951 0.17 
0.10 Log(3) 3 MVNI -0.04 0.34 0.30 0.969 0.09 
    -0.29 0.37 0.30 0.901 0.17 
   MVNI + deletion 0.11 0.35 0.35 0.957 0.13 
    -0.11 0.42 0.38 0.954 0.16 
   FCS 0.05 0.35 0.35 0.955 0.13 
    0.02 0.44 0.45 0.957 0.21 
   FCS + deletion 0.05 0.35 0.35 0.948 0.13 
    0.03 0.44 0.45 0.958 0.21 
   CCA 0.04 0.39 0.39 0.954 0.16 










0.30 Log(2) 2 MVNI -0.01 0.14 0.13 0.959 0.02 
    -0.13 0.15 0.14 0.884 0.04 
   MVNI + deletion 0.03 0.14 0.14 0.950 0.02 
    -0.07 0.17 0.15 0.941 0.03 
   FCS 0.01 0.14 0.14 0.949 0.02 
    -0.03 0.17 0.17 0.954 0.03 
   FCS + deletion 0.01 0.14 0.14 0.950 0.02 
    -0.01 0.17 0.17 0.953 0.03 
   CCA 0.01 0.16 0.16 0.949 0.02 
    0.00 0.17 0.17 0.957 0.03 
0.30 Log(2) 3 MVNI 0.01 0.15 0.15 0.958 0.02 
    -0.14 0.17 0.16 0.881 0.04 
   MVNI + deletion 0.05 0.16 0.15 0.949 0.03 
    -0.07 0.18 0.17 0.939 0.03 
   FCS 0.02 0.16 0.16 0.953 0.02 
    -0.02 0.19 0.19 0.950 0.04 
   FCS + deletion 0.01 0.16 0.16 0.949 0.02 
    -0.01 0.19 0.19 0.952 0.04 
   CCA 0.00 0.17 0.17 0.948 0.03 
    0.01 0.19 0.19 0.951 0.04 
0.30 Log(3) 2 MVNI -0.01 0.16 0.15 0.955 0.02 
    -0.26 0.17 0.15 0.682 0.09 
   MVNI + deletion 0.05 0.16 0.16 0.948 0.03 
    -0.12 0.19 0.18 0.893 0.05 
   FCS 0.01 0.16 0.16 0.954 0.03 
    -0.06 0.20 0.20 0.933 0.04 
   FCS + deletion 0.01 0.16 0.16 0.951 0.03 
    -0.03 0.20 0.20 0.946 0.04 
   CCA 0.01 0.18 0.18 0.954 0.03 
    0.01 0.20 0.20 0.955 0.04 
0.30 Log(3) 3 MVNI 0.03 0.18 0.18 0.948 0.03 
    -0.27 0.19 0.18 0.719 0.10 
   MVNI + deletion 0.08 0.18 0.19 0.931 0.04 
    -0.13 0.22 0.20 0.901 0.06 
   FCS 0.03 0.19 0.19 0.940 0.04 
    -0.06 0.23 0.22 0.934 0.05 
   FCS + deletion 0.02 0.18 0.19 0.938 0.04 
    -0.02 0.23 0.23 0.945 0.05 
   CCA 0.01 0.20 0.21 0.942 0.04 
    0.01 0.23 0.23 0.950 0.05 
Abbreviations: MVNI, multivariate normal imputation; FCS, fully conditional specification; CCA, complete case 





Table 5.6. Simulation results for  and  binary, coordinated mechanism, = 2. 
Outcome 
prevalence 





0.10 Log(2) 2 MVNI -0.07 0.26 0.24 0.954 0.06 
    -0.15 0.30 0.26 0.936 0.09 
   MVNI + deletion 0.03 0.27 0.27 0.956 0.07 
    -0.05 0.33 0.31 0.958 0.10 
   FCS 0.01 0.27 0.27 0.947 0.07 
    -0.00 0.34 0.34 0.957 0.12 
   FCS + deletion 0.01 0.27 0.27 0.950 0.07 
    0.00 0.34 0.34 0.955 0.12 
   CCA -0.01 0.32 0.32 0.954 0.10 
    0.01 0.34 0.34 0.953 0.11 
0.10 Log(2) 3 MVNI -0.05 0.29 0.28 0.951 0.08 
    -0.14 0.33 0.29 0.948 0.11 
   MVNI + deletion 0.05 0.30 0.31 0.947 0.10 
    -0.04 0.36 0.34 0.956 0.12 
   FCS 0.02 0.30 0.31 0.942 0.10 
    0.00 0.37 0.37 0.949 0.14 
   FCS + deletion 0.01 0.30 0.31 0.943 0.10 
    0.01 0.37 0.37 0.950 0.14 
   CCA -0.01 0.35 0.36 0.952 0.13 
    0.02 0.36 0.37 0.948 0.14 
0.10 Log(3) 2 MVNI -0.08 0.30 0.28 0.951 0.08 
    -0.28 0.35 0.28 0.896 0.15 
   MVNI + deletion 0.06 0.30 0.31 0.955 0.10 
    -0.09 0.39 0.35 0.956 0.13 
   FCS 0.02 0.30 0.31 0.955 0.10 
    -0.00 0.40 0.40 0.962 0.16 
   FCS + deletion 0.02 0.30 0.31 0.948 0.09 
    0.01 0.40 0.40 0.962 0.16 
   CCA 0.01 0.34 0.34 0.953 0.12 
    0.03 0.40 0.40 0.964 0.16 
0.10 Log(3) 3 MVNI -0.03 0.34 0.32 0.961 0.10 
    -0.28 0.39 0.32 0.893 0.18 
   MVNI + deletion 0.10 0.34 0.35 0.955 0.13 
    -0.10 0.43 0.39 0.955 0.16 
   FCS 0.05 0.35 0.35 0.947 0.13 
    -0.00 0.44 0.45 0.956 0.20 
   FCS + deletion 0.04 0.34 0.35 0.949 0.12 
    0.02 0.44 0.45 0.960 0.20 
   CCA 0.03 0.38 0.40 0.951 0.16 
    0.04 0.44 0.45 0.963 0.20 
0.30 Log(2) 2 MVNI 0.00 0.14 0.14 0.949 0.02 
    -0.16 0.16 0.14 0.836 0.04 










    -0.07 0.17 0.16 0.933 0.03 
   FCS 0.01 0.14 0.14 0.943 0.02 
    -0.05 0.17 0.17 0.940 0.03 
   FCS + deletion 0.01 0.14 0.14 0.946 0.02 
    -0.02 0.17 0.17 0.949 0.03 
   CCA -0.00 0.16 0.16 0.945 0.03 
    0.00 0.17 0.17 0.953 0.03 
0.30 Log(2) 3 MVNI 0.03 0.15 0.15 0.955 0.02 
    -0.16 0.17 0.16 0.843 0.05 
   MVNI + deletion 0.05 0.15 0.15 0.949 0.03 
    -0.07 0.18 0.18 0.927 0.04 
   FCS 0.02 0.16 0.16 0.948 0.03 
    -0.05 0.19 0.19 0.930 0.04 
   FCS + deletion 0.01 0.15 0.16 0.945 0.02 
    -0.02 0.19 0.19 0.940 0.04 
   CCA 0.00 0.17 0.17 0.954 0.03 
    0.00 0.19 0.20 0.941 0.04 
0.30 Log(3) 2 MVNI 0.03 0.16 0.15 0.952 0.02 
    -0.32 0.17 0.16 0.547 0.13 
   MVNI + deletion 0.05 0.16 0.16 0.948 0.03 
    -0.15 0.20 0.19 0.872 0.06 
   FCS 0.03 0.16 0.16 0.951 0.03 
    -0.11 0.20 0.21 0.893 0.05 
   FCS + deletion 0.02 0.16 0.16 0.955 0.02 
    -0.06 0.21 0.21 0.932 0.05 
   CCA 0.01 0.17 0.17 0.953 0.03 
    0.01 0.21 0.22 0.949 0.05 
0.30 Log(3) 3 MVNI 0.07 0.18 0.18 0.938 0.04 
    -0.31 0.20 0.18 0.640 0.13 
   MVNI + deletion 0.07 0.18 0.18 0.939 0.04 
    -0.14 0.22 0.21 0.895 0.06 
   FCS 0.04 0.18 0.18 0.946 0.04 
    -0.10 0.23 0.22 0.921 0.06 
   FCS + deletion 0.02 0.18 0.18 0.949 0.03 
    -0.04 0.23 0.23 0.939 0.06 
   CCA -0.00 0.19 0.20 0.952 0.04 
    0.02 0.23 0.23 0.942 0.06 
Abbreviations: MVNI, multivariate normal imputation; FCS, fully conditional specification; CCA, complete case 





Table 5.7. Simulation results for  and  binary, opposite mechanism, = 1. 
Outcome 
prevalence 





0.10 Log(2) 2 MVNI -0.05 0.26 0.23 0.964 0.06 
    -0.13 0.30 0.25 0.953 0.08 
   MVNI + deletion 0.04 0.27 0.26 0.958 0.07 
    -0.03 0.32 0.30 0.961 0.09 
   FCS 0.01 0.27 0.27 0.953 0.07 
    0.03 0.33 0.34 0.950 0.12 
   FCS + deletion 0.01 0.27 0.27 0.954 0.07 
    0.03 0.33 0.34 0.950 0.12 
   CCA 0.01 0.33 0.34 0.950 0.11 
    0.03 0.33 0.34 0.951 0.12 
0.10 Log(2) 3 MVNI -0.04 0.29 0.26 0.969 0.07 
    -0.14 0.32 0.28 0.950 0.10 
   MVNI + deletion 0.05 0.30 0.29 0.961 0.09 
    -0.04 0.35 0.33 0.957 0.11 
   FCS 0.00 0.31 0.30 0.951 0.09 
    0.04 0.37 0.38 0.949 0.15 
   FCS + deletion -0.00 0.30 0.30 0.951 0.09 
    0.04 0.36 0.38 0.946 0.15 
   CCA 0.01 0.36 0.37 0.950 0.14 
    0.04 0.36 0.38 0.947 0.14 
0.10 Log(3) 2 MVNI -0.08 0.30 0.26 0.956 0.08 
    -0.24 0.33 0.26 0.907 0.13 
   MVNI + deletion 0.07 0.30 0.31 0.952 0.10 
    -0.06 0.37 0.34 0.959 0.12 
   FCS 0.02 0.31 0.32 0.948 0.10 
    0.06 0.39 0.41 0.953 0.17 
   FCS + deletion 0.02 0.30 0.31 0.946 0.10 
    0.07 0.39 0.41 0.953 0.17 
   CCA 0.06 0.38 0.69 0.950 0.48 
    0.06 0.38 0.41 0.952 0.17 
0.10 Log(3) 3 MVNI -0.04 0.33 0.29 0.973 0.09 
    -0.27 0.36 0.28 0.907 0.15 
   MVNI + deletion 0.10 0.35 0.35 0.955 0.13 
    -0.09 0.40 0.36 0.957 0.14 
   FCS 0.03 0.35 0.36 0.948 0.13 
    0.05 0.43 0.45 0.955 0.21 
   FCS + deletion 0.03 0.35 0.36 0.945 0.13 
    0.06 0.43 0.45 0.958 0.21 
   CCA 0.06 0.43 0.45 0.956 0.21 
    0.05 0.43 0.45 0.959 0.20 
0.30 Log(2) 2 MVNI -0.02 0.14 0.13 0.951 0.02 
    -0.10 0.15 0.14 0.905 0.03 










    -0.03 0.16 0.16 0.943 0.03 
   FCS -0.00 0.14 0.14 0.946 0.02 
    0.00 0.17 0.17 0.947 0.03 
   FCS + deletion -0.00 0.14 0.14 0.946 0.02 
    0.02 0.17 0.17 0.944 0.03 
   CCA 0.01 0.17 0.17 0.949 0.03 
    0.01 0.17 0.17 0.944 0.03 
0.30 Log(2) 3 MVNI 0.00 0.15 0.14 0.964 0.02 
    -0.11 0.17 0.15 0.901 0.04 
   MVNI + deletion 0.04 0.16 0.15 0.949 0.02 
    -0.04 0.18 0.17 0.945 0.03 
   FCS 0.00 0.16 0.16 0.956 0.02 
    0.01 0.19 0.19 0.947 0.03 
   FCS + deletion -0.00 0.16 0.16 0.952 0.02 
    0.02 0.19 0.19 0.951 0.04 
   CCA 0.01 0.18 0.18 0.949 0.03 
    0.01 0.18 0.18 0.948 0.03 
0.30 Log(3) 2 MVNI -0.03 0.16 0.15 0.955 0.02 
    -0.19 0.17 0.16 0.798 0.06 
   MVNI + deletion 0.03 0.16 0.15 0.958 0.02 
    -0.05 0.19 0.18 0.942 0.04 
   FCS -0.01 0.16 0.16 0.952 0.02 
    0.00 0.20 0.20 0.954 0.04 
   FCS + deletion -0.01 0.16 0.16 0.947 0.02 
    0.04 0.20 0.20 0.952 0.04 
   CCA 0.00 0.19 0.20 0.949 0.04 
    0.01 0.19 0.20 0.955 0.04 
0.30 Log(3) 3 MVNI 0.01 0.18 0.17 0.960 0.03 
    -0.21 0.19 0.18 0.810 0.07 
   MVNI + deletion 0.05 0.18 0.18 0.951 0.04 
    -0.07 0.21 0.20 0.944 0.05 
   FCS -0.00 0.19 0.19 0.947 0.04 
    0.01 0.23 0.23 0.949 0.05 
   FCS + deletion -0.01 0.18 0.19 0.944 0.04 
    0.05 0.23 0.23 0.949 0.06 
   CCA 0.01 0.22 0.23 0.943 0.05 
    0.02 0.22 0.23 0.946 0.05 
Abbreviations: MVNI, multivariate normal imputation; FCS, fully conditional specification; CCA, complete case 




Table 5.8. Simulation results for  and  binary, opposite mechanism, = 2. 
Outcome 
prevalence 





0.10 Log(2) 2 MVNI -0.06 0.26 0.24 0.963 0.06 
    -0.13 0.31 0.27 0.951 0.09 
   MVNI + deletion 0.04 0.27 0.27 0.959 0.07 
    -0.03 0.33 0.32 0.960 0.10 
   FCS 0.01 0.27 0.27 0.959 0.07 
    0.03 0.34 0.36 0.955 0.13 
   FCS + deletion 0.01 0.27 0.27 0.959 0.07 
    0.03 0.34 0.36 0.946 0.13 
   CCA 0.02 0.34 0.34 0.962 0.12 
    0.02 0.34 0.36 0.954 0.13 
0.10 Log(2) 3 MVNI -0.05 0.29 0.27 0.959 0.08 
    -0.14 0.33 0.28 0.952 0.10 
   MVNI + deletion 0.05 0.30 0.30 0.949 0.09 
    -0.04 0.36 0.33 0.960 0.11 
   FCS 0.01 0.31 0.31 0.943 0.10 
    0.04 0.38 0.39 0.948 0.15 
   FCS + deletion -0.00 0.30 0.31 0.940 0.10 
    0.05 0.38 0.39 0.949 0.16 
   CCA 0.03 0.37 0.39 0.954 0.15 
    0.04 0.37 0.39 0.947 0.15 
0.10 Log(3) 2 MVNI -0.08 0.29 0.28 0.949 0.08 
    -0.26 0.34 0.26 0.908 0.13 
   MVNI + deletion 0.05 0.30 0.30 0.955 0.09 
    -0.07 0.37 0.33 0.964 0.11 
   FCS 0.01 0.30 0.31 0.952 0.10 
    0.03 0.39 0.39 0.963 0.16 
   FCS + deletion 0.01 0.30 0.31 0.950 0.09 
    0.05 0.39 0.40 0.964 0.16 
   CCA 0.03 0.39 0.41 0.956 0.17 
    0.03 0.39 0.39 0.965 0.15 
0.10 Log(3) 3 MVNI -0.04 0.33 0.30 0.967 0.09 
    -0.27 0.38 0.29 0.906 0.16 
   MVNI + deletion 0.09 0.34 0.32 0.965 0.11 
    -0.09 0.41 0.37 0.952 0.14 
   FCS 0.02 0.34 0.34 0.956 0.12 
    0.05 0.44 0.46 0.956 0.22 
   FCS + deletion 0.01 0.34 0.34 0.956 0.11 
    0.07 0.44 0.47 0.957 0.22 
   CCA 0.05 0.44 0.45 0.961 0.20 
    0.05 0.44 0.46 0.954 0.21 
0.30 Log(2) 2 MVNI -0.01 0.14 0.13 0.955 0.02 
    -0.10 0.16 0.14 0.916 0.03 










    -0.02 0.17 0.16 0.959 0.03 
   FCS -0.01 0.14 0.14 0.949 0.02 
    0.01 0.17 0.17 0.953 0.03 
   FCS + deletion -0.01 0.14 0.14 0.946 0.02 
    0.03 0.18 0.18 0.955 0.03 
   CCA 0.00 0.17 0.18 0.951 0.03 
    0.01 0.17 0.17 0.952 0.03 
0.30 Log(2) 3 MVNI 0.01 0.15 0.15 0.952 0.02 
    -0.11 0.17 0.16 0.914 0.04 
   MVNI + deletion 0.03 0.15 0.15 0.950 0.02 
    -0.03 0.19 0.18 0.953 0.03 
   FCS -0.01 0.16 0.16 0.941 0.03 
    0.01 0.19 0.20 0.954 0.04 
   FCS + deletion -0.02 0.16 0.16 0.938 0.03 
    0.04 0.19 0.20 0.948 0.04 
   CCA 0.00 0.19 0.20 0.935 0.04 
    0.01 0.19 0.19 0.951 0.04 
0.30 Log(3) 2 MVNI -0.00 0.16 0.15 0.961 0.02 
    -0.20 0.18 0.16 0.805 0.06 
   MVNI + deletion 0.03 0.16 0.15 0.961 0.02 
    -0.02 0.20 0.19 0.952 0.03 
   FCS -0.00 0.16 0.16 0.951 0.02 
    0.01 0.20 0.20 0.948 0.04 
   FCS + deletion -0.02 0.16 0.15 0.949 0.02 
    0.07 0.21 0.21 0.947 0.05 
   CCA 0.01 0.20 0.20 0.952 0.04 
    0.02 0.20 0.20 0.952 0.04 
0.30 Log(3) 3 MVNI 0.04 0.18 0.17 0.961 0.03 
    -0.22 0.20 0.18 0.809 0.08 
   MVNI + deletion 0.05 0.18 0.17 0.961 0.03 
    -0.04 0.22 0.21 0.946 0.05 
   FCS -0.00 0.18 0.18 0.956 0.03 
    0.01 0.23 0.24 0.948 0.06 
   FCS + deletion -0.02 0.18 0.18 0.951 0.03 
    0.07 0.24 0.24 0.942 0.06 
   CCA 0.02 0.23 0.22 0.956 0.05 
    0.01 0.23 0.23 0.949 0.05 
Abbreviations: MVNI, multivariate normal imputation; FCS, fully conditional specification; CCA, complete case 






Table 5.9. Simulation results for  and  continuous, coordinated mechanism, = 1. 
Outcome 
prevalence 





0.10 Log(2) 0.30 MVNI -0.18 0.29 0.24 0.952 0.09 
    -0.11 0.33 0.29 0.963 0.10 
   MVNI + deletion -0.01 0.33 0.31 0.962 0.10 
    -0.01 0.35 0.34 0.958 0.12 
   FCS -0.02 0.31 0.30 0.958 0.09 
    -0.02 0.34 0.33 0.955 0.11 
   FCS + deletion -0.00 0.33 0.31 0.964 0.10 
    -0.01 0.35 0.34 0.961 0.11 
   CCA -0.00 0.39 0.39 0.935 0.15 
    0.01 0.34 0.34 0.940 0.12 
0.10 Log(2) 0.70 MVNI -0.20 0.42 0.36 0.953 0.17 
    -0.11 0.45 0.40 0.971 0.17 
   MVNI + deletion 0.01 0.47 0.45 0.963 0.20 
    -0.00 0.49 0.47 0.958 0.22 
   FCS -0.01 0.44 0.43 0.953 0.19 
    -0.03 0.47 0.46 0.955 0.21 
   FCS + deletion 0.01 0.47 0.45 0.959 0.20 
    -0.01 0.49 0.47 0.963 0.22 
   CCA 0.00 0.51 0.52 0.935 0.27 
    0.01 0.47 0.48 0.943 0.23 
0.10 Log(3) 0.30 MVNI -0.29 0.30 0.24 0.892 0.15 
    -0.21 0.34 0.29 0.943 0.13 
   MVNI + deletion -0.01 0.35 0.32 0.969 0.10 
    -0.04 0.37 0.35 0.964 0.12 
   FCS -0.05 0.32 0.30 0.963 0.09 
    -0.09 0.35 0.33 0.953 0.12 
   FCS + deletion -0.01 0.35 0.32 0.972 0.10 
    -0.04 0.37 0.35 0.958 0.12 
   CCA 0.01 0.41 0.42 0.938 0.18 
    -0.01 0.35 0.36 0.940 0.13 
0.10 Log(3) 0.70 MVNI -0.31 0.45 0.37 0.939 0.23 
    -0.23 0.47 0.40 0.963 0.22 
   MVNI + deletion 0.03 0.50 0.47 0.970 0.22 
    -0.06 0.52 0.48 0.970 0.23 
   FCS -0.02 0.46 0.44 0.965 0.19 
    -0.12 0.48 0.45 0.965 0.22 
   FCS + deletion 0.03 0.50 0.47 0.971 0.22 
    -0.06 0.52 0.48 0.969 0.23 
   CCA 0.02 0.55 0.56 0.940 0.32 
    0.00 0.50 0.51 0.942 0.26 
0.30 Log(2) 0.30 MVNI -0.11 0.16 0.13 0.956 0.03 
    -0.10 0.18 0.14 0.956 0.03 










    -0.02 0.19 0.16 0.981 0.03 
   FCS -0.04 0.17 0.14 0.975 0.02 
    -0.06 0.18 0.15 0.965 0.03 
   FCS + deletion -0.00 0.19 0.15 0.985 0.02 
    -0.02 0.19 0.16 0.983 0.03 
   CCA 0.00 0.20 0.19 0.953 0.04 
    0.01 0.17 0.17 0.950 0.03 
0.30 Log(2) 0.70 MVNI -0.10 0.23 0.19 0.968 0.05 
    -0.12 0.24 0.20 0.959 0.05 
   MVNI + deletion 0.02 0.26 0.22 0.984 0.05 
    -0.04 0.26 0.22 0.986 0.05 
   FCS -0.02 0.23 0.21 0.976 0.04 
    -0.08 0.24 0.21 0.971 0.05 
   FCS + deletion 0.02 0.26 0.22 0.983 0.05 
    -0.04 0.26 0.22 0.986 0.05 
   CCA 0.00 0.26 0.26 0.942 0.07 
    0.01 0.24 0.24 0.953 0.06 
0.30 Log(3) 0.30 MVNI -0.22 0.17 0.13 0.820 0.07 
    -0.22 0.18 0.14 0.842 0.07 
   MVNI + deletion -0.06 0.20 0.16 0.983 0.03 
    -0.09 0.20 0.16 0.970 0.03 
   FCS -0.12 0.17 0.14 0.939 0.04 
    -0.16 0.18 0.15 0.906 0.05 
   FCS + deletion -0.06 0.20 0.16 0.981 0.03 
    -0.10 0.20 0.16 0.968 0.03 
   CCA 0.00 0.20 0.21 0.947 0.04 
    -0.00 0.18 0.18 0.956 0.03 
0.30 Log(3) 0.70 MVNI -0.17 0.24 0.19 0.946 0.07 
    -0.25 0.24 0.19 0.887 0.10 
   MVNI + deletion -0.00 0.28 0.22 0.985 0.05 
    -0.12 0.27 0.22 0.969 0.06 
   FCS -0.05 0.24 0.21 0.977 0.05 
    -0.19 0.24 0.21 0.921 0.08 
   FCS + deletion 0.01 0.28 0.22 0.987 0.05 
    -0.12 0.27 0.22 0.966 0.06 
   CCA 0.01 0.26 0.27 0.947 0.07 
    0.01 0.24 0.24 0.947 0.06 
Abbreviations: MVNI, multivariate normal imputation; FCS, fully conditional specification; CCA, complete case 














0.10 Log(2) 0.30 MVNI -0.27 0.31 0.24 0.933 0.13 
    -0.13 0.33 0.28 0.965 0.09 
   MVNI + deletion -0.01 0.38 0.36 0.969 0.13 
    -0.02 0.35 0.33 0.967 0.11 
   FCS -0.03 0.35 0.33 0.963 0.11 
    -0.04 0.34 0.32 0.964 0.10 
   FCS + deletion -0.01 0.38 0.36 0.969 0.13 
    -0.02 0.35 0.33 0.966 0.11 
   CCA -0.01 0.45 0.45 0.945 0.20 
    -0.01 0.34 0.33 0.947 0.11 
0.10 Log(2) 0.70 MVNI -0.32 0.44 0.35 0.939 0.23 
    -0.13 0.45 0.40 0.969 0.17 
   MVNI + deletion 0.01 0.51 0.47 0.964 0.23 
    -0.01 0.49 0.47 0.959 0.22 
   FCS -0.02 0.47 0.45 0.964 0.20 
    -0.05 0.46 0.45 0.961 0.20 
   FCS + deletion 0.01 0.51 0.47 0.963 0.23 
    -0.01 0.49 0.47 0.962 0.22 
   CCA 0.02 0.57 0.58 0.941 0.34 
    -0.00 0.47 0.48 0.940 0.23 
0.10 Log(3) 0.30 MVNI -0.46 0.32 0.25 0.758 0.27 
    -0.21 0.35 0.31 0.934 0.14 
   MVNI + deletion 0.00 0.42 0.39 0.964 0.15 
    -0.03 0.38 0.37 0.959 0.14 
   FCS -0.07 0.35 0.34 0.953 0.12 
    -0.11 0.35 0.34 0.952 0.13 
   FCS + deletion 0.01 0.42 0.39 0.969 0.15 
    -0.03 0.38 0.37 0.958 0.13 
   CCA 0.03 0.50 0.51 0.944 0.26 
    -0.00 0.36 0.38 0.935 0.15 
0.10 Log(3) 0.70 MVNI -0.56 0.48 0.39 0.838 0.47 
    -0.22 0.50 0.43 0.958 0.24 
   MVNI + deletion 0.01 0.58 0.55 0.965 0.30 
    -0.03 0.55 0.53 0.959 0.28 
   FCS -0.08 0.51 0.49 0.961 0.25 
    -0.14 0.50 0.48 0.950 0.25 
   FCS + deletion 0.02 0.58 0.55 0.964 0.30 
    -0.04 0.55 0.53 0.961 0.28 
   CCA 0.01 0.66 0.67 0.943 0.45 
    0.01 0.53 0.55 0.936 0.30 
0.30 Log(2) 0.30 MVNI -0.16 0.17 0.14 0.919 0.04 










   MVNI + deletion 0.00 0.22 0.18 0.984 0.03 
    -0.02 0.19 0.17 0.975 0.03 
   FCS -0.06 0.18 0.16 0.970 0.03 
    -0.08 0.18 0.15 0.957 0.03 
   FCS + deletion 0.00 0.22 0.18 0.985 0.03 
    -0.02 0.19 0.17 0.978 0.03 
   CCA 0.00 0.23 0.23 0.947 0.05 
    0.00 0.17 0.17 0.949 0.03 
0.30 Log(2) 0.70 MVNI -0.17 0.24 0.20 0.934 0.07 
    -0.14 0.24 0.20 0.945 0.06 
   MVNI + deletion 0.02 0.29 0.25 0.977 0.06 
    -0.04 0.27 0.24 0.969 0.06 
   FCS -0.05 0.24 0.22 0.966 0.05 
    -0.10 0.24 0.22 0.951 0.06 
   FCS + deletion 0.02 0.29 0.25 0.978 0.06 
    -0.04 0.27 0.24 0.968 0.06 
   CCA -0.00 0.30 0.31 0.941 0.09 
    0.00 0.24 0.25 0.940 0.06 
0.30 Log(3) 0.30 MVNI -0.29 0.18 0.14 0.689 0.11 
    -0.24 0.18 0.15 0.789 0.08 
   MVNI + deletion -0.04 0.24 0.19 0.984 0.04 
    -0.08 0.20 0.17 0.970 0.03 
   FCS -0.16 0.18 0.15 0.909 0.05 
    -0.19 0.18 0.15 0.849 0.06 
   FCS + deletion -0.04 0.24 0.19 0.983 0.04 
    -0.08 0.20 0.17 0.969 0.03 
   CCA 0.01 0.25 0.25 0.951 0.06 
    0.01 0.18 0.18 0.948 0.03 
0.30 Log(3) 0.70 MVNI -0.26 0.26 0.20 0.890 0.11 
    -0.27 0.25 0.20 0.859 0.11 
   MVNI + deletion 0.01 0.31 0.26 0.978 0.07 
    -0.11 0.28 0.23 0.963 0.07 
   FCS -0.09 0.26 0.22 0.962 0.06 
    -0.24 0.24 0.21 0.878 0.10 
   FCS + deletion 0.02 0.31 0.26 0.980 0.07 
    -0.12 0.28 0.23 0.963 0.07 
   CCA 0.02 0.32 0.32 0.951 0.11 
    -0.00 0.25 0.26 0.950 0.07 
Abbreviations: MVNI, multivariate normal imputation; FCS, fully conditional specification; CCA, complete case 





Table 5.11. Simulation results for  and  continuous, opposite mechanism, = 1. 
Outcome 
prevalence 





0.10 Log(2) 0.30 MVNI -0.18 0.29 0.24 0.948 0.09 
    -0.09 0.32 0.29 0.962 0.09 
   MVNI + deletion -0.01 0.33 0.31 0.961 0.10 
    0.01 0.35 0.34 0.960 0.11 
   FCS -0.02 0.31 0.30 0.956 0.09 
    -0.01 0.34 0.33 0.962 0.11 
   FCS + deletion -0.01 0.33 0.31 0.961 0.10 
    0.01 0.35 0.34 0.962 0.11 
   CCA 0.00 0.37 0.39 0.936 0.15 
    0.01 0.33 0.33 0.944 0.11 
0.10 Log(2) 0.70 MVNI -0.20 0.41 0.35 0.961 0.16 
    -0.10 0.43 0.39 0.969 0.16 
   MVNI + deletion 0.00 0.46 0.43 0.966 0.18 
    0.00 0.47 0.45 0.961 0.21 
   FCS -0.01 0.43 0.41 0.964 0.17 
    -0.02 0.45 0.44 0.961 0.20 
   FCS + deletion 0.01 0.46 0.43 0.965 0.18 
    -0.00 0.47 0.45 0.960 0.21 
   CCA 0.00 0.47 0.48 0.946 0.23 
    -0.00 0.43 0.45 0.943 0.20 
0.10 Log(3) 0.30 MVNI -0.29 0.30 0.23 0.896 0.14 
    -0.15 0.33 0.28 0.958 0.10 
   MVNI + deletion -0.01 0.34 0.31 0.970 0.10 
    0.02 0.36 0.33 0.966 0.11 
   FCS -0.04 0.31 0.29 0.963 0.09 
    -0.03 0.34 0.31 0.965 0.10 
   FCS + deletion -0.00 0.34 0.31 0.973 0.10 
    0.01 0.36 0.32 0.966 0.11 
   CCA -0.00 0.37 0.38 0.947 0.14 
    0.01 0.32 0.32 0.949 0.10 
0.10 Log(3) 0.70 MVNI -0.34 0.42 0.35 0.922 0.24 
    -0.16 0.45 0.38 0.972 0.17 
   MVNI + deletion -0.01 0.48 0.44 0.972 0.19 
    0.02 0.49 0.45 0.969 0.21 
   FCS -0.05 0.44 0.41 0.961 0.17 
    -0.03 0.46 0.43 0.964 0.19 
   FCS + deletion -0.01 0.48 0.44 0.968 0.19 
    0.02 0.49 0.45 0.970 0.21 
   CCA -0.01 0.48 0.48 0.941 0.23 
    0.01 0.44 0.45 0.946 0.20 
0.30 Log(2) 0.30 MVNI -0.10 0.16 0.13 0.952 0.03 
    -0.06 0.18 0.15 0.975 0.03 










    0.02 0.20 0.17 0.976 0.03 
   FCS -0.03 0.16 0.15 0.971 0.02 
    -0.01 0.18 0.16 0.970 0.03 
   FCS + deletion 0.00 0.19 0.16 0.984 0.02 
    0.02 0.20 0.17 0.976 0.03 
   CCA 0.00 0.19 0.19 0.941 0.04 
    0.00 0.16 0.17 0.939 0.03 
0.30 Log(2) 0.70 MVNI -0.12 0.23 0.19 0.960 0.05 
    -0.06 0.24 0.20 0.977 0.05 
   MVNI + deletion -0.01 0.26 0.22 0.979 0.05 
    0.02 0.27 0.23 0.974 0.05 
   FCS -0.04 0.23 0.20 0.970 0.04 
    -0.01 0.24 0.22 0.972 0.05 
   FCS + deletion -0.01 0.26 0.22 0.981 0.05 
    0.02 0.27 0.23 0.976 0.05 
   CCA 0.01 0.24 0.24 0.948 0.06 
    -0.00 0.22 0.22 0.945 0.05 
0.30 Log(3) 0.30 MVNI -0.14 0.17 0.13 0.940 0.04 
    -0.10 0.19 0.15 0.958 0.03 
   MVNI + deletion 0.02 0.20 0.16 0.989 0.03 
    0.02 0.21 0.17 0.981 0.03 
   FCS -0.02 0.17 0.14 0.987 0.02 
    -0.03 0.19 0.16 0.979 0.03 
   FCS + deletion 0.02 0.20 0.16 0.989 0.03 
    0.01 0.21 0.17 0.986 0.03 
   CCA 0.01 0.19 0.19 0.943 0.04 
    0.01 0.17 0.17 0.951 0.03 
0.30 Log(3) 0.70 MVNI -0.17 0.23 0.18 0.946 0.06 
    -0.11 0.25 0.20 0.956 0.05 
   MVNI + deletion 0.01 0.26 0.21 0.983 0.04 
    0.02 0.27 0.23 0.979 0.05 
   FCS -0.04 0.23 0.19 0.981 0.04 
    -0.04 0.25 0.22 0.970 0.05 
   FCS + deletion 0.01 0.26 0.21 0.985 0.04 
    0.01 0.27 0.23 0.979 0.05 
   CCA 0.00 0.23 0.24 0.940 0.06 
    0.00 0.22 0.23 0.933 0.05 
Abbreviations: MVNI, multivariate normal imputation; FCS, fully conditional specification; CCA, complete case 





Table 5.12. Simulation results for  and  continuous, opposite mechanism, = 2. 
Outcome 
prevalence 





0.10 Log(2) 0.30 MVNI -0.27 0.31 0.24 0.932 0.13 
    -0.09 0.34 0.32 0.961 0.11 
   MVNI + deletion -0.00 0.38 0.36 0.966 0.13 
    0.02 0.37 0.37 0.948 0.14 
   FCS -0.02 0.35 0.33 0.959 0.11 
    -0.01 0.35 0.36 0.946 0.13 
   FCS + deletion 0.00 0.38 0.36 0.965 0.13 
    0.02 0.37 0.37 0.946 0.14 
   CCA 0.01 0.49 0.49 0.939 0.24 
    0.01 0.34 0.37 0.931 0.14 
0.10 Log(2) 0.70 MVNI -0.31 0.44 0.36 0.939 0.23 
    -0.12 0.46 0.41 0.963 0.18 
   MVNI + deletion 0.03 0.52 0.49 0.962 0.24 
    -0.01 0.50 0.48 0.956 0.24 
   FCS -0.00 0.47 0.45 0.960 0.21 
    -0.05 0.48 0.46 0.957 0.21 
   FCS + deletion 0.04 0.52 0.49 0.965 0.24 
    -0.01 0.50 0.48 0.962 0.23 
   CCA 0.03 0.59 0.59 0.942 0.35 
    -0.02 0.46 0.48 0.939 0.23 
0.10 Log(3) 0.30 MVNI -0.45 0.32 0.25 0.783 0.27 
    -0.18 0.35 0.30 0.952 0.12 
   MVNI + deletion 0.01 0.41 0.39 0.967 0.15 
    0.01 0.38 0.36 0.959 0.13 
   FCS -0.05 0.35 0.34 0.953 0.12 
    -0.06 0.36 0.34 0.951 0.12 
   FCS + deletion 0.02 0.41 0.39 0.966 0.15 
    0.01 0.38 0.36 0.962 0.13 
   CCA 0.01 0.50 0.51 0.946 0.26 
    -0.00 0.35 0.35 0.938 0.13 
0.10 Log(3) 0.70 MVNI -0.58 0.47 0.37 0.830 0.47 
    -0.17 0.48 0.42 0.961 0.21 
   MVNI + deletion -0.00 0.56 0.52 0.966 0.28 
    0.02 0.53 0.51 0.959 0.26 
   FCS -0.08 0.48 0.46 0.961 0.22 
    -0.07 0.49 0.47 0.959 0.22 
   FCS + deletion 0.01 0.56 0.52 0.971 0.27 
    0.01 0.53 0.51 0.962 0.26 
   CCA 0.00 0.60 0.62 0.939 0.39 
    0.01 0.48 0.50 0.938 0.25 
0.30 Log(2) 0.30 MVNI -0.15 0.17 0.14 0.924 0.04 
    -0.07 0.19 0.16 0.963 0.03 










    0.02 0.21 0.18 0.972 0.03 
   FCS -0.05 0.18 0.16 0.969 0.03 
    -0.03 0.19 0.17 0.968 0.03 
   FCS + deletion 0.01 0.22 0.19 0.980 0.03 
    0.02 0.21 0.18 0.971 0.03 
   CCA 0.01 0.25 0.24 0.954 0.06 
    -0.01 0.17 0.18 0.942 0.03 
0.30 Log(2) 0.70 MVNI -0.19 0.24 0.19 0.933 0.07 
    -0.07 0.25 0.21 0.972 0.05 
   MVNI + deletion -0.01 0.29 0.24 0.981 0.06 
    0.03 0.28 0.24 0.981 0.06 
   FCS -0.08 0.24 0.21 0.966 0.05 
    -0.03 0.25 0.22 0.970 0.05 
   FCS + deletion -0.01 0.29 0.24 0.982 0.06 
    0.03 0.28 0.24 0.978 0.06 
   CCA 0.00 0.29 0.29 0.945 0.09 
    -0.00 0.23 0.23 0.954 0.05 
0.30 Log(3) 0.30 MVNI -0.18 0.18 0.13 0.912 0.05 
    -0.09 0.20 0.16 0.962 0.03 
   MVNI + deletion 0.04 0.23 0.18 0.983 0.04 
    0.05 0.22 0.18 0.977 0.04 
   FCS -0.03 0.18 0.15 0.975 0.02 
    -0.03 0.20 0.17 0.972 0.03 
   FCS + deletion 0.05 0.23 0.18 0.982 0.04 
    0.04 0.22 0.18 0.978 0.04 
   CCA 0.01 0.24 0.25 0.946 0.06 
    0.01 0.17 0.18 0.945 0.03 
0.30 Log(3) 0.70 MVNI -0.25 0.24 0.19 0.886 0.10 
    -0.07 0.26 0.20 0.981 0.05 
   MVNI + deletion 0.01 0.30 0.25 0.983 0.06 
    0.06 0.29 0.23 0.980 0.06 
   FCS -0.07 0.24 0.21 0.974 0.05 
    -0.02 0.26 0.22 0.980 0.05 
   FCS + deletion 0.02 0.29 0.25 0.983 0.06 
    0.05 0.29 0.23 0.982 0.06 
   CCA -0.00 0.29 0.29 0.945 0.08 
    0.01 0.23 0.22 0.949 0.05 
Abbreviations: MVNI, multivariate normal imputation; FCS, fully conditional specification; CCA, complete case 




Web appendix C. Full results from null-case sensitivity analyses. 
 
Table 5.13. Bias in scenarios with  and  binary, coordinated missing data 
mechanism. 
Simulation scenario Parameter MVNI  MVNI + 
deletion  
FCS FCS + 
deletion 
1. Outcome prevalence = 0.10, RR( , ) =
3, 	 = = log	(3), = 2 
 -0.03 0.10 0.05 0.04 
 -0.28 -0.10 0.00 0.02 
2. As in (1.), but with RR( , ) = 1  -0.14 0.01 0.01 0.01 
  -0.28 -0.08 0.01 0.03 
3. As in (1.), but with 	 = 0  0.02 0.05 0.01 0.01 
  -0.17 -0.05 0.00 0.01 
4. As in (1.), but with 	 = 0  -0.15 0.00 0.00 0.00 
  0.02 0.02 0.01 0.01 
5. As in (1.), but with 	 = = 0  0.00 0.00 0.00 0.00 
  0.00 -0.01 -0.02 -0.01 
6. As in (1.), but with 	 = 0 (MCAR)  -0.12 0.11 0.04 0.04 
  -0.28 -0.10 0.05 0.06 
7. Outcome prevalence = 0.30, RR( , ) =
3, 	 = = log	(3), = 2 
 0.07 0.07 0.04 0.02 
 -0.31 -0.14 -0.10 -0.04 
8. As in (7.), but with RR( , ) = 1  -0.07 -0.01 -0.01 -0.01 
 -0.32 -0.16 -0.12 -0.07 
9. As in (7.), but with 	 = 0  0.03 0.03 0.00 0.00 
  -0.12 -0.05 0.01 0.01 
10. As in (7.), but with 	 = 0  -0.06 0.00 0.00 0.00 
  0.00 0.00 0.00 0.00 
11. As in (7.), but with 	 = = 0  0.00 0.00 0.00 0.00 
  0.00 0.00 0.00 0.00 
12. As in (7.), but with 	 = 0 (MCAR)  -0.04 0.07 0.00 0.01 
  -0.21 -0.11 0.00 0.01 
Abbreviations: RR, relative risk; MCAR, missing completely at random; MVNI, multivariate normal imputation; 





Table 5.14. Bias in scenarios with  and  continuous, coordinated missing data 
mechanism. 
Simulation scenario Parameter MVNI  MVNI + 
deletion  
FCS FCS + 
deletion 
1. Outcome prevalence = 0.10, Corr( , ) =
0.70, 	 = = log	(3), = 2 
 -0.56 0.01 -0.08 0.02 
 -0.22 -0.03 -0.14 -0.04 
2. As in (1.), but with Corr( , ) = 0  -0.38 0.00 -0.06 0.00 
  -0.20 -0.02 -0.08 -0.02 
3. As in (1.), but with 	 = 0  -0.13 0.01 0.01 0.01 
  -0.17 0.00 -0.04 0.00 
4. As in (1.), but with 	 = 0  -0.37 0.01 -0.04 0.01 
  0.00 0.00 0.00 -0.01 
5. As in (1.), but with 	 = = 0  0.00 0.00 0.01 0.00 
  0.00 0.00 0.00 0.00 
6. As in (1.), but with 	 = 0 (MCAR)  -0.15 0.00 0.00 0.00 
  -0.17 -0.03 -0.03 -0.03 
7. Outcome prevalence = 0.30, Corr( , ) =
0.70, 	 = = log	(3), = 2 
 -0.26 0.01 -0.09 0.02 
 -0.27 -0.11 -0.24 -0.12 
8. As in (7.), but with Corr( , ) = 0  -0.27 -0.05 -0.15 -0.05 
 -0.21 -0.06 -0.16 -0.06 
9. As in (7.), but with 	 = 0  -0.04 0.02 0.01 0.02 
  -0.17 -0.03 -0.10 -0.03 
10. As in (7.), but with 	 = 0  -0.24 0.00 -0.10 0.00 
  0.00 0.00 0.00 0.00 
11. As in (7.), but with 	 = = 0  -0.01 -0.01 -0.01 -0.01 
  0.01 0.01 0.01 0.01 
12. As in (7.), but with 	 = 0 (MCAR)  -0.11 0.00 0.00 0.00 
  -0.17 -0.08 -0.08 -0.08 
Abbreviations: Corr, correlation; MCAR, missing completely at random; MVNI, multivariate normal imputation; 
FCS, fully conditional specification. 
 
** End of submitted article *** 
 
5.4. Additional discussion 
 
Since the data generation models in the simulation study were known, the 
shortcomings of MI could be attributed to differences between the imputation and 
data generation models (i.e. imputation model misspecification). Alternatively, 
since the analysis models were equivalent to the data generation models, the 
shortcomings of MI could be attributed to inconsistencies between imputation and 
analysis models (i.e. imputation model incompatibility). In practice the log 
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binomial analysis model could also be misspecified, in which case performance 
deficits due to imputation model misspecification might differ to those of 
imputation model incompatibility. Which is the larger concern in practice is 
beyond the scope of this thesis. It should be reiterated that if the log binomial 
analysis model is deemed inappropriate for a given dataset due to apparent 
misspecification, relative risks can instead be estimated from a model with a 
different link function (e.g. logistic regression) by applying marginal or 








This chapter presents the third article contributing to this thesis, published in 
Statistical Methods in Medical Research. The aims of the article are to evaluate 
the performance of MI for handling missing outcome data in RCTs and to explore 
the merits of imputing overall and separately by randomised group in this context. 
The article covers the common scenarios of missing data in a continuous or a 
binary outcome variable measured once or repeatedly over time, where interest 
lies in estimating the effect of treatment according to the ITT principle. The article 
also considers the use of MI for handling missing data in a baseline covariate for 
adjustment, for example a baseline measure of the outcome variable. Although not 
a missing outcome data problem, which is the focus of this thesis, the use of MI 
for handling missing data in a baseline covariate is considered in the article for the 
sake of completeness (as another common scenario encountered in the analysis of 
RCTs). Relevant literature on handling missing baseline data in RCTs is described 
within the article. 
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The use of multiple imputation has increased markedly in recent years, and 
journal reviewers may expect to see multiple imputation used to handle missing 
data. However in randomised trials, where treatment group is always observed 
and independent of baseline covariates, other approaches may be preferable. 
Using data simulation we evaluated multiple imputation, performed both overall 
and separately by randomised group, across a range of commonly encountered 
scenarios. We considered both missing outcome and missing baseline data, with 
missing outcome data induced under missing at random mechanisms. Provided 
the analysis model was correctly specified, multiple imputation produced 
unbiased treatment effect estimates, but alternative unbiased approaches were 
often more efficient. When the analysis model overlooked an interaction effect 
involving randomised group, multiple imputation produced biased estimates of the 
average treatment effect when applied to missing outcome data, unless imputation 
was performed separately by randomised group. Based on these results, we 
conclude that multiple imputation should not be seen as the only acceptable way 
to handle missing data in randomised trials. In settings where multiple imputation 





Research articles and guidance documents have emphasised the role of prevention 
in minimising the impact of missing data (65, 71, 107, 108), but most randomised 
controlled trials (RCTs) have some missing data (109). Given the potential for 
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biased and inefficient treatment effect estimates, it is crucial that missing data are 
handled appropriately during the analysis. 
 
All statistical analyses involve assumptions about the mechanism responsible for 
the missing data. Rubin (4) introduced three classes of mechanisms for missing 
data: missing completely at random (MCAR), where the probability of 
missingness is unrelated to observed or unobserved data; missing at random 
(MAR), where the probability of missingness is unrelated to unobserved data 
conditional on observed data; and missing not at random (MNAR), where the 
probability of missingness depends on unobserved data conditional on observed 
data. Since MAR and MNAR cannot be distinguished from observed data, it is 
essential that the assumptions of the analytic approach are scientifically plausible 
and clearly stated (1, 20). To assess the robustness of findings to the assumption 
made about the missing data mechanism in the primary analysis of an RCT, 
additional sensitivity analyses are strongly recommended (1, 13, 19, 20, 110). 
 
Multiple imputation (MI) (4) is a statistical approach to handling missing data that 
has been widely adopted due to its flexibility and ease of implementation (17, 29). 
MI involves fitting a statistical model to the observed data and using it to estimate 
values for the missing data. To incorporate missing data uncertainty, multiple 
values are imputed for each missing observation, producing multiple complete 
datasets. Following analysis of these datasets using standard complete data 
techniques, the multiple parameter estimates are combined using Rubin's rules (4) 
to give a single MI estimate. Standard implementations of MI assume that data are 
MAR, although it can also be applied under an MNAR assumption (4). Provided 
the assumption about the missing data mechanism is met and models used for 
imputation and analysis are correctly specified, MI produces consistent and 
asymptotically efficient parameter estimates with nominal coverage (4). Of the 
various methods of imputation available, MI based on the multivariate normal 
distribution (11) and MI by chained equations (5, 9, 10) are most commonly used 




With the use of MI in RCTs rising dramatically in recent years (7, 17, 111), 
editors and journal reviewers may expect to see MI used to handle missing data. 
Indeed, we are aware of several recent instances where reviewers have pushed 
with little justification for trial data to be re-analysed using MI. However, whether 
MI should be viewed as the gold standard approach for handling missing data in 
RCTs is questionable. Importantly, results derived in general regression settings 
supporting the use of MI may not be applicable to RCTs. Unlike observational 
studies, the key exposure in RCTs (randomised group) is always observed and 
known to be independent of baseline covariates. In addition, missing data occur 
primarily in the outcome variable, although baseline covariates may also have 
missing data. Under these conditions, some of the value of MI may be lost and 
other methods of analysis may be preferable.  
 
Another uncertainty around the use of MI in RCTs is whether imputation is best 
carried out across all participants or separately by randomised group. If subgroup 
analyses are of interest, it is essential that interaction terms are accounted for in 
the imputation process to avoid biasing interaction tests towards the null. Rather 
than specifying interaction terms within the imputation model, several authors 
have recommended fitting separate imputation models within each randomised 
group (13-15, 102). This strategy is appealing due to its simplicity and ability to 
facilitate subgroup comparisons for any baseline covariate included in the 
imputation model. Unfortunately its performance is not well understood, and it is 
unclear how imputation should proceed when subgroup analyses are not of 
interest and the intention is to only produce average treatment effects from main 
effects models.  
 
This article describes the performance of MI in the RCT setting, covering the 
common scenarios of missing data in an outcome measured once or repeatedly 
over time and missing data in a baseline covariate. Using a series of illustrative 
data simulations and a case study, we compare MI with other standard approaches 
for handling missing data and explore the merits of imputing overall and 
separately by randomised group. Throughout we assume that missing data are 
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unplanned rather than by design, and that interest lies in estimating the effect of 
treatment according to the intention to treat (ITT) principle. If treatment 
discontinuations occur, we therefore assume the aim is to estimate a “de facto” 
estimand (66, 112) and that data are equally available before and after treatment 
discontinuations; we consider the case where data cannot be collected after 
treatment discontinuation in the discussion (Section 6.3.9). For missing outcome 
data, we restrict attention to settings where they are assumed to be MAR, since 
this assumption is often made in the primary analysis of an RCT and corresponds 
with the standard implementation of MI. 
 
The remainder of the article is structured as follows. Section 6.3.3 describes issues 
in adhering to the ITT principle in the presence of missing data and implications 
for the use of MI in RCTs. Section 6.3.4 defines key notation and outlines general 
simulation methods for evaluating the performance of MI. Section 6.3.5 focuses 
on the performance of MI for handling missing data in an outcome measured at a 
single time point. Section 6.3.6 considers missing data in an outcome measured 
repeatedly over time and the use of auxiliary variables in MI, while Section 6.3.7 
focuses on missing data in a baseline covariate for adjustment. Section 6.3.8 
shows the application of MI to the DINO trial. Finally, conclusions and general 
recommendations are provided in Section 6.3.9. 
 
6.3.3. Intention to treat and missing data 
 
The goal of ITT, or analysing as randomised, is to maintain the balance in 
prognostic factors achieved by randomisation, which is critical for avoiding 
selection bias and establishing causation (69, 70). In addition to preserving the 
benefits of randomisation, an ITT analysis may better inform changes in 
subsequent clinical practice, where patients do not always comply with treatment. 
Following the ITT principle entails estimating the ITT estimand, which is defined 
as the average effect of randomisation, irrespective of treatment received, over all 
randomised individuals (68). Due to fluctuating use of the term ITT, this has more 
recently been described as a de facto estimand (66, 112). Interest in the ITT 
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estimand has implications both for trial conduct and analysis. First, attempts 
should be made to collect outcome data on all randomised participants, 
irrespective of adherence to the protocol (1, 20, 68). For example, outcome data 
should still be retrieved for participants that discontinue or switch treatments 
during the course of a trial. Second, all collected outcome data should be included 
in the analysis, including data from participants that deviate from the protocol (1, 
20, 68). Although there are settings where it may not be feasible to measure 
outcomes following a protocol deviation, or where exclusion of collected outcome 
data may be justifiable, we do not tackle these scenarios in this article.  
 
Despite efforts to collect data on all randomised participants, invariably there will 
be some missing data. Exactly what constitutes an ITT analysis in the presence of 
missing data has been much debated (113). Some researchers have suggested that 
missing outcome data ought to be imputed, so that the full randomised sample can 
be included in the analysis (70, 72, 73). Others have argued that imputation is 
unnecessary and that an ITT analysis need only provide a valid estimate of the 
ITT estimand (1, 20, 74). Given recent commentary on the importance of defining 
and validly estimating the causal estimand of interest (1), and noting that none of 
the current guidance documents strictly recommend imputing missing outcomes, 
we adopt the second view. In differentiating between competing statistical 
methods, we therefore focus on their capacity to provide an unbiased and precise 







Let  and  define values for the ith participant (i = 1 to ) on an outcome 
variable and a baseline variable, respectively. Assume the ith participant is 
randomised independently to treatment group   (0 = control, 1 = new treatment) 
with probability 0.5. Let  and  denote whether  and  are missing or 
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observed (1 = missing, 0 = observed). In the absence of missing data, suppose the 
adjusted analysis model 
 
( ) = + +        (1) 
 
is of interest, where = ( | , ) and  is an appropriate link function. Of 
principal importance is the (adjusted) treatment coefficient . Note we focus 
primarily on adjusted estimates in this article, since adjustment for pre-specified 
baseline covariates is common and can lead to substantial increases in power for 
testing the effect of treatment (114, 115). As conclusions about treatment are 
typically based on main effects models (65), we also restrict attention to analysis 




In the first stage of MI, multiple values (  > 1) for each missing observation are 
independently simulated from an imputation model. For missing data restricted to 
the outcome, the imputation model would typically regress observed values of  
on  and . Additional auxiliary variables that are not in the analysis model can 
also be added to the imputation model to improve the prediction of missing 
values. Let  denote the parameter estimates from the imputation model and ∗ 
(j= 1 to ) random draws from the posterior distribution of . For each random 
draw, missing values in  are replaced by simulated values from the posterior 
predictive distribution of  according to ∗. For missing data restricted to a 
baseline covariate, the imputation model instead describes the conditional 
distribution of  according to  and . If MI is performed separately by 
randomised group,  is omitted from the separate imputation models. 
 
In the second stage of MI, the intended analysis is performed on each of the  
complete datasets, in this case model (1). Let  denote the estimate of  from the 
jth imputed dataset and  the corresponding variance estimate. Using Rubin's 
rules (4), the combined MI treatment effect estimate  is calculated as the mean of 
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the  estimates, i.e. = 1⁄ ∑ . The variance is given by var = +
(1 + 1⁄ ), where = 	1⁄ ∑  is the average within-imputation 
variance and = ( − 1) ∑ ( − )  the between imputation variance. 
Hypothesis tests and confidence intervals can be obtained using a t-distribution 
with = ( − 1)[1 + (1 + )⁄ ]  degrees of freedom. 
 
General simulation methods 
 
Simulation studies were undertaken to describe the performance of MI for 
handling missing data in a univariate outcome (Section 6.3.5), a multivariate 
outcome (Section 6.3.6), and a baseline covariate (Section 6.3.7). For each 
scenario, 2,000 datasets of size 	= 600 were generated, with 300 observations 
allocated to each group. The sample size was chosen to be similar to that of a case 
study (see Section 6.3.8) and to represent a medium-sized trial. Three statistical 
methods were considered across all settings based on the adjusted analysis model 
(1): complete case analysis (CCA), MI performed overall, and MI performed by 
randomised group. For MI, linear and logistic regression were used for the 
imputation of continuous and binary variables, respectively, with  = 50 
imputations based on the rule of thumb that the number of imputations should at 
least equal the percentage of missing data (5). Completed datasets were analysed 
using linear and logistic regression as appropriate, with treatment effect estimates 
combined using Rubin's rules (4). Performance was evaluated in terms of bias, 
empirical standard error (SE), power, and the coverage of estimated 95% 
confidence intervals. Based on 2,000 simulated datasets, on 95% of occasions the 
coverage is expected to lie between 0.94 and 0.96 for a true coverage of 0.95. All 
analyses were performed in SAS version 9.3 (SAS Institute, Inc., Cary, North 
Carolina). 
 
6.3.5. Missing data in a univariate outcome 
 
When a univariate (once-measured) outcome is MAR conditional on fully 
observed covariates, a correctly specified CCA with covariate adjustment 
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produces unbiased and efficient estimates of regression parameters (18, 23, 24). It 
has also been shown that MI with a large number of imputations approximates a 
CCA in this setting, provided that imputation and analysis models are the same 
(81). Using data simulation, we verify these results for RCTs, explore the 
implications of imputing overall or by randomised group and investigate settings 
where the analysis model is misspecified. 
 
Correctly specified analysis model 
 
Data were simulated from the model = 0.30 + + , with  and  
~ (0,1). To assess whether model performance depended on the strength of 
association between  and ,  was varied so that corr( , | ) = 0.30	or	0.70. 
Since comparisons were insensitive to the treatment effect,  was fixed at 0.30 to 
reflect a small effect size. Following generation of complete datasets, values in  
were set to missing according to three MAR mechanisms: 
 
1) MAR X: Odds of missing  increase by a factor  per standard deviation 
(SD) increase in . 
 
2) MAR X+T: Odds of missing  are  times higher in the control group and 
increase by a factor  per SD increase in . 
 
3) MAR X×T: Odds of missing  are  times higher for treatment group 
participants with ≤ 0 and for control group participants with > 0.  
 
Each missingness mechanism was simulated using a logistic regression model, 
with  = 1.5 or 2.5 to indicate weak and strong mechanisms, respectively, and 
with the model intercept varied to produce 20% (realistic) or 50% (extreme) 
missing data. This resulted in 24 simulation scenarios (12 missing data scenarios 
and two values for ). Supposing that  is a measure of disease severity, the 
MAR X and MAR X+T mechanisms might reflect settings where participants 
with more severe disease or randomised to the control group are more likely to 
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have missing outcome data. The MAR X×T mechanism could apply in settings 
where treatment group participants with less severe disease are also more likely to 
have missing outcome data due to a perceived lack of need to continue treatment. 
 
As expected, CCA, MI overall and MI by group all produced unbiased treatment 
effect estimates across the 24 simulation scenarios, with coverage probabilities 
remaining close to 0.95 throughout (range 0.94, 0.96). Compared to CCA, 
empirical SEs were on average 0.4% and 2.7% larger with MI overall and MI by 
group, respectively, which translated to an average loss of power of 0.8% for MI 
overall and 2.6% for MI by group. Figure 6.1 shows the performance of the 
various approaches in scenarios with 50% missing data, a strong MAR 
mechanism, and where corr( , | ) = 0.70; these more extreme scenarios were 
chosen to highlight differences between approaches. Results from an unadjusted 
CCA are also displayed for comparison. In all figures, note that error bars indicate 
estimation efficiency (±1 empirical SE). Unsurprisingly, MI offered no 
advantages over a CCA across the range of missingness mechanisms. Of note, 
unadjusted CCA produced biased estimates when the probability of missing data 
depended on  and , with coverage dropping to 0.39 under the MAR X×T 
mechanism. 
 
Similar results were obtained from a simulation study involving a binary outcome 




Figure 6.1. Mean treatment effect estimates for 50% missing data in a continuous 
outcome, corr( , | ) = 0.70, strong MAR mechanisms, correctly specified 
analysis model. Error bars correspond to empirical standard errors (± 1 standard 
error) across 2,000 simulated datasets. 
 
Misspecified analysis model, continuous outcome 
 
We now consider settings where an interaction between  and  is overlooked in 
favor of producing an estimate of the average treatment effect (ATE). This 
approach is common in practice, since ATEs are commonly used to draw 
conclusions about treatment and are of greater relevance to policy-related 
questions (65, 116). Further, tests of interaction are often viewed as exploratory 
and can be underpowered (65). For effect modification by discrete , we assume 
that interest lies in estimating the ATE given by ∑ , where = ( = ) 
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Considering binary  with = = 0.5, data were generated from the model 
= + 0.30 + + , where ~ (0,1). Fixing the ATE at 0.30, we 
investigated both weak ( = = 0.20 or equivalently  = 0.20, = 0.40) 
and strong ( = 0, = 0.60 or  = 0, = 0.60) interaction effects between 
 and . Following generation of complete datasets, values in  were set to 
missing according to the three mechanisms described earlier. Analysis model (1), 
misspecified due to the absence of the interaction term between  and , was the 
substantive model of interest.  
 
Across all simulation scenarios MI by group produced unbiased estimates of the 
ATE with nominal coverage (coverage range 0.94, 0.96). In contrast, CCA and 
MI overall produced biased estimates under the MAR X and MAR X+T 
mechanisms. Figure 6.2 illustrates performance for the MAR X mechanism in 
scenarios with 50% missing data. As seen in the figure, the bias of CCA and MI 
overall increased with the strength of the missing data mechanism and the degree 
of effect modification. For a strong missing data mechanism and a strong 
interaction, the ATE was estimated to be 0.17 (absolute bias = 0.13), with 
coverage dropping to 0.81 for both approaches. Similar results were observed 
with 20% missing data, although predictably biases were smaller in magnitude 
(absolute bias  0.06). Instead of estimating the desired ATE, CCA and MI 
overall produced an estimate that was weighted by the probability of missing data 
within strata defined by  and . In particular, the estimated ATE was 
proportional to ∑ /( + ), where = ( = 0| =
, = ). No bias was observed for these approaches for the MAR X×T 
mechanism, since =  and =  under this mechanism. Although the 
bias of MI overall could be eliminated by including the interaction term in the 
imputation model (results not shown), this may not be an obvious strategy if 





Figure 6.2. Mean average treatment effect estimates for 50% missing data in a 
continuous outcome under the MAR X mechanism (odds of  missing 1.5 (weak 
MAR) or 2.5 (strong MAR) times higher per standard deviation increase in ), 
incorrectly specified analysis model. Error bars correspond to empirical standard 
errors (± 1 standard error) across 2,000 simulated datasets. 
 
Misspecified analysis model, binary outcome 
 
For binary outcomes, the notion of an ATE from a misspecified logistic regression 
model is more complex. Assuming effect modification by discrete , omission of 
the interaction effect from the analysis model can lead to an ATE estimate that 
differs substantially from a weighted average of stratum specific effects (on both 
odds and log odds scales). In this setting, we consider the ATE that would have 
been observed with complete data as the “least false” ATE. In the presence of 
missing data, we assume the goal is to reproduce this least false ATE. 
 
Considering binary  with = = 0.5, data were generated from the model 
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chosen so that ( = 1| = 0) = 0.20, while the coefficient for  gives 
OR( , | = 0) = 2.0. Fixing the average of the stratum specific effects on the 
logit scale at 0.69 (OR = 2.0), we evaluated both weak ( = = 0.46) and 
strong ( = 0, = 1.38) interaction effects between  and . Following 
generation of complete datasets, values in  were set to missing according to the 
three mechanisms described earlier. 
 
Across the 24 simulation scenarios (12 missing data scenarios × 2 interactions), 
MI by group was unbiased in reproducing the least false ATE (absolute bias  
0.02), with coverage remaining close to 0.95 (range 0.94, 0.96). In contrast, CCA 
and MI overall produced biased estimates under the MAR X and MAR X+T 
mechanisms. Figure 6.3 summarises performance under the MAR X mechanism 
for 50% missing data. In parallel with results for continuous outcome data, the 
bias of CCA and MI overall increased with the strength of the missing data 





Figure 6.3. Mean average treatment effect estimates for 50% missing data in a 
binary outcome under the MAR X mechanism (odds of  missing 1.5 (weak 
MAR) or 2.5 (strong MAR) times higher per standard deviation increase in ), 
incorrectly specified analysis model. Horizontal reference lines illustrate the least 
false average treatment effect in the absence of missing data. Error bars 
correspond to empirical standard errors (± 1 standard error) across 2,000 
simulated datasets. 
 
6.3.6. Missing data in a multivariate outcome 
 
We now consider missing data in an outcome measured at repeated intervals 
following randomisation, where interest concerns the effect of treatment at the 
final time point. Unlike the univariate case, the validity of CCA is questionable in 
this setting since it cannot incorporate information from intermediate measures of 
the outcome. Such measures may be associated with the probability of missing 
data and the value of the outcome at the final time point. By exploiting 
information in partially observed cases, MI and likelihood-based approaches have 
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117). In what follows, we briefly introduce likelihood approaches for multivariate 
outcome data, describe the link between intermediate outcome measures and 
auxiliary variables, and present results from a simulation study comparing MI 
with alternatives. 
 
Likelihood-based estimation of a linear mixed model (LMM) (79) is a popular 
alternative to MI for handling missing data in a multivariate outcome. Based on 
the multivariate normal distribution, this approach incorporates all observed 
information on the repeated measures of the outcome to produce estimates that are 
valid under a MAR assumption. No explicit imputation is involved. For outcomes 
collected at a limited number of fixed time points following randomisation, a 
LMM would typically include fixed effects for time (categorical), randomised 
group, and the interaction between randomised group and time. Within-subject 
dependence due to repeated measurements is accounted for through specification 
of a covariance structure. Several authors have recommended the unstructured 
covariance matrix since it is easily pre-specified, entails minimal power loss 
compared with more parsimonious choices (19, 118, 119) and ensures that 
estimates are approximately equivalent to and slightly more efficient than those 
obtained from a comparable MI procedure (11, 19). With a single intermediate 




+ + , 	.    (2) 
 
In applying MI, the repeated measurements of the outcome are usually treated as 
distinct variables in the imputation model. Where interest lies in the treatment 
effect at the final time point, the analysis model need not include the intermediate 
outcome measures; following imputation a comparison of final time point results 
is sufficient (120). In this case, the intermediate measures operate as auxiliary 
variables, assisting with the prediction of missing values at the final time point 
and making the MAR assumption more plausible. Other auxiliary variables, for 
instance measures of compliance or related outcomes, can also be added to the 
128 
 
imputation model as required. If data are collected but more likely to be missing 
following treatment discontinuation, an indicator variable for discontinuation may 
also be valuable as an auxiliary variable. The ability to incorporate auxiliary 
variables, both for univariate and multivariate outcomes, is considered one of the 
key strengths of MI (6). Less well known is that LMMs can also benefit from 
auxiliary variables through joint modelling with the outcome (19, 80). Using 
model (2) for illustration,  could be an auxiliary variable rather than an 
intermediate outcome measure. By assuming an unstructured covariance matrix, 
multiple auxiliary variables are easily handled within a LMM (19). 
 
For the simulation study, intermediate ( ) and final ( ) values of a continuous 
outcome were simulated from model (2) with = = 0, = = 0.30, and 
= = 1. To evaluate whether the correlation between  and  impacted on 
model performance, we considered = 0.30	or	0.70. We also examined both 
weak (0.30) and strong (0.70) correlations between  and the outcome measures. 
Following generation of complete datasets, values in  were set to missing such 
that the odds of missingness were  times higher per SD increase in  (with  = 
1.5 or 2.5 and for 20% or 50% missing data). In addition to CCA and MI, data 
were analysed using a LMM with an unstructured covariance matrix. Treatment 
effect estimates for LMMs in this article were obtained using restricted maximum 
likelihood estimation with degrees of freedom calculated according to the 
Kenward-Roger method (121).  
 
MI overall, MI by group and the LMM produced unbiased treatment effect 
estimates across the 16 simulation scenarios (4 missing data scenarios × 4 
correlations), with coverage ≥ 0.94 throughout. Compared to the LMM, empirical 
SEs were on average 0.5% and 3.2% higher with MI overall and MI by group, 
respectively. The lost efficiency with MI by group was most noticeable in 
scenarios with 50% missing data and a strong MAR mechanism. Power was on 
average 0.3% lower for MI overall and 2.2% lower for MI by group compared to 
the LMM. By ignoring the intermediate measure of the outcome, CCA was, as 
expected, the least efficient approach. Although minimal in most settings, some 
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bias was also evident with CCA. Figure 6.4 illustrates performance in scenarios 
with 50% missing data, a strong MAR mechanism and where corr( , | ) =
0.30. As seen in the figure, the relative performance of CCA was poor for =
0.70 (bias = 0.03, empirical SE 10.7% larger than the LMM). While 
outperforming CCA, MI offered no advantages over the LMM. 
 
 
Figure 6.4. Mean treatment effect estimates for 50% missing data in a continuous 
multivariate outcome, corr( , | ) = 0.30, strong MAR mechanism. Error bars 
correspond to empirical standard errors (± 1 standard error) across 2,000 
simulated datasets. 
 
Similar results were obtained from a simulation study allowing missing data to 
occur in the intermediate as well as the final measure of the outcome, although the 
shortcomings of CCA were less pronounced in this setting (see web appendix B, 
Section 6.3.10; also available online at the journal website). We did not consider a 
simulation study for binary multivariate outcome data due to complexities in 





Corr(Y,Z) = 0.30 Corr(Y,Z) = 0.70















6.3.7. Missing data in a baseline covariate 
 
Although missing baseline data can be avoided by requiring complete data 
collection before randomisation, this may not always be feasible (e.g. if a lengthy 
baseline interview is required). Unless baseline data are missing by design, it is 
implausible that missingness depends on randomised group given that baseline 
variables are measured before randomisation (19, 122). In this context, group 
comparisons based on complete cases should be unbiased, even if baseline data 
are MNAR. One potential limitation of the standard implementation of MI for 
imputing missing baseline data is that it ignores the independence of  and . 
Chance imbalances in  in the observed data are incorrectly extrapolated to the 
missing data, which may result in a loss of efficiency (122). In this section, we 
evaluate the efficiency of MI using simulation, both for continuous and binary 
variables, and compare performance with alternative approaches. 
 
Continuous baseline covariate and outcome 
 
The binary indicator  for missing data in the baseline covariate  was first 
simulated with a probability of 0.20. Unlike other scenarios, we did not consider 
50% missing data, since this degree of missingness seems unlikely for a baseline 
covariate pre-specified for adjustment. Next, baseline and outcome data were 
simulated from the models = +  and = 0.30 + + +
, with 	and	 	~ (0,1). The parameters  and  in these models allow  
and , respectively, to be associated with . Both MCAR ( = = 0) and 
MNAR ( = = 0.30) mechanisms were considered in separate simulation 
scenarios. In choosing values for , we allowed corr( , | , = 0) to range 
between 0.10 and 0.90 in increments of 0.20. 
 
In addition to MI and CCA, we evaluated the performance of mean imputation, 
the missing indicator method and a LMM with baseline as an outcome. In mean 
imputation, missing baseline values are replaced with the mean of the observed 
values across both groups (i.e. ∗ = 	if	 = 1). Although mean imputation 
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for addressing missing outcome data has been widely criticised for failing to 
incorporate missing data uncertainty (1, 71), overstated precision is not a concern 
in this setting given the independence of  and  and interest only in the effect of 
treatment (and not the effect of the covariate) (122). The missing indicator method 
involves mean imputation and the addition of a dummy variable indicating 
missing data to the analysis model (i.e. adding ). Despite being inappropriate 
for general use (123, 124), the missing indicator method has been validated for 
addressing missing covariate data in RCTs, where  and  are independent and 
missingness in  is conditionally independent of 	(122, 125). For strong 
correlations between  and , White and Thompson (122) found that mean 
imputation and the missing indicator method became more efficient when 
participants with missing data were given a weight of 1− corr( , | , = 0)  
in the analysis (with observed cases retaining a weight of 1). We investigated both 
unweighted and weighted approaches. For the LMM, we considered a joint model 
for  and , where  was assumed to be independent of , i.e. 
  
~ + , . 
 
Under both MCAR and MNAR mechanisms, all methods produced unbiased 
treatment effect estimates with nominal coverage throughout (range 0.94, 0.96). 
Despite this, noticeable differences in efficiency were apparent across the 
different approaches to handling missing data. Figure 6.5 summarises 
performance under the MCAR mechanism for corr( , | , = 0) = 0.10, 0.50, 
and 0.90. As seen in the figure, CCA was close to optimal for a strong correlation 
between  and  but inefficient for weak to moderate correlations. Both mean 
imputation and the missing indicator method performed well, with weighting 
becoming important for strong correlations. MI was marginally less efficient than 
the weighted approaches and the LMM (empirical SEs on average 0.3% larger), 
with little difference seen between MI overall and MI by group. Lastly unadjusted 
CCA was highly inefficient for moderate to strong correlations between  and . 
Efficiency results under the MNAR mechanism closely mirrored those of the 
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MCAR mechanism, with MI performing similarly to weighted mean imputation 
and the LMM across all values for corr( , | , = 0) (empirical SEs on 
average 0.3% larger with MI overall and MI by group than mean imputation and 
the LMM). Interestingly, the missing indicator method incorporating weights held 
a slight advantage over MI under the MNAR mechanism (empirical SEs on 
average 1.1% smaller than with MI), which can be attributed to inclusion of the 
prognostic variable  in the analysis model. A graphical summary of 
performance under the MNAR mechanism is shown in web appendix C (see 
Section 6.3.10; also available online at the journal website); we do not present 
results here given their similarity to the MCAR setting. Given the simplicity of 
alternative approaches to handling missing data in baseline covariates, there 
appears to be little reason to adopt MI in this setting. 
 
 
Figure 6.5. Mean treatment effect estimates for 20% missing data in a continuous 
baseline covariate, MCAR mechanism. Error bars correspond to empirical 
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Binary baseline covariate and outcome 
 
Following simulation of  with probability 0.20, baseline and outcome data 
were generated from the models logit	P( = 1) =  and logit	P( = 1) =
+ 0.69 + + . The coefficient  was varied so that 
OR( , | , = 0) =2.0, 4.0, or 8.0, while  was chosen to give 
( = 1| = 0, = 0) = 0.20. Both MCAR ( = = 0) and MNAR ( =
= 0.69) mechanisms were considered. We did not consider weighted methods 
or a LMM as in the continuous case, since these approaches are not applicable for 
binary outcomes.  
 
Mean treatment effect estimates and empirical SEs for the MCAR mechanism are 
displayed in Figure 6.6. The clear outlier on these performance measures was 
unadjusted CCA. Since adjustment in logistic regression has the effect of 
increasing SEs and producing odds ratios that are further from the null (126), this 
finding is not surprising. Both MI overall and MI by group produced unbiased 
treatment effect estimates (absolute bias  0.004) with nominal coverage (range 
0.95, 0.96) throughout, with little difference in empirical SEs between 
approaches. CCA produced treatment effect estimates with minimal bias, however 
empirical SEs were on average 10% larger than those of MI. For mean imputation 
and the missing indicator method, we observed a trade-off between efficiency and 
bias. For OR( , | , = 0) = 8.0, both approaches exhibited modest efficiency 
advantages over MI (empirical SEs 4% smaller) at the expense of a small bias (-
0.02) towards the null. In terms of average power, there were minimal differences 
between mean imputation (93.0%), the missing indicator method (93.0%) and the 
MI approaches (92.9%). The small bias of mean imputation and the missing 
indicator method arises because the methods estimate a treatment effect that lies 
between the marginal (unadjusted) and conditional (adjusted) estimands. As the 
proportion of missing data in  is increased, the methods shift from estimating the 
conditional estimand with no missing data to estimating the marginal estimand 
with no observed data (results not shown). Since for logistic regression the 
marginal estimand is always closer to the null, mean imputation and the missing 
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indicator method produce estimates of the conditional treatment effect that are 
biased towards the null. 
 
 
Figure 6.6. Mean treatment effect estimates for 20% missing data in a binary 
baseline covariate, MCAR mechanism. OR (odds ratio) refers to OR( , | ). 
Error bars correspond to empirical standard errors (± 1 standard error) across 
2,000 simulated datasets. 
 
Although for ≠ 0 the omission of  from analysis models changes the 
treatment effect estimated by logistic regression, the observed changes were 
minimal across the MNAR scenarios considered. Based on complete data, the 
“least false” treatment effect from a misspecified model omitting  was 
approximately 0.68 for all values of OR( , | , = 0). That distinction aside, 
results from the MNAR setting closely followed those of the MCAR setting (see 
Figure 6.7). In comparing MI with mean imputation, we once again observed a 
trade-off between efficiency and bias. For OR( , | , = 0) = 8.0, the 
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was slightly more pronounced (-0.05 vs. -0.02). The missing indicator method 
performed similarly to mean imputation in terms of efficiency, however biases 
were smaller in magnitude with the missing indicator method due to correct 
specification of the analysis model. Excluding unadjusted CCA, all methods 
produced treatment effect estimates with correct coverage (range 0.94, 0.95).   
 
 
Figure 6.7. Mean treatment effect estimates for 20% missing data in a binary 
baseline covariate, MNAR mechanism. OR (odds ratio) refers to OR( , | ). 
Error bars correspond to empirical standard errors (± 1 standard error) across 
2,000 simulated datasets. 
 
6.3.8. Case study 
 
The Docosahexaenoic Acid for the Improvement of Neurodevelopmental 
Outcome in Preterm Infants (DINO) trial was a blinded RCT conducted in five 
Australian hospitals between 2001 and 2007 (Australian New Zealand Clinical 
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gestation (n=657) were randomised to receive a high docosahexaenoic acid 
(DHA) or a standard DHA diet from within 5 days of commencing enteral feeds 
through to term. Randomisation was stratified by hospital, sex, and birth weight 
(<1250g, ≥1250g), with infants from a multiple birth randomised according to the 
sex and birth weight of the first born infant. Results for primary and key 
secondary outcomes have been published previously (91, 127, 128). In the 
primary trial publication (91), outcomes were re-analysed using MI following 
feedback from reviewers that all randomised infants had to be included in ITT 
analyses and that MI would be an appropriate approach to achieve this. To 
simplify the dataset for illustration purposes, second and subsequent born infants 
from a multiple birth and infants that died before term were ignored, resulting in 
an example dataset with 262 and 260 infants in the high and standard DHA 
groups, respectively. 
 
To illustrate approaches for handling missing outcome data, we consider 
comparisons of fat free mass (FFM) at 7 years corrected age. Excluding two 
children that died after term, FFM was missing for 65/262 (24.8%) and 46/258 
(17.8%) children in the high and standard DHA groups, respectively. Logistic 
regression analysis revealed differences between the five study centres in the odds 
of missing outcome data (global p-value = 0.03). No other predictors of missing 
data were identified. For predictors of the outcome, linear regression analysis 
revealed associations between FFM and centre, sex, and weight, height and 
systolic blood pressure at 7 years corrected age. Since centre and sex were 
baseline measures, for illustration purposes we imagine these variables were pre-
specified as covariates for adjustment. Weight, height, and systolic blood pressure 
at 7 years corrected age were treated as auxiliary variables. 
 
We estimated the effect of treatment using CCA, MI overall, MI by group, and a 
LMM. An unadjusted CCA was also conducted for comparison. Since the 
auxiliary variables contained missing data (approximately 10% for each variable), 
values were imputed using a Markov chain Monte Carlo algorithm assuming 
multivariate normality (11). Following a burn-in of 5000 iterations,  = 50 
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completed datasets were created. For the LMM, the three auxiliary variables and 
FFM were jointly modelled assuming an unstructured covariance matrix, with 
adjustment for centre and sex.  
 
Treatment effect estimates are presented in Table 6.1. Although there was little 
evidence for an effect of treatment on FFM, subtle differences between the 
approaches are apparent. As expected, adjustment for prognostic baseline 
covariates in a CCA reduced the SE of the treatment effect estimate compared 
with the unadjusted analysis. By incorporating information from auxiliary 
variables, additional efficiency gains were evident for MI and the LMM, with 
similar estimates from the two approaches (as expected). However gains were 
small, perhaps because 48% of the children with a missing FFM value also had 
missing data on the three auxiliary variables. Even when fully observed, auxiliary 
variables may only have a meaningful impact on estimation when strongly 
correlated with the outcome (6, 48, 49). 
 
Table 6.1. Treatment effect estimates for fat free mass (kg) at 7 years corrected 
age from the Docosahexaenoic Acid for the Improvement of Neurodevelopmental 
Outcome in Preterm Infants trial. 
Method of analysis Mean difference Standard error 95% confidence interval
Unadjusted CCA -0.007 0.259 -0.514 to 0.500
CCA 0.048 0.238 -0.420 to 0.515
MI overall m=50 -0.104 0.233 -0.562 to 0.353
MI by group m=50 -0.118 0.227 -0.563 to 0.327
Linear mixed model -0.097 0.231 -0.551 to 0.356
Abbreviations: CCA, complete case analysis; MI, multiple imputation. 
 
For missing data in a baseline covariate, we consider group comparisons of head 
circumference (HC) at term adjusted for birth HC. To focus on the problem of 
missing baseline data, 20 infants with missing outcome data were excluded from 
the analysis. Seven of these infants were missing birth HC and hence contained no 
information for estimating treatment effects, while the remaining 13 were 
assumed to be MAR and hence could be validly excluded (as demonstrated in 
Section 6.3.5). Of the remaining infants, birth HC was missing for 39/251 (15.5%) 
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and 42/251 (16.7%) in the high and standard DHA groups, respectively. 
Treatment effects were estimated using the same methods as in Section 6.3.7 for a 
continuous baseline covariate and outcome, with 50 imputations used for MI. In 
relation to the calculation of weights for mean imputation and the missing 
indicator method, in complete cases, the correlation between birth HC and HC at 
term was 0.43.  
 
As illustrated in Table 6.2, estimates were similar across the nine statistical 
approaches. In line with simulation results for a moderate correlation between the 
baseline and outcome measure, CCA and unadjusted CCA produced the largest 
SEs for the effect of treatment. While outperforming CCA, MI did not offer any 
efficiency improvements over the remaining approaches.  
 
Table 6.2. Treatment effect estimates for head circumference (cm) at term from 
the Docosahexaenoic Acid for the Improvement of Neurodevelopmental Outcome 
in Preterm Infants trial. 
Method of analysis Mean difference Standard error 95% confidence interval
Unadjusted CCA -0.060 0.136 -0.326 to 0.206
CCA -0.058 0.134 -0.320 to 0.204
MI overall m=50 -0.023 0.125 -0.267 to 0.221
MI by group m=50 -0.027 0.125 -0.273 to 0.218
Mean imputation -0.024 0.125 -0.269 to 0.221
Mean imputation with weights -0.029 0.125 -0.274 to 0.215
Missing indicator -0.028 0.125 -0.272 to 0.217
Missing indicator with weights -0.032 0.124 -0.276 to 0.211
Linear mixed model -0.029 0.125 -0.275 to 0.217
Abbreviations: CCA, complete case analysis; MI, multiple imputation. 
 
Since the probability of missing baseline data differed across the five study 
centres, we considered additional sensitivity analyses where centre was added as a 
covariate in adjusted models and mean imputation was performed separately by 
centre. Although this resulted in small increases in precision compared to models 
ignoring centre, again MI did not outperform simpler approaches such as mean 
imputation and the missing indicator method with or without weights (SE = 0.123 





In this article, we evaluated the performance of MI in the RCT setting. In line 
with theoretical results, in its standard implementation, MI produced unbiased 
treatment effect estimates when data were MAR and the analysis model was 
correctly specified. However, due to Monte Carlo simulation error, MI was often 
less efficient than alternative unbiased approaches. For missing outcome data, MI 
was less efficient than CCA for univariate outcomes and the LMM for 
multivariate outcomes. For missing data in a baseline covariate, MI failed to 
outperform methods such as mean imputation and the missing indicator method. 
As well as being less efficient, MI was generally more difficult to implement and 
took longer to run compared with alternatives. Being a stochastic analysis, it also 
had the disadvantage of not producing a unique treatment effect estimate. Given 
these limitations, we believe that MI should not be seen as the only acceptable 
way to address missing data in RCTs. 
 
Collectively, our results underline the importance of context in choosing an 
approach for handling missing data. While MI is an extremely useful general 
purpose tool, it appears most beneficial in observational settings when there are 
missing data in confounding variables (93). In RCTs some of the value of MI is 
lost, and other approaches that are not widely recommended can be employed. For 
example, our simulation results confirm that mean imputation and the missing 
indicator method, whose use is ill-advised in most settings (1, 71, 123, 124), can 
be validly applied for addressing missing covariate data in RCTs. Similarly,  
despite general recommendations against the use of CCA (1, 71), it is optimal 
when missing data are restricted to a univariate outcome and variables associated 
with missingness are included as covariates in the analysis model (18, 23, 24). 
This scenario seems most pertinent to RCTs, where missing data tend to occur in 
the outcome. Of course should post-randomisation auxiliary variables for a 
univariate outcome be available, as is often the case, we then move into the setting 




Regarding choice of imputation strategy, we found that MI by group was slightly 
less efficient than MI overall for a correctly specified analysis model. However, 
when the analysis model overlooked an interaction effect involving randomised 
group, only MI by group produced unbiased estimates of the ATE. Thus in 
settings where MI is adopted, we recommend imputing by randomised group; 
compared to MI overall, this approach offers greater robustness at little cost. The 
approach is also consistent with general recommendations for over- rather than 
under-specifying imputation models (6, 11). It should be noted that imputing by 
group only protects against bias in estimating the ATE if effect modifiers are 
included in the imputation model. Another possibility is to include interaction 
terms in a single imputation model, but this approach is more complex and may 
not be obvious when analysis models do not include interaction terms. Although 
not considered in this article, we agree with previous recommendations for 
performing imputation separately by randomised group in settings involving 
subgroup analyses (13-15, 102). 
 
Despite highlighting alternatives to MI in this article, we are not suggesting that it 
is inappropriate to use MI. To the contrary, we view MI as an attractive option 
given its considerable flexibility. It is not uncommon in RCTs for researchers to 
collect data on a large number of secondary outcomes. One of the strengths of MI 
is its ability to easily incorporate variables of different types (e.g. continuous, 
binary) in the imputation model, whether for univariate or multivariate data. An 
added benefit of including all outcomes in a single imputation model is that 
associations between related outcomes can aid imputation. Another appealing 
feature of MI is its ability to be implemented under an assumption that data are 
MNAR. This property makes MI well suited to undertaking sensitivity analyses 
around a primary assumption that data are MAR (76), and as a primary method of 
analysis in settings where data are believed to be MNAR. One such setting is 
RCTs where participants cannot followed up after discontinuing treatment. If all 
observed data are “on-treatment”, a MAR assumption entails estimating the effect 
of treatment had all participants remained on their assigned treatment (68). 
However, for a de facto type estimand (such as ITT), it may be more appropriate 
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to assume that data are MNAR. In this situation, reference-based sensitivity 
analyses have been proposed, which at present require the use of MI (112). 
 
A limitation of the current study is that conclusions were based on a restricted set 
of simulation scenarios. Although we only considered simple randomisation to 
two groups, we anticipate that findings would extend to RCTs involving three or 
more randomised groups, unequal allocation probabilities, and randomisation 
using stratified blocks or minimisation. We also expect that our results for 
normally distributed and binary outcome variables would apply to most other 
outcome types. Three exceptions worth noting are time to event outcomes, where 
missing outcome data can be addressed via censoring, composite (scale) outcomes 
derived from multiple items, and binary multivariate outcomes. For missing data 
in a composite outcome, MI at the item level is a particularly convenient approach 
when the individual items are partially observed. Although likelihood-based 
alternatives for composite outcomes are also available (129), they are more 
difficult to implement. For binary multivariate outcomes, complexities arise due 
to differences between population-averaged and subject-specific estimands (130). 
Generalised mixed models can be implemented in a similar manner to LMMs for 
continuous data if subject-specific estimates are of interest (19); however, these 
models can be challenging to fit given the variety of estimation procedures 
available and the computational difficulties that can arise with large numbers of 
repeated measurements (131). MI is more appealing for producing population-
averaged estimates (19). 
 
A further limitation is that we did not consider the performance of inverse 
probability weighting (IPW). This approach, which involves weighting complete 
cases by the inverse of the probability of being a complete case, requires only a 
correctly specified model for the probability of missing data to produce valid 
estimates under a MAR assumption. However, IPW tends to be less efficient than 
MI and can be difficult to implement for non-monotone missing data patterns 
(26). Of relevance to the settings considered in this article, IPW is capable of 
producing population-averaged estimates for multivariate binary outcome data 
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and unbiased estimates of an ATE from a misspecified analysis model (26). IPW 
can also be appropriate in settings where data are missing by design and hence 
where the probability of being a complete case is known. We also did not evaluate 
multiple imputation, then deletion, which is a modification to standard MI where 
participants with imputed outcomes (but not imputed covariate values) are deleted 
from analysis datasets (8). The rationale behind this approach is that following 
imputation, participants with missing outcomes only contribute noise to the 
estimation procedure (8). Whether multiple imputation, then deletion is useful in 
the RCT setting is debatable however, since it is only applicable in settings where 
both covariate and outcome data are missing. Further, the approach should be 
avoided when auxiliary variables for the outcome are included in the imputation 
model (104), as is often the case.  
 
In summary, MI is not the only option for handling missing data in RCTs. 
Although MI is appropriate in all contexts, simpler alternatives are often slightly 
superior. For missing outcome data, MI can be inferior to CCA and likelihood-
based approaches, adding in unnecessary simulation error. For missing data in a 
baseline covariate, simpler approaches such as mean imputation and the missing 
indicator method can outperform MI. Should MI be adopted, we recommend 
imputing separately by randomised group. 
 
6.3.10. Web appendix 
 
Web appendix A. Missing data in a univariate binary outcome, where there is a 
correctly specified analysis model. 
 
Considering = 0	or	1 with probability 0.5, binary outcomes were generated 
from the model logit	P( = 1) = + 0.69 + , where the treatment effect 
of 0.69 corresponds to an odds ratio (OR) of 2.0. To explore the impact that the 
strength of association between  and  had on model performance, the 
coefficient  was varied so that OR( , | ) = 2.0	or	4.0. Lastly the coefficient 
 was chosen so that ( = 1| = 0) = 0.20. Following the generation of 
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complete datasets, values in  were set to missing according to the MAR X, MAR 
X+T and MAR X×T mechanisms outlined in Section 6.3.5 (with  now a binary 
variable). Once again,  (increase in odds of missing data per standard deviation 
increase in ) was set to 1.5 or 2.5 to indicate weak and strong missing data 
mechanisms, respectively, and both 20% and 50% missing data were considered. 
 
CCA, MI overall and MI by group performed well in estimating the treatment 
effect for a binary outcome with missing data. Each method produced a mean 
treatment effect estimate of 0.70 across the 24 simulation scenarios (range 0.68, 
0.71), with the small bias away from the null a product of the finite sample bias of 
logistic regression. CCA was the most efficient approach in all scenarios, with 
empirical standard errors on average 0.4% and 2.9% larger with MI overall and 
MI by group, respectively; differences were more pronounced with 50% missing 
data and under the strong MAR X and MAR X+T mechanisms. Compared to 
CCA, power was on average 0.6% and 2.8% lower with MI overall and MI by 
group, respectively. Coverage for the three approaches remained close to 0.95 
throughout (range 0.94, 0.96). Figure 6.8 illustrates performance in scenarios with 
50% missing data, a strong MAR mechanism and for OR( , | ) = 4.0. For 
reference, results are also displayed for unadjusted CCA. As seen in the figure, 
treatment effect estimates were noticeably different with unadjusted CCA, due 
both to inadequate handling of the missing data and the estimation of a different 
treatment effect in unadjusted logistic regression. For MI, empirical standard 
errors were marginally lower with MI overall than MI by group. As observed for 






Figure 6.8. Mean treatment effect estimates for 50% missing data in a binary 
outcome, OR( , | ) = 4.0, strong MAR mechanisms, correctly specified 
analysis model. Error bars correspond to empirical standard errors (± 1 standard 
error) across 2,000 simulated datasets. 
 
Web appendix B. Missing data in a continuous multivariate outcome where there 
is missing data in an intermediate measure of the outcome and the final outcome. 
 
Intermediate ( ) and final ( ) values of a continuous outcome were simulated 
using the data generation model from Section 6.3.6 of the main article. Again we 
considered weak (0.30) and strong (0.70) values for  and for the correlation 
between the baseline covariate  and the two outcome measures. Missingness was 
induced in a monotone pattern using two steps. In the first step, values in both  
and  were simultaneously set to missing such that the odds of missingness were 
 times higher in the control group and increased by a factor  per SD increase in 
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additional values in  were set to missing such that the odds of missingness were 
 times higher per SD increase in observed . We considered  = 1.5 or 2.5, with 
missing data proportions in ( , ) of (0.10, 0.20) or (0.25, 0.50). In addition to 
CCA and MI (using multivariate normal imputation), data were analysed using a 
LMM with an unstructured covariance matrix.  
 
As expected for a MAR mechanism, MI overall, MI by group and the LMM 
produced unbiased treatment effect estimates with correct coverage (range 0.94, 
0.46) across all scenarios. Compared to the LMM, empirical SEs were on average 
0.4% and 3.0% higher with MI overall and MI by group, respectively (translating 
to average power losses of 0.1% and 2.8%). Although CCA was outperformed by 
MI and the LMM, deficiencies were not as pronounced as when missing data was 
restricted to the final outcome measure, as presented in Section 6.3.6. In fact, 
CCA was only marginally less efficient than the LMM for  = 0.30 (empirical 
standard errors 0.9% larger). This is not an unexpected result, since  has less 
information to contribute to estimation when it contains missing data. Figure 6.9 
shows performance in scenarios with 50% missing data in , where 
corr( , | ) = 0.30 and  = 2.5. As seen in the figure, the shortcomings of CCA 
were most pronounced for = 0.70 (bias = 0.02, empirical SE 6.6% larger than 




Figure 6.9. Mean treatment effect estimates for 25% and 50% missing data in an 
intermediate and final measure of a continuous multivariate outcome, 
respectively, corr( , | ) = 0.30, strong MAR mechanism. Error bars 
correspond to empirical standard errors (± 1 standard error) across 2,000 
simulated datasets. 
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Figure 6.10. Mean treatment effect estimates for 20% missing data in a 
continuous covariate for adjustment, MNAR mechanism. Error bars correspond to 
empirical standard errors (± 1 standard error) across 2,000 simulated datasets. 
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This chapter contains the last of a series of four articles contributing to this thesis. 
The article, published in Clinical Trials, systematically reviews recently published 
extended follow-up studies of RCTs to summarise the extent and common sources 
of missing outcome data in this setting. The use of statistical approaches for 
handling missing outcome data in extended follow-up studies is also reviewed. 
Based on the findings of the systematic review, and using the DINO trial as a case 
study, some general recommendations for implementing MI in extended follow-
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Background/Aims: After completion of a randomised controlled trial, an 
extended follow-up period may be initiated to learn about longer term impacts of 
the intervention. Since extended follow-up studies often involve additional 
eligibility restrictions and consent processes for participation, and a longer 
duration of follow-up entails a greater risk for participant attrition, missing data 
can be a considerable threat in this setting. As a potential source of bias, it is 
critical that missing data are appropriately handled in the statistical analysis, yet 
little is known about the treatment of missing data in extended follow-up studies. 
The aims of this review were to summarise the extent of missing data in extended 
follow-up studies and the use of statistical approaches to address this potentially 
serious problem. 
 
Methods: We performed a systematic literature search in PubMed to identify 
extended follow-up studies published from January to June 2015. Studies were 
eligible for inclusion if the original randomised controlled trial results were also 
published and if the main objective of extended follow-up was to compare the 
original randomised groups. We recorded information on the extent of missing 
data and the approach used to treat missing data in the statistical analysis of the 
primary outcome of the extended follow-up study. 
 
Results: Of the 81 studies included in the review, 36 (44%) reported additional 
eligibility restrictions and 24 (30%) consent processes for entry into extended 
follow-up. Data were collected at a median of 7 years after randomisation. 
Excluding 28 studies with a time to event primary outcome, 51/53 studies (96%) 
reported missing data on the primary outcome. The median percentage of 
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randomised participants with complete data on the primary outcome was just 66% 
in these studies. The most common statistical approach to address missing data 
was complete case analysis (51% of studies), while likelihood-based analyses 
were also well represented (25%). Sensitivity analyses around the missing data 
mechanism were rarely performed (25% of studies), and when they were, they 
often involved unrealistic assumptions about the mechanism. 
 
Conclusions: Despite missing data being a serious problem in extended follow-up 
studies, statistical approaches to addressing missing data were often inadequate. 
We recommend researchers clearly specify all sources of missing data in follow-
up studies and use statistical methods that are valid under a plausible assumption 
about the missing data mechanism. Sensitivity analyses should also be undertaken 





After a randomised controlled trial (RCT) has come to its protocol defined end, it 
may be desirable to instigate an extended follow-up period to learn about longer 
term impacts of the intervention. In prevention and treatment trials, extended 
follow-up can be important for verifying that early effects on biomarkers of 
disease activity translate to longer term effects on more clinically meaningful 
endpoints (83, 84). In perinatal trials, extended follow-up may be initiated to 
evaluate impacts on development in later childhood. In other settings, 
investigators may choose to follow up participants to learn more about disease 
progression, long-term safety, treatment-related costs, or the maintenance of early 
effects (16). The key benefit of initiating extended follow-up is the cost saving 
associated with using an already established cohort. Given the substantial 
investment required in designing a trial, recruiting participants, providing 
treatment and collecting baseline data, it is not surprising that many trials do 




Like standard RCTs, missing data can threaten the validity of findings from 
extended follow-up studies. The process of transitioning to an extended follow-up 
study may occur years after completion of the original RCT, leaving the task of 
re-contacting participants and obtaining outcome data particularly difficult. Even 
without a delay in commencing extended follow-up, the longer time between 
randomisation and final outcome assessment may be associated with greater 
participant attrition. In multicentre trials, some centres might not participate in 
extended follow-up, or investigators could impose other eligibility restrictions for 
inclusion into extended follow-up. Depending on the information provided to 
participants in the original RCT, a separate consent form for extended follow-up 
may also be necessary. Some participants may be unwilling to consent at this 
stage. Finally, participants may simply fail to provide information about a 
particular measure during extended follow-up. Taken together these varied 
sources of missing data (attrition over time, ineligibility, non-consent and item 
non-response) could result in a large proportion of the original randomised cohort 
having missing outcome data. 
 
The most effective way to minimise the impact of missing data in extended 
follow-up studies is to prevent it. In a recent review, Drye et al. (16) considered 
logistical issues in undertaking extended follow-up studies, with several of their 
recommendations focusing on the prevention of missing data. Suggestions 
included minimising the time between trial completion and follow-up study 
commencement, maintaining participant contact details at a central facility, 
informing participants about possible future contact, and attempting to contact 
participants who were unable to complete the original RCT. Even with the most 
rigorous planning, however, there will invariably be some missing data in 
extended follow-up studies. Since inadequate treatment of missing data in an 
analysis can result in substantial bias and inefficiency (1), it is critical that 
appropriate statistical methods are adopted. 
 
The validity of any statistical method used to handle missing data depends on the 
mechanism responsible for the data being missing. Using Rubin’s system (2), data 
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can be classified as missing completely at random if missingness is independent 
of observed and unobserved data, missing at random if missingness is independent 
of unobserved data given observed data, and missing not at random if missingness 
is dependent on unobserved data given observed data. Since the mechanism 
cannot be verified from observed data, researchers are encouraged to state and 
justify the assumption made about the missing data mechanism in the main 
analysis and to undertake sensitivity analyses around this assumption (1, 13, 17, 
20). 
 
A common approach to handling missing data in RCTs is to perform a complete 
case analysis (109, 132), which involves restricting the analysis to participants 
with complete data on all variables in the analysis model. Although simple to 
implement, complete case analysis is often inefficient and can introduce bias 
when data are not missing completely at random (1, 14). Single imputation 
methods, which involve replacing missing values with single imputed values, are 
also commonly used in RCTs (109, 132). A major concern with the application of 
these methods is that analyses are often incorrectly conducted as if all data were 
observed, which can lead to overstated precision (1, 13). A noteworthy single 
imputation method for longitudinal settings is the last observation carried forward, 
where missing outcomes are replaced by the last observed measurement. As well 
as concerns around overstated precision, this method can introduce bias when 
outcome values change following the last observed measurement (13).  
 
Several more principled alternatives for handling missing data are available. 
Inverse probability weighting, where complete cases are weighted by the inverse 
of the probability of being a complete case (26), and likelihood-based methods 
(e.g. mixed models for repeated measures data) (79, 117) produce valid inference 
under a missing at random assumption. Another approach typically implemented 
under a missing at random assumption is multiple imputation (4), although 
application under missing not at random mechanisms is also possible. In its 
standard implementation, multiple imputation involves replacing each missing 
observation with multiple independent draws from the posterior predictive 
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distribution of the missing data conditional on the observed data, a process that 
generates multiple complete datasets. Following analysis, results for each 
complete dataset can be combined using appropriate rules to give a single 
estimate. An alternative to multiple imputation is model-based single imputation; 
however, special methods such as the jackknife are required to obtain valid 
standard error estimates (133). 
 
Given recommendations for the use of inverse probability weighting, likelihood-
based methods, and multiple imputation in guidance documents for RCTs (1, 71), 
it seems reasonable that these methods should be preferred in extended follow-up 
studies. Yet implementation in this setting may be more complex given the 
additional sources of missing data present. Consider an extended follow-up study 
involving a separate consent process and where eligibility is restricted to 
participants who completed the original RCT, as illustrated in Figure 7.1. The 
analysis could include all randomised, all eligible, or all consenting participants. 
Incorporating the full randomised cohort in the analysis preserves the benefits of 
randomisation, but there may be a large amount of missing data to account for and 
a mixture of missing data mechanisms at play, since reasons for missing data 
could differ between ineligible participants, non-consenters, and consenters. 
Satisfying an assumption about the missing data mechanism might be more 
feasible if calculations only incorporate eligible or consenting participants, but 
then the benefits of randomisation are diminished. The population of interest for 
the chosen measure of intervention effect (e.g. all randomised participants for 
intention to treat) should also be taken into account when choosing a participant 
group to incorporate in the analysis. Discussion of these issues is lacking in the 






Figure 7.1. Timeline of an extended follow-up study. 
 
We undertook a systematic review of the literature to investigate the treatment of 
missing data in extended follow-up studies. Although reviews on the treatment of 
missing data have been undertaken for other research designs, for example 
randomised trials (12, 109, 132) and cluster randomised trials (134, 135), to our 
knowledge, this is the first review of missing data in extended follow-up studies. 
The aims of the review were to summarise the extent of missing data in follow-up 
studies, the quality of reporting around missing data, and the use of statistical 




Research articles published in English between 1 January 2015 and 30 June 2015 
were reviewed. Studies were eligible for inclusion if the original trial results were 
also published and if the main objective of extended follow-up was to compare 
the original randomised groups. Since options for handling missing data are 
limited in small sample sizes, only studies involving the randomisation of at least 
100 participants were considered eligible. Articles were excluded if the original 
trial was a pilot or dose-finding study, if extended follow-up was pre-specified in 
the original trial protocol, or if the article included multiple trial cohorts (as this 
would lead to additional complexities in handling missing data). Where multiple 
articles reporting on the same follow-up study were discovered, only the first 
published article was included in the review to avoid replicating results. 
 
 




















The search was conducted in PubMed on 18 January 2016. Search terms were 
based on the Cochrane sensitivity and precision maximising search strategy for 
identifying randomised trials (136), with additional terms for “follow-up”, 
“continuation study” and “long-term effects”. The search strategy is detailed in 
Table 7.1. Titles and abstracts of identified articles were examined and classified 
as potentially eligible or ineligible. Full texts of potentially eligible articles were 
then examined to confirm eligibility, with information from eligible articles 
transcribed to a pre-piloted data extraction form developed specifically for this 
review. Details reported in Supplementary Materials and Web Appendices were 
included in this review process. The assessment was carried out in full by one 
reviewer (T.R.S.), with a second reviewer (L.N.Y.) independently examining 20% 
of the articles. Interrater agreement for article eligilibity, as indicated by a Kappa 
statistic (137), was estimated to be 0.89. All disagreements were resolved by 
discussion. 
 
Table 7.1. Search strategy to identify extended follow-up studies (PubMed search 
date 18 January 2016). 
(randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR 
randomised[tiab] OR placebo[tiab] OR clinical trials as topic [mesh: noexp] OR randomly[tiab] OR 
trial[ti]) NOT (animals[mh] NOT humans[mh]) AND ("follow-up" [ti] OR "followup" [ti] OR 
"continuation study" [ti] OR "long-term effects" [ti]) AND ("2015/01/01"[PDat] : "2015/06/30"[PDat]) 
AND English[lang] 
 
For each eligible follow-up study, key details about the original RCT were 
recorded, including the unit of randomisation (individuals vs. clusters), number of 
randomised participants, number of treatment arms, and type of intervention. 
Information on the use of separate eligibility restrictions and consent processes for 
entry into extended follow-up was then documented, including numbers eligible 
and consenting where applicable. The duration of time between randomisation or 
completion of the original RCT and completion of the extended follow-up study 




In extracting information about the handling of missing data, the review focused 
on the analysis of a single primary outcome. If multiple primary outcomes were 
identified in the article, the primary outcome of interest was defined as the first 
primary outcome used to determine the sample size, or the first primary outcome 
identified otherwise. If no primary outcome was identified, it was taken to be the 
first outcome used to justify the sample size, otherwise the first outcome 
presented in a table or figure. With the exception of time to event outcomes, 
where missing data can, in part, be addressed through censoring, the number of 
complete cases for the primary outcome was recorded. For outcomes measured 
repeatedly over time, the number of complete cases was taken to be the number 
available at the final assessment. In studies with missing data on the primary 
outcome, the following information was extracted: measure of intervention effect 
of interest (e.g. intention to treat), statement and justification of the missing data 
mechanism assumed, and statistical method used to handle missing data in both 




The electronic search identified 420 articles, of which 274 were excluded based 
on a review of titles and abstracts. Of the remaining 146 articles, 81 satisfied 
eligibility criteria and were included in the review (Figure 7.2). The full list of 
included articles is provided in the web appendix (see Section 7.3.6; also available 





Figure 7.2. Flow diagram for systematic review. 
 
Characteristics of original trial 
 
Key characteristics of the original trial are presented in Table 7.2. The median 
number of randomised participants was 299, with the majority of trials having two 
treatment arms and randomising individuals rather than clusters. The most 
common type of intervention was a drug or medical device (41%), with surgical 
(12%), psychological (11%) and nutritional supplement (10%) interventions also 
well represented. Reporting of blinding was poor, with 56% of articles providing 
insufficient detail to determine the type of blinding employed. In many articles, 




Full text articles excluded (n=65) 
- not extended follow-up of a trial (n=42) 
- randomised sample size < 100 (n=7) 
- objective not to compare randomised groups (n=7) 
- initial trial a pilot study (n=1) 
- multiple follow-up studies in article (n=1) 
- follow-up study in original protocol (n=6) 
- subsequent article reporting on same study (n=1) Articles included in the review 
(n=81) 
Full text articles assessed for 
eligibility (n=146) 
Articles excluded during title and abstract review (n=274) 
- study not in humans (n=2) 
- not extended follow-up of a trial (n=141) 
- randomised sample size < 100 (n=95) 
- objective not to compare randomised groups (n=30) 
- initial trial a pilot study (n=3) 
- multiple follow-up studies in article (n=1) 
- follow-up study in original protocol (n=2) 




Table 7.2. Characteristics of the original trialsa. 
Characteristic Number of studies (n=81) 
Number of participants: median (inter) 299 (154, 1152) [n=80] 
Number of treatment arms  
2 65 (80%) 
3 or more 16 (20%) 
Randomisation  
Individual 67 (83%) 
Cluster 8 (10%) 
Unclear 6 (7%) 
Intervention  
Drug/device 33 (41%) 
Exercise/diet/lifestyle 7 (9%) 
Nutritional supplement 8 (10%) 
Psychological 9 (11%) 
Surgical 10 (12%) 
Other 14 (17%) 
Blinding  
Unblinded 14 (17%) 
Participants blinded 1 (1%) 
Outcome assessors blinded 14 (17%) 
Both participants and outcome assessors blinded 7 (9%) 
Unclear 45 (56%) 
Abbreviations: IQR, interquartile range. 
a Values are n(%) unless otherwise indicated. 
 
Characteristics of extended follow-up study 
 
Information on the transition to extended follow-up is presented in Table 7.3. Of 
the 81 articles included in the review, 36 (44%) reported separate eligibility 
restrictions for entry into extended follow-up. The most common restriction 
concerned satisfactory adherence to the protocol in the original trial (22 studies). 
Participants were also ruled ineligible according to their enrolling centre (three 
studies), treatment arm (two studies), or other baseline (three studies) or post-
randomisation (six studies) characteristics. Across studies reporting eligibility 
restrictions, the median percentage of randomised participants eligible for follow-
up was 86%. A total of 24 studies (30%) reported using a separate consent process 
for follow-up; the median percentage of randomised participants providing 
consent was 70% in these studies. It is possible that other studies used eligibility 
restrictions and consent processes for follow-up but failed to report them. Overall, 
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the median duration of time from randomisation to completion of extended 
follow-up was 84 months, representing a median of 52 months of additional 
follow-up beyond the original RCT. 
 
Table 7.3. Characteristics of the extended follow-up studiesa. 
Characteristic Number of studies 
(n=81) 
Reported on an eligibility restriction for the follow-up study  
Yes 36 (44%) 
No 45 (56%) 
Percentage of randomised participants eligible: median (IQR) 85.6 (73.1, 91.9) [n=32]  
Reported on the use of a separate consent process for the follow-up study  
Yes 24 (30%) 
No 57 (70%) 
Percentage of randomised participants consenting: median (IQR) 70.3 (54.2, 77.2) [n=20] 
Months from randomisation to follow-up study completion: median (IQR) 84 (38, 120) [n=77] 
Months from original RCT completion to follow-up study completion: median (IQR) 52 (24, 72) [n=72] 
Same primary outcome as in original RCT but at a later time point  
Yes 17 (21%) 
No 22 (27%) 
Unclear 42 (52%) 
Type of primary outcome in follow-up study  
Continuous 36 (44%) 
Binary 14 (17%) 
Categorical 3 (4%) 
Time to event 28 (35%) 
Number of measurements on primary outcomeb  
Single 17 (32%) 
Repeated 36 (68%) 
Accounted for missing data in sample size calculationsc  
Yes 5 (10%) 
No 1 (2%) 
No calculation provided 45 (88%) 
Reported information on the amount of missing datac  
By treatment arm 47 (92%) 
Overall only 4 (8%) 
Percentage complete cases among all randomised: median (IQR)c 65.9 (53.1, 78.6) [n=48] 
Abbreviations: IQR, interquartile range; RCT, randomised controlled trial. 
a Values are n(%) unless otherwise indicated. 
b Excluding n=28 studies with a time to event primary outcome. 
c Excluding n=28 studies with a time to event primary outcome and n=2 studies that did not report missing data. 
 
Table 7.3 also provides details on the primary outcome of extended follow-up. In 
17 studies (44%), the primary outcome was unchanged from the original RCT, 
albeit measured at a later time point. The majority of studies involved either a 
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continuous (44%), time to event (35%), or binary (17%) primary outcome. 
Excluding 28 studies with a time to event primary outcome, 51/53 studies (96%) 
reported missing data on the primary outcome. In one study, all randomised 
participants had primary outcome data available, while another study provided 
insufficient details to determine if there were missing data. Of the 51 studies 
reporting missing data, only five accounted for missing data in sample size or 
power calculations; 45 did not provide any justification for the sample size in the 
extended follow-up study at all. Reporting on the extent of missing data was fairly 
rigorous, with 47/51 studies reporting some information on missing data 
proportions separately by treatment arm. Across treatment arms, the precise 
number of complete cases on the primary outcome was presented or possible to 
infer in 48/51 studies. Among these studies, the median percentage of randomised 
participants with complete data on the primary outcome was just 66% 
(interquartile range 53%, 79%). 
 
Handling of missing data in the main analysis 
 
Of the 51 studies reporting missing data on the primary outcome, 26 (51%) failed 
to identify the measure of intervention effect, or estimand, of interest (Table 7.4). 
A total of 18 studies undertook analyses according to the intention to treat 
principle and three according to a per-protocol approach. The remaining four 
studies defined some other estimand of interest. Of the 18 studies reportedly 
following the intention to treat principle, six restricted eligibility for extended 
follow-up according to adherence to the protocol in the original RCT. Only 5/51 
studies with missing data explicitly stated the missing data mechanism assumed in 
the main analysis, with just three of these providing justification for the 
assumption. In two studies, a missing at random assumption was deemed 
plausible since baseline characteristics were similar between participants with 
missing and observed outcomes (suggesting data might have been missing 
completely at random). Another study identified predictors of missing data and 
justified a missing at random assumption by incorporating these predictors into a 
likelihood-based linear mixed model. 
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Table 7.4. Analysis of the primary outcomea. 
Characteristic Number of studies (n=51)b 
Measure of intervention effect (estimand) of interest  
Intention to treat 18 (35%) 
Per protocol 3 (6%) 
Other 4 (8%) 
Not stated 26 (51%) 
Reported on missing data mechanism assumed in the analysis  
Missing at random 5 (10%) 
Not stated 46 (90%) 
Justified the assumption made about the missing data mechanism  
Yes 3 (6%) 
No 2 (4%) 
Not applicable 46 (90%) 
Statistical approach  
Complete case analysis 26 (51%) 
Single imputation 3 (6%) 
Multiple imputation 4 (8%) 
Likelihood based 13 (25%) 
Estimating equation method 4 (8%) 
Unclear 1 (2%) 
Performed a sensitivity analysis around the missing data mechanism  
Yes 13 (25%) 
No 38 (75%) 
a Values are n(%). 
b Excluding n=28 studies with a time to event primary outcome and n=2 studies that did not report missing data. 
 
The most common approach for handling missing data in the main analysis was to 
perform a complete case analysis (26/51 studies; Table 7.4). Of studies using 
complete case analysis, 17/26 (65%) involved a primary outcome that was 
measured repeatedly over time, and so analyses (final time point analysis or 
analysis of variance (ANOVA)) may have excluded participants with available 
data on earlier measurements. Among the nine studies using complete case 
analysis for a univariate (once-measured) primary outcome, only one adjusted for 
baseline covariates. A total of 13 studies used a likelihood-based approach in the 
main analysis, 10 involving a repeatedly measured outcome and 3 a univariate 
outcome with clustering in the data. Single imputation methods were used in three 
studies: two used last observation carried forward and one assumed that 
participants were disease free if data were missing. Four studies used estimating 
equations (without probability weights) to account for clustering, which relies on 
data being missing completely at random (138). In one study, the method of 
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analysis was unclear, while four studies used multiple imputation to address 
missing data. In three studies using multiple imputation, imputed datasets 
included all randomised participants. In the other, where interest concerned the 
intention to treat estimand, data were only imputed for participants who consented 
to extended follow-up, although imputation back to the full randomised cohort 
was explored in a sensitivity analysis. Regarding method of multiple imputation, 
two studies used chained equations to generate 100 imputed datasets, with 
additional predictors of the outcomes and of missing data (known as auxiliary 
variables) included in the imputation model. One study used an expectation 
maximisation algorithm to generate 20 imputed datasets, while another did not 




Of the 51 follow-up studies with missing data, 13 (25%) reported undertaking 
sensitivity analyses where an alternative statistical method was used to address 
missing data. Methods of sensitivity analysis included complete case analysis 
(five studies), likelihood-based (three studies), multiple imputation (two studies), 
last observation carried forward (two studies), other single imputation procedure 
ignoring missing data uncertainty (two studies), and estimating the range of 
possible treatment effects for missing data in a binary outcome (one study). Of 
note, only six studies were judged to have made a less restrictive assumption 
about the missing data mechanism in sensitivity analyses, with just two 
considering missing not at random mechanisms. Eight studies presented treatment 
effect estimates along with confidence intervals or standard errors from sensitivity 
analyses, one graphically presented a range of p-values, while the remaining four 




In this article, we reviewed the occurrence and treatment of missing data in 
recently published extended follow-up studies. With primary outcome data 
165 
 
collected at a median of 7 years after randomisation, and with many studies 
reporting separate eligibility restrictions and consent processes for entry into 
extended follow-up, it was not surprising to find high proportions of missing data. 
We found that the median percentage of randomised participants with complete 
data on the primary outcome was just 66%. In comparison, systematic reviews of 
RCTs have reported median complete data proportions in the vicinity of 90% 
(range 89 to 92%) (7, 12, 109). Despite the considerable threat of missing data, 
several weaknesses in the statistical handling of missing data were identified. 
Only half the included articles reported the estimand of interest, less than 10% 
explicitly stated the missing data mechanism assumed in the analysis and just 25% 
undertook sensitivity analyses around the missing data mechanism. Further, 
roughly 60% of studies performed the main analysis under the strong assumption 
that data were missing completely at random. Clearly there is room for 
improvement. 
 
Complete case analysis was the most popular statistical approach in this review, 
despite criticism in guidance documents for RCTs (1, 71). It is possible that 
researchers remain unclear about the underlying assumptions required to 
guarantee the validity of this approach. Indeed, one study employing complete 
case analysis claimed they made “no assumptions about missing data” (139). For 
outcomes measured repeatedly over time, there is little justification for complete 
case analysis. Even in the unlikely scenario that repeated measures data are 
missing completely at random, complete case analysis tends to be inefficient since 
participants with intermediate measures on the outcome can be excluded from the 
analysis. For univariate outcomes, complete case analysis may be more 
defensible. Research has shown that complete case analysis with covariate 
adjustment produces unbiased and efficient estimates of regression parameters 
when univariate outcome data are missing at random conditional on covariates 
(18, 23, 24). In the context of extended follow-up studies, this means that 
inference can be improved by identifying and subsequently adjusting for baseline 
predictors of missing data. Unfortunately we only observed one study where 
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baseline variables were adjusted for in a complete case analysis of a univariate 
outcome. 
 
Encouragingly, likelihood-based approaches or multiple imputation were used in 
33% of the included studies, which is higher than usage rates of around 25% 
observed in recent systematic reviews of RCTs (109, 132). It was also promising 
to find only two studies that used last observation carried forward in the main 
analysis. This method relies on the questionable assumption that responses remain 
stable beyond the last observed measurement. Even in settings where this 
assumption is plausible, the approach tends to produce confidence intervals that 
are too narrow (1, 13, 110). 
 
As well as choosing and justifying a sensible method of analysis in the presence 
of missing data, it is critical that researchers explicitly state the estimand of 
interest (1). Since discussion on the topic is still evolving (66, 68, 140), we avoid 
trying to define here exactly what constitutes an estimand, yet it remains clear that 
one must know what is being estimated to judge the appropriateness of a 
statistical approach. Unfortunately less than half of the included studies stated the 
estimand of interest. Among studies where it was stated, the majority focused on 
the intention to treat estimand. Interestingly, three studies undertaking intention to 
treat analyses used a complete case analysis for repeated measures data, and so 
may have excluded participants with available outcome data at earlier time points. 
In addition, six studies restricted eligibility for entry into extended follow-up 
according to adherence to the protocol in the original RCT. Both these approaches 
ignore recommendations for undertaking intention to treat analyses, which 
specifically advocate using all available outcome data in the analysis and 
attempting to collect outcome data on all randomised participants (1, 20, 68). 
 
Another major shortcoming identified in the review concerned the use of 
sensitivity analyses around the missing data mechanism. Sensitivity analyses were 
infrequently performed, and when they were, they often involved strong 
assumptions about the missing data mechanism. Only two studies considered 
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missing not at random mechanisms in sensitivity analyses. Guidance documents 
for RCTs have emphasised the need to consider plausible alternative assumptions 
about the missing data in sensitivity analyses (1, 20, 71), typically by relaxing the 
assumption about the missing data mechanism. Given the high levels of missing 
data observed in this review, we believe these recommendations are especially 
relevant in extended follow-up studies. 
 
Contrary to expectations, we did not find any discussion on the merits of 
incorporating the full randomised cohort in the analysis compared with a sub-
sample in follow-up studies involving separate eligibility restrictions and/or 
consent processes. Although one study employing multiple imputation included 
consenting participants in the main analysis and the full randomised sample in a 
sensitivity analysis, the rationale for this approach was not described. In 
encouraging researchers to adopt principled approaches such as inverse 
probability weighting, likelihood-based methods and multiple imputation, some 
guidance around the choice of participant group to incorporate in such an analysis, 
and factors that might influence this decision, would be a welcome contribution. 
 
A limitation of this review is that for feasibility we extracted information only 
from published follow-up studies and associated supplementary materials. Further 
details could have been obtained from the original RCT publication, in published 
protocols or by contacting authors. Other approaches to addressing missing data 
may have been implemented but not reported due to journal space constraints. It is 
also possible that the search strategy missed a number of studies, since there is no 
current standard for identifying extended follow-up studies in titles or abstracts. 
Finally, our review only considered studies where the main objective of extended 
follow-up was to compare the original randomised groups. Extended follow-up 






Extended follow-up studies of RCTs can provide vital information about the long-
term impacts of an intervention and are an effective use of established trial 
cohorts. However, the validity of findings from extended follow-up studies relies 
on appropriate handling of missing data. In this systematic review, we found that 
a majority of recently published follow-up studies failed to adequately account for 
missing data in the analysis. This is particularly concerning given the high levels 
of missing data observed. We encourage researchers working on extended follow-
up studies to adhere to recommendations for RCTs by stating the estimand of 
interest and adopting statistical methods that are valid under a stated assumption 
about the missing data mechanism. In justifying this assumption, researchers 
should carefully detail all sources of missing data, including any additional 
consent processes and eligibility restrictions employed. Sensitivity analyses 
should also be undertaken to assess the robustness of findings to the assumption 
made about the missing data in the main analysis. For extended follow-up studies 
planning an intention to treat analysis, we recommend researchers attempt to 
collect outcome data on all participants, not just those that adhered to the protocol 
in the original trial.  
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*** End of published article *** 
 
7.4. Guidance on the use of multiple imputation 
 
The systematic review presented in Section 7.3 provides an overview of how 
missing outcome data are handled in published extended follow-up studies. A 
further aim of this thesis is to provide guidance on the implementation of MI in 
this setting. Although MI was rarely used in the extended follow-up studies 
included in the systematic review, valuable information on the extent and 
common sources of missing outcome data in this setting was obtained. In 
particular, the systematic review indicated that the amount of missing data in 
extended follow-up studies tends to be high and that eligibility restrictions and 
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separate consent processes are often used. The implications of eligibility 
restrictions and separate consent processes on the implementation of MI are now 
considered in more detail. 
 
It is assumed throughout this section of the thesis that the goal of analysis is to 
provide an unbiased and efficient estimate of the estimand of interest in the 
extended follow-up study, hereafter referred to simply as the estimand. 
Importantly, to focus on issues in implementing MI, the appropriateness or 
otherwise of specific estimands is not evaluated in this section. Suppose for 
example the estimand relates to the effect of treatment in participants that 
complied with their allocated intervention in the original trial. Since randomised 
groups are unlikely to be comparable once non-compliant participants are 
excluded from consideration, such an estimand provides a measure of association 
rather than causation. Rather than questioning the merits of the estimand, we 
consider only the implementation of MI for best estimating it. Attention is also 
restricted to settings where the design of the extended follow-up is consistent with 
its estimand. Most notably, we do not tackle the case in which an eligibility 
restriction based on adherence to the protocol in the original trial is employed, yet 
where interest in the extended follow-up study concerns the ITT estimand. 
 
7.4.1. Multiple imputation and eligibility restrictions  
 
Before detailing common eligibility restrictions in extended follow-up studies and 
their implications for the use of MI in this setting, it is useful to clarify what was 
intended by the term “eligibility restriction” in the systematic review. Broadly, an 
eligibility restriction was taken to be any rule that prevented individuals who 
otherwise could have taken part in the extended follow-up from participating in 
this phase of the trial. In addition to eligibility restrictions, individuals could be 
precluded from participating in extended follow-up for the following reasons: 
 
 death; 
 loss to follow-up; 
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 withdrawal from the original RCT preventing further contact; 
 non-selection in a random sample chosen for extended follow-up; and 
 non-consent to extended follow-up. 
 
While some studies included in the systematic review stated that loss to follow-up 
or non-consent to extended follow-up rendered a participant ineligible, for 
consistency in this discussion the reason for not participating in extended follow-
up in these cases was taken to be loss to follow-up or non-consent, respectively 
(rather than ineligibility). Conversely, withdrawal from the original RCT was 
classified as an eligibility restriction if a study both described it as such, and did 
not explicitly detail whether the withdrawal process prevented further contact with 
participants. 
 
Of the 81 articles included in the review, 36 (44%) reported eligibility restrictions 
for entry into extended follow-up. The most common class of eligibility restriction 
concerned adherence to the protocol in the original RCT (22 studies), typically 
defined according to satisfactory completion of outcome assessments and/or 
sufficient compliance with the allocated intervention. Studies where withdrawal 
from the original RCT was taken to be an eligibility restriction according to the 
criteria given above were also included in this eligibility restriction class, as 
withdrawing from a study generally entails incomplete outcome assessments 
and/or non-compliance with the intervention. Studies in the systematic review 
also ruled participants ineligible according to their enrolling centre (three studies), 
randomised arm (two studies, both involving three arms in the original RCT), 
geographic availability (three studies), or other baseline (three studies) or post-
randomisation (three studies) characteristics. Across studies reporting eligibility 
restrictions, the median percentage of participants randomised in the original trial 
that were eligible for extended follow-up was 86%.  
 
An important function of eligibility restrictions, as identified in the systematic 
review, is to limit entry into the extended follow-up to participants contained 
within the target population of the estimand. Should the intention of the extended 
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follow-up be to estimate the effect of treatment in individuals who complied with 
their allocated intervention, for example, then it is logical to restrict participation 
to compliers. Likewise, if the goal of extended follow-up is to estimate the effect 
of treatment in participants with particular baseline characteristics, only 
participants with these characteristics need to be included in the follow-up study. 
Using the Normoglycemia in Intensive Care Evaluation-Survival Using Glucose 
Algorithm Regulation (NICE-SUGAR) study as a specific example, excluding 
participants without traumatic brain injury at baseline was consistent with the aim 
of this extended follow-up study to “compare the effect of intensive versus 
conventional blood glucose control in patients with traumatic brain injury” (139). 
Another function of eligibility restrictions is to ensure the logistical feasibility of 
successfully completing the extended follow-up study. For example, in 
multicentre trials it may only be feasible to recruit participants randomised at 
some of the centres (e.g. (141, 142)), or, for international trials, to centres within 
particular countries (e.g. (143)). Alternatively, participation could be restricted to 
individuals living within reasonable geographic proximity of the research team at 
the time of the extended follow-up (e.g. (144-146)).  
 
Although not observed in the systematic review, it is also conceivable that 
eligibility restrictions could be employed based on statistical power 
considerations. In particular, if the sample size required to achieve the desired 
power for the primary outcome of the extended follow-up study is substantially 
less than the sample size of the original trial, then an additional eligibility 
restriction could be applied to reduce the sample size. For an estimand defined for 
all randomised individuals, ideally the chosen eligibility restriction would not lead 
to systematic differences between eligible and ineligible participants. Candidate 
eligibility restrictions in this case could be based on enrolling centre (if eligible 
centres are considered representative of all participating centres) or the 
chronological order of participants in the randomisation sequence (e.g. restricting 
entry to the first 100 participants randomised, assuming that the characteristics of 
participants did not change over time). Rather than applying an eligibility 
restriction, where the ability to participate in extended follow-up is decided 
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according to a deterministic rule, the reduced sample size might instead be 
achieved by randomly selecting a sample of participants to take part in extended 
follow-up. This latter situation is slightly different to an eligibility restriction as 
each participant has some chance of taking part in the extended follow-up study, 
which has implications for analysis. This situation is considered separately in 
Section 7.4.3.  
 
An important consideration when implementing MI in extended follow-up studies 
with eligibility restrictions is whether participants deemed ineligible for extended 
follow-up should be included in the imputation model. In practice, a useful way to 
approach this question is to first identify whether ineligible participants are 
contained within the target population of the estimand. Importantly, if there is no 
interest in the effect of treatment in participants ruled ineligible, then clearly there 
is no need to impute missing outcome data in these participants. Again using the 
extended follow-up of the NICE-SUGAR study as an example (139), there is no 
reason to impute missing outcome data in participants ruled ineligible due to not 
having a traumatic brain injury at baseline, if interest lies only in the effect of 
treatment in those with traumatic brain injury. A general recommendation then is 
that ineligible participants should not be included in the imputation model when 
the function of the eligibility restriction is to limit participation to individuals 
contained within the target population of the estimand.  
 
In settings where eligibility restrictions are used to ensure the feasibility of the 
extended follow-up study or to reduce the sample size according to a power 
calculation, it may be the case that participants ruled ineligible are contained 
within the target population of the estimand. Indeed, the systematic review 
identified several extended follow-up studies that employed eligibility restrictions 
for the sake of feasibility while also reporting interest in the ITT estimand (i.e. the 
effect of randomisation over all randomised individuals). In studies such as these, 
a general recommendation is to include ineligible participants in the imputation 
model if this is likely to lead to improved estimation of the estimand. As well as 
the ability to satisfy an assumption about the missing data mechanism, the 
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decision of whether or not to include ineligible participants in the imputation 
model could be influenced by the availability of auxiliary variables in the original 
RCT. Importantly, if there is little auxiliary information to aid with the imputation 
of outcomes collected during extended follow-up, then including ineligible 
participants in the imputation model may simply add noise to the estimation 
process. 
 
Clearly eligibility restrictions could be employed for reasons other than those 
identified in the systematic review, and so the above recommendations are limited 
to the scenarios encountered in this review. It is also possible that multiple 
eligibility restrictions could be applied within a single extended follow-up study, 
in which case it may be reasonable to impute missing outcome data for some 
ineligible participants and not others. In light of this, ultimately the choice of 
whether to impute missing outcome data for ineligible participants is perhaps best 
evaluated on a case by case basis, with careful justification for the decision made. 
 
7.4.2. Multiple imputation and separate consent processes 
 
Depending on the information provided to participants in the original RCT and the 
specifics of the extended follow-up study in question, it may be necessary to 
obtain informed consent from participants prior to initiating the extended follow-
up (16). In the systematic review, 24 of the 81 included studies (30%) reported the 
use of a separate consent process for entry into the extended follow-up. The 
median percentage of participants randomised in the original trial providing 
consent in these studies was 70%. It is possible, of course, that additional studies 
employed separate consent processes for extended follow-up but failed to report 
them. 
 
A key consideration when applying MI in extended follow-up studies with 
separate consent processes is whether missing outcome data should be imputed 
for participants who were approached but failed to provide consent to the 
extended follow-up. Arguably this problem is more straightforward than in the 
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corresponding case for eligibility restrictions. Unlike eligibility restrictions, which 
are often applied to limit recruitment to those participants contained in the target 
population of the estimand, separate consent processes function only to educate 
individuals about study processes so they can make an informed decision about 
participating. As a result, there is typically interest in the effect of treatment in 
non-consenting participants. Indeed, of those studies included in the systematic 
review that explicitly defined the estimand and reported the use of a separate 
consent process (11 studies), not one excluded non-consenting participants from 
the target population of the estimand. 
 
Assuming the goal of the analysis is to estimate the effect of treatment in a 
population that includes non-consenting participants, the decision of whether to 
include non-consenting participants in the imputation model can be based on the 
expected bias and efficiency of the treatment effect estimate. Factors that could 
influence this decision once again include the availability of auxiliary variables to 
assist with the imputation of missing outcomes, and the ability to satisfy an 
assumption about the missing data mechanism. Ultimately it is recommended that 
non-consenting participants be included in the imputation model if this is likely to 
lead to improved estimation of the estimand. 
 
7.4.3. Multiple imputation and other sources of missing data  
 
As described previously, individuals could be precluded from participating in 
extended follow-up due to death, loss to follow-up, withdrawal from the original 
RCT preventing further contact, or non-selection in a random sample chosen for 
extended follow-up. Participants recruited into the extended follow-up phase of 
the trial could also fail to contribute outcome data. With the exception of non-
selection in a random sample, these potential sources of missing outcome data are 
common to standard RCTs, hence recommendations for their handling in this 
context can also be applied to extended follow-up studies. In particular,  missing 
outcome data should be imputed in an analysis involving MI for participants 
contained within the target population of the estimand (1). As with ineligible or 
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non-consenting participants, one difficulty in imputing missing outcome data in 
participants who withdraw or are lost to follow-up before the commencement of 
extended follow-up is that there will be no information collected during the 
extended follow-up to aid imputation. Although ideally these participants would 
be included in the imputation model, the lack of auxiliary information to impute 
the missing values may simply add noise to the estimation procedure. In the case 
of non-selection in a random sample chosen for extended follow-up, the 
probability of selection will be known to researchers, hence a weighting approach 
might be applied in place of MI to handle missing outcome data.  
 
Although not a focus of this thesis, the issue of how to handle unobserved 
outcome data due to participant death warrants brief mention here. Importantly, if 
an outcome variable is not considered meaningful in participants that died, then 
the outcome should be considered undefined rather than missing in these 
participants and MI should not be applied (1). Several statistical approaches have 
been proposed to address undefined outcome data due to death. If death is known 
to be unrelated to treatment, the effect of treatment can simply be estimated using 
data from surviving patients (1). Could death be related to treatment, it may be 
possible to include death as a component of a composite outcome, or to attribute 
to death a utility score on the same scale as the outcome (66). Alternatively, 
principal stratification could be used to estimate the effect of treatment in the 
subset of participants who would have remained alive on either treatment (147). 
For further discussion on these and other techniques for addressing undefined 
outcome data due to death, see (1, 66). 
 
7.4.4. Inverse probability weighting and multiple imputation 
 
Assuming interest in the effect of treatment over all randomised participants, as 
with an ITT analysis, a concern with implementing MI is that a substantial 
proportion of randomised participants could be missing data on all variables 
collected during the extended follow-up. Since the imputation model describes the 
joint distribution of all variables subject to missing data, a greater number of 
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variables requiring imputation is likely to mean an increased risk of imputation 
model misspecification. In turn, any deficiencies in the imputation model will 
have a proportionately larger effect on estimation when larger amounts of data 
require imputation. Ultimately this could lead to serious bias. Another concern is 
that participants with missing data on a large number of variables might simply 
add noise to the imputation process, which could result in reduced efficiency. 
 
In settings where data are missing on many variables in many participants, as is 
often the case in extended follow-up studies, IPW may be an appealing alternative 
to MI. Whereas MI requires appropriate specification of a joint (i.e. multivariate) 
model for the missing data conditional on the observed data in order to produce 
valid inference, IPW only requires an appropriately specified univariate model for 
the probability that an individual has complete data. Of course, as with any 
approach to handling missing data, IPW is not without limitations. In its standard 
implementation, IPW can be inefficient relative to MI, as it discards information 
from partially observed cases. Further, the approach can be difficult to implement 
for non-monotone patterns of missing data (26). 
 
Another possibility for handling missing outcome data, as introduced in Seaman 
et al. (148), is to combine IPW and MI. The basic idea of this approach, termed 
“IPW/MI”, is to use MI to account for missingness in participants with few 
variables subject to missing data, and IPW to account for participants with larger 
blocks of missing data. In this way, IPW/MI could acquire some of the efficiency 
advantages of MI while minimising potential bias due to imputing large blocks of 
missing data. A key precursor in applying IPW/MI is the determination of a rule 
for when to include a participant in the imputation model. In the context of 
extended follow-up studies, a sensible rule might be to impute results for 
individuals who participate in extended follow-up but have sporadic missing data 
in outcomes collected during this phase of the trial, and to use IPW to handle 
individuals who did not participate in the extended follow-up. After defining the 
inclusion rule for imputation, missing values in included participants are multiply 
imputed using standard MI techniques. Resulting completed datasets are then 
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analysed separately using IPW, that is, with included participants weighted in the 
analysis according to the inverse of the probability of satisfying the inclusion rule, 
and with a robust error variance calculated to account for the weights. Finally, 
results from the weighted analyses are then combined using Rubin’s rules, which 
have been shown to perform well following IPW/MI (see Seaman et al. (148) for 
details).  
 
Arguably the IPW/MI approach is best reserved for extended follow-up studies 
where data are missing on many variables in many participants, and where there is 
concern over the appropriate specification of the imputation model. In these 
settings, IPW/MI could be employed as a primary method of analysis, as a form of 
sensitivity analysis, or as a diagnostic check for MI. Should IPW/MI and standard 
MI produce similar results, this might offer reassurance that the imputation model 
is appropriately specified. Conversely, should the results of IPW/MI and standard 
MI differ greatly, this might highlight ways in which the imputation model could 
be improved. 
 
7.4.5. Case study 
 
To illustrate some of the challenges in implementing MI in extended follow-up 
studies, and how IPW/MI can be used as a diagnostic check for MI in this setting, 
once again the DINO trial was considered (91). As described previously, in DINO 
n = 657 preterm infants born < 33 weeks gestation were randomised to receive a 
high docosahexaenoic acid (DHA) or a standard DHA diet from within 5 days of 
commencing enteral feeds through to term-equivalent age. Randomisation was 
stratified by centre (5 centres), sex, and birth weight (<1250g, ≥1250g), with 
infants from a multiple birth randomised according to the sex and birth weight of 
the first born infant. The initial DINO trial concluded following the assessment of 
neurodevelopmental outcomes in the children at 18 months corrected age. Later 
an extended follow-up period was initiated to assess neurodevelopmental and 
growth outcomes in the children at 7 years corrected age. Consent to participate in 
the extended follow-up phase of the trial was obtained from a parent or guardian 
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prior to the initiation of extended follow-up. No eligibility restrictions were 
employed for entry into extended follow-up. To illustrate the application of MI to 
this study, once again the primary ITT analysis of fat free mass (FFM) at 7 years 
corrected age was considered. To simplify the dataset for illustration purposes, 
second and subsequent born infants from a multiple birth and infants that died 
before the extended follow-up were ignored, resulting in an example dataset with 
262 and 258 infants in the high and standard DHA groups, respectively. 
 
The flow of children through the original DINO trial and its extended follow-up 
phase is summarised in Table 7.5. As shown in this table, only 25 of the 520 
randomised children (4.8%) failed to enter the extended follow-up phase of the 
trial; 9 were lost to follow-up, 9 were withdrawn during the original trial and 
could not be re-contacted, and 7 had families that were approached but failed to 
consent to extended follow-up. This remarkably high retention rate was attributed 
partly to the families of the preterm children, who were keen for their child’s 
development to be monitored, and partly to the efforts of the research team in 
keeping in regular contact with families prior to the commencement of extended 
follow-up. Of the 495 children who entered the extended follow-up phase of 
DINO, 10 later withdrew consent and a further 11 were unable to secure an 
appointment for an outcome assessment (and hence had no outcome data in the 
extended follow-up study).  
 






Number of children randomised in original trial 262 258 520
Number of children not entering extended follow-up phase 16 9 25
Loss to follow-up 5 4 9
Withdrawal from original RCT preventing further contact 6 3 9
Family approached but did not consent to extended follow-up 5 2 7
Number of children whose families consented to extended follow-up 246 249 495
Number of children providing some outcome data during extended follow-up 237 237 474
Number of children who did not complete any assessments during extended follow-up 9 12 21
Withdrawal during extended follow-up 5 5 10
Unable to secure appointment 4 7 11
a Numbers exclude second and subsequent born infants from a multiple birth and infants that died before the 
commencement of the extended follow-up study 
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As described previously (see Section 6.3.8), FFM was missing for 65/262 (24.8%) 
and 46/258 (17.8%) children in the high and standard DHA groups, respectively. 
Key predictors of FFM that could potentially be useful for imputation included 
centre, sex, and weight, height and systolic blood pressure at 7 years corrected 
age. Since centre and sex were baseline measures, these variables were treated as 
covariates for adjustment in the analysis models. In contrast, the post-
randomisation measures of weight, height, and systolic blood pressure at 7 years 
corrected age were treated as auxiliary variables in analyses involving MI. 
 
Table 7.6 summarises the patterns of missing data on FFM and the three auxiliary 
variables used for imputation. As displayed in this table, 403 of the 520 
randomised children (77.5%) provided complete data on all of these variables. 
Conversely, 53/520 children (10.2%) failed to contribute any data on these 
extended follow-up measures. Another common pattern was to have complete 
data on all variables except for the outcome variable FFM (pattern 3, n = 35). 
 
Table 7.6. Missing data patterns for fat free mass and key auxiliary variables. 
Pattern Frequency (%) Fat free mass Weight Height Systolic blood 
pressure 
1 403 (77.5) + + + + 
2 6 (1.2) + + + - 
3 35 (6.7) - + + + 
4 11 (2.1) - + + - 
5 1 (0.2) - + - + 
6 11 (2.1) - - + + 
7 53 (10.2) - - - - 
+ indicates observed data, - indicates missing data 
 
In estimating the effect of treatment on FFM, the following three MI strategies 
were considered: 
  
1. MI including all n = 520 randomised children; 
2. MI restricted to the n = 467 children who contributed at least some data on 
FFM and the three auxiliary variables; and 
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3. IPW/MI, with MI applied to the n = 467 children who contributed at least 
some data on FFM and the three auxiliary variables, and IPW used to 
recover the sample size to the 520 randomised children.  
 
For each MI strategy, missing values in FFM and the three auxiliary variables 
were imputed using a Markov chain Monte Carlo algorithm assuming multivariate 
normality (11). Each imputation model involved a burn-in of 5000 iterations, with 
 = 50 complete datasets created. Imputation was performed separately by 
randomised group according to the findings of Chapter 6, with the fully observed 
baseline covariates centre and sex also added to imputation models to ensure 
consistency with the intended analysis. For IPW/MI, logistic regression analysis 
revealed that the odds of failing to contribute any data during extended follow-up 
was higher in one of the five study centres (odds ratio vs. coordinating centre = 
2.37; 95% CI 1.08 to 5.21; p = 0.03) and decreased with the age of the child’s 
mother at randomisation (odds ratio = 0.92; 95% CI 0.88 to 0.97; p = 0.001). As 
centre and mother’s age at randomisation were both fully observed, weights were 
calculated directly from a logistic regression model involving these two 
predictors. It is worth noting that weights can also be calculated using incomplete 
predictors of missing data, although the statistical procedure is more complex than 
with complete predictors (see (26) for details).  
 
Treatment effect estimates from the three methods for handling missing outcome 
data are presented in Table 7.7. Results from a complete case analysis, both 
unadjusted and adjusted for centre and sex, are also presented for comparison. As 
shown in the table, treatment effect estimates and corresponding 95% confidence 
intervals were very similar for the three MI approaches. Evidently the decision of 
whether to incorporate the 53 children with missing data on FFM and the three 
auxiliary variables made little difference to estimation. This finding might be 
attributable both to the small number of children accounted for in this group 
(10.2% of the randomised sample), and the small amount of information on the 
effect of treatment provided by these children. Perhaps these children might have 
contributed more information about the treatment effect had useful auxiliary 
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variables for FFM been available from the original DINO trial. Comparing MI to 
all randomised children (n = 520) with IPW/MI, the similar estimates of the 
treatment effect suggests that any bias due to imputing large blocks of missing 
data was likely minimal. This demonstrates the usefulness of IPW/MI as a 
diagnostic check for MI. 
 
Table 7.7. Treatment effect estimates for fat free mass (kg) at 7 years corrected 
age from the DINO extended follow-up study. 






Unadjusted CCA (n = 409) -0.007 0.259 -0.514 to 0.500
CCA (n = 409) 0.048 0.238 -0.420 to 0.515
MI to full randomised group (n = 520) -0.118 0.227 -0.563 to 0.327
MI to those with some data at follow-up (n = 467) -0.104 0.229 -0.553 to 0.346
MI to those with some data at follow-up (n = 467) + IPW (n = 53) -0.108 0.230 -0.559 to 0.344
Abbreviations: CCA, complete case analysis; MI, multiple imputation; IPW, inverse probability weighting. 
 
Although the treatment effect estimate was stable across the different MI 
strategies in this example, such a pattern of results might not be seen in other 
extended follow-up studies. Importantly, unlike many of the extended follow-up 
studies included in the systematic review, DINO did not involve eligibility 
restrictions for participation in the extended follow-up. In addition, the overall 
percentage of randomised participants with complete data on FFM was 78.7%, 
quite a bit higher than the median value of 65.9% observed in the systematic 
review. Finally, the imputation model employed in this case study was relatively 
simple, involving just the four variables with missing data, and so was unlikely to 
be substantially misspecified. All of these factors may have contributed to the 




When implementing MI to handle missing outcome data in extended follow-up 
studies, a key task is to identify which participants are contained in the target 
population for the estimand. Importantly, if there is no interest in the effect of 
treatment in participants with particular characteristics, then there is no need to 
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include these participants in the imputation model. Often participants ruled 
ineligible for extended follow-up will not be of interest for analysis, while 
participants that have missing outcome data for other reasons will be. Having 
established the group of participants of interest for analysis, it may be the case 
that a large proportion have missing data on a range of variables due to not 
partaking in the extended follow-up. In this case, it can be useful to contrast the 
results of a standard MI analysis (i.e. involving all participants in the target 
population) with an MI analysis restricted to those participants who commenced 
extended follow-up, and/or with IPW/MI. Should these approaches produce 
similar results, this would offer reassurance that results are robust to the decision 
regarding the handling of the missing data. Conversely, differences between the 
approaches would highlight the sensitivity of results to the assumption made 
about the missing data, and potentially suggest ways in which the imputation 
model might be refined. As with any other research setting subject to missing 
data, additional sensitivity analyses in which the assumption about the missing 




8. Summary and conclusions 
 
This thesis has explored several issues in the practical application of MI for 
handling missing outcome data. In particular, the thesis has addressed specific 
aims concerning the imputation of missing outcome data (1) in the presence of 
auxiliary variables, (2) for estimating relative risks, (3) in RCTs, and (4) in 
extended follow-up studies based on RCTs. New contributions from this thesis to 
the field are timely given the increasing popularity of MI and the widespread 
occurrence of missing outcome data in the medical literature. In this final chapter, 
key findings and contributions are summarised, limitations of the work are 
discussed, and suggestions for further research are highlighted. 
 
8.1. Key findings and contributions 
 
8.1.1. Thesis aim 1 
 
The first aim of this thesis was to compare the performance of MI and MID in 
settings where missing data are evident in both outcome and exposure variables, 
and where auxiliary variables associated with the outcome are included in the 
imputation model. Two types of auxiliary variables were of interest in this 
investigation: those associated just with the outcome, which would be included for 
efficiency gains, and those associated with both the outcome and missingness in 
the outcome, which would be included for efficiency gains and bias reduction. 
 
As described in Chapter 4, the performance of MI and MID in the presence of an 
auxiliary variable for the outcome was evaluated using data simulation. In 
simulation settings where the auxiliary variable was associated with the outcome, 
but not missingness in the outcome, both MI and MID exhibited negligible bias in 
estimating regression parameters when data were MAR. In terms of precision, 
MID performed marginally better than standard MI when there was a weak 
correlation between the auxiliary variable and the outcome, while MI was 
noticeably more efficient than MID for moderate-to-strong correlations. In 
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simulation settings where the auxiliary variable was associated with both the 
outcome and missingness in the outcome, it was shown for the first time that MID 
produces biased estimates of regression parameters when data are MAR, whereas 
standard MI does not. The magnitude of the bias with MID increased with the 
amount of missing data and with the strength of the correlation between the 
auxiliary variable and the outcome. 
 
The practical implications of this research are that if the imputation model 
includes auxiliary variables for the outcome, then it is important that imputed 
outcomes are kept in the analysis. MID is better reserved for settings where 
auxiliary variables for the outcome are unavailable.  
 
8.1.2. Thesis aim 2 
 
The second major aim of this thesis was to assess the performance of standard 
model-based methods of MI for handling missing data in outcome and exposure 
variables when estimating the relative risk. While relative risks are typically 
estimated using log binomial models, standard model-based methods for imputing 
incomplete binary outcomes involve logistic regression or an assumption of 
multivariate normality. It was unclear whether inconsistencies between imputation 
and analysis models in this setting could result in biased and/or inefficient 
estimates of the relative risk. A supplementary aim was to evaluate whether 
deleting imputed outcomes prior to analysis improves the performance of MI in 
this setting. 
 
The performance of standard model-based methods of MI for handling missing 
data when estimating the relative risk was evaluated in Chapter 5 using data 
simulation. The investigation considered the performance of MVNI and FCS with 
a logistic imputation model for the outcome, with both MI approaches applied 
with or without the deletion of imputed outcomes prior to analysis. Results 
indicated that MVNI is likely to be a poor choice for handling missing data when 
interest concerns the relative risk, with the approach consistently producing 
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estimates of the relative risk that were biased towards the null. Deleting imputed 
outcomes following MVNI tended to reduce the bias of this imputation method, 
but this came at the expense of decreased efficiency. Although outperforming 
MVNI, FCS was also associated with biased estimates of the relative risk, with 
the magnitude of the bias positively associated with the outcome prevalence and 
the size of the relative risk. Deleting imputed outcomes following FCS did not 
improve the performance of this imputation approach. 
 
As the first study to explore the performance of standard model-based methods of 
MI for estimating the relative risk, this work has important practical implications. 
Most notably, the research shows that FCS with a logistic imputation model for 
the outcome, despite its shortcomings, should be preferred over MVNI for 
handling an arbitrary pattern of missing data in outcome and exposure variables 
when estimating the relative risk. Further, imputed outcomes should be retained 
for analysis in this setting. In demonstrating performance deficits with both MVNI 
and FCS when estimating the relative risk, these findings reinforce the importance 
of appropriately replicating the functional form of a chosen analysis within the 
imputation model. Ultimately, it is hoped that this research will lead to the 
development of new approaches within the MI framework for more suitably 
handling missing outcome data when estimating the relative risk. 
 
8.1.3. Thesis aim 3 
 
The third aim of this thesis was to evaluate the performance of MI for handling 
missing outcome data in RCTs, and to explore the merits of imputing overall and 
separately by randomised group in this context. Of interest was the utility of MI 
for estimating treatment effects according to the ITT principle. There were two 
primary motivating reasons for undertaking this work. First, editors and journal 
reviewers are increasingly requesting the use of MI to handle missing outcome 
data in RCTs, despite limited evidence that MI outperforms alternative statistical 
approaches in this setting. Second, MI is often implemented separately by 
randomised group in RCTs in order to facilitate subgroup analyses, however 
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whether this approach might also offer benefits in settings where subgroup 
analyses are not of interest had not been previously investigated. 
 
In line with theoretical results in the literature, MI was observed to produce 
unbiased treatment effect estimates in simulation settings where outcome data 
were MAR and where imputation and analysis models were correctly specified 
(see Chapter 6). However, MI was often less efficient than alternative unbiased 
approaches for handling missing data in RCTs. For example, MI was less efficient 
than a CCA for univariate outcomes with missing data and the likelihood-based 
LMM for continuous multivariate outcomes with missing data. In settings where 
the analysis model overlooked an interaction effect involving randomised group, 
MI only produced unbiased estimates of the average treatment effect when 
implemented separately by randomised group. 
 
A key contribution of this research to the literature is that it demonstrates that MI 
should never be seen as the only acceptable option for handling missing outcome 
data in RCTs. In many cases a simpler approach to missing data can be preferable. 
The work also indicates that where MI is employed in the analysis of an RCT, 
imputation should be performed separately by randomised group. Compared to 
including all randomised participants in a single imputation model, imputing 
separately by randomised group offers greater robustness against imputation 
model misspecification at little cost. It is hoped that the publication from this 
work will be a useful reference for researchers involved with the analysis of RCT 
data, and for editors and journal reviewers tasked with judging the appropriateness 
of statistical methods for handling missing outcome data in reports of RCTs.  
 
8.1.4. Thesis aim 4 
 
The fourth and final aim of this thesis was to review the extent and common 
sources of missing outcome data in recently published extended follow-up studies, 
and to provide general recommendations around the implementation of MI in this 
setting. This aim was developed in response to the potentially serious threat to 
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inference posed by missing outcome data in extended follow-up studies, and to 
the scarcity of literature on this type of study design. 
 
As described in Chapter 7 of the thesis, a systematic review of recently published 
extended follow-up studies was undertaken to characterise the nature and handling 
of missing outcome data in this setting. High rates of missing outcome data were 
observed in the review, an unsurprising finding given that primary outcomes in 
included studies were collected at a median of 7 years after randomisation in the 
original trial. As well as attrition over time, eligibility restrictions and consent 
processes for entry into extended follow-up were common reasons why 
randomised participants failed to contribute outcome data during this phase of the 
trial. Despite the serious threat to inference presented by missing outcome data, 
the statistical approaches used to address this problem in the studies reviewed 
were often inadequate. Importantly, only half of the included studies defined the 
estimand of interest, less than 10% stated the missing data mechanism assumed in 
the analysis, and just 25% undertook sensitivity analyses around the missing data 
mechanism. In addition, more than half the included studies performed the main 
analysis under the strong and often unrealistic assumption that outcome data were 
MCAR. 
 
Findings from the systematic review were used to develop recommendations 
around the implementation of MI as a primary method of analysis in extended 
follow-up studies. The main recommendations were to include participants in the 
imputation model when (a) they were of interest for analysis, and (b) where their 
inclusion would likely lead to improved estimation of the chosen estimand. It was 
also suggested that IPW/MI and/or MI restricted to participants who commenced 
extended follow-up could be used as a form of sensitivity analysis or diagnostic 
check for a standard MI analysis involving all participants of interest. 
 
As the first study to quantify the considerable threat posed by missing outcome 
data in extended follow-up studies, it is hoped that this research will raise 
awareness of this problem and lead to the adoption of more suitable statistical 
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approaches when analysing such studies. It is also hoped that recommendations 
from this research will simplify the process of applying MI in the analysis of 
extended follow-up studies, particularly around how to address missing outcome 
data resulting from the use of eligibility restrictions and separate consent 
processes. 
 
8.2. Limitations and future directions 
 
The limitations of each individual study contributing to this thesis have been 
described in the relevant chapter discussions. In this section, the limitations of the 
thesis as an overall body of work are discussed, and areas for future research are 
identified. 
 
This thesis has relied heavily on data simulation to evaluate the performance of 
MI for handling missing outcome data. In order to attribute any deficiencies in 
performance to the method of MI, only simple simulation scenarios were 
considered throughout the thesis. In particular, attention was restricted to main 
effects models involving at most two covariates, where individual variables in the 
analysis model followed either a normal or a Bernoulli distribution. In practice, 
interest might concern more complex relationships (e.g. containing interaction 
terms) involving a larger number of variables from a variety of different 
distribution types. Although similar performance might be anticipated with MI in 
more complex practical settings, additional simulation studies are needed to 
determine whether the findings of this thesis extend to such settings. In addition to 
the focus on simple analysis models, this thesis considered only a narrow 
assortment of missing data mechanisms. In particular, data in outcome and 
exposure variables were set to be missing according to simple logistic regression 
models or, following previous simulation work on the MID method, according to 
the cumulative distribution function of the normal distribution. In settings where 
bias and precision losses were evident with a given method of MI, it is possible 
that performance deficits could be quite sensitive to the functional form of the 
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MAR mechanism. Hence it would be beneficial for future research to expand 
upon the range of missing data mechanisms considered. 
 
Another limitation of this thesis is that it only considered the application of MI 
under an assumption that data were MAR. Although this corresponds with the 
standard implementation of MI, in any given analysis data may instead be MNAR, 
which occurs when the probability of missing data depends on unobserved values.   
Although the implementation of MI under an MNAR assumption is an active area 
of research, there is little indication that this research extends to problems such as 
the estimation of relative risks or the handling of missing outcome data in 
extended follow-up studies. Given the utility of MI under an MNAR assumption, 
this is an area for future research. 
 
This thesis focused predominantly on the application of MI in settings where 
observations were independent. Yet many datasets in medical research involve 
some form of clustering, where observations can be classified into a number of 
distinct groups or “clusters”, such that observations within the same cluster are 
likely to be more similar than observations in different clusters. Common 
examples include repeated measurements on the same participant over time (i.e. 
longitudinal data), students within schools, or studies within a meta-analysis. 
Another example of clustering is provided by the DINO case study, where infants 
from a multiple birth were clustered within families. For illustration purposes the 
clustering in DINO was removed by excluding second and subsequent born 
infants from a multiple birth from the analysis dataset; such an approach would 
not be recommended in practice. Since ignoring clustering can lead to biased 
standard errors for parameter estimates (149), it is important that clustering is 
accounted for in the analysis. When the analysis model allows for clustering, for 
example in a mixed effects model or using generalised estimating equations, the 
imputation model should also account for the clustering. Excluding the case of 
longitudinal data, where missing data can be imputed by treating the different 
measurements over time as different variables in the dataset (i.e. data in wide 
format), accounting for clustering in the imputation model can be a challenging 
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process. Potential approaches include treating cluster as a fixed effect within the 
imputation model, imputing separately by cluster, or fitting a multilevel 
imputation model (5, 15). Although it is expected that the main findings of this 
thesis apply to these more complex types of imputation models, this is a topic for 
future research. 
 
Another limitation of this thesis is that the missing data problem in the DINO case 
study was not severe. As described in chapters 6 and 7 of the thesis, treatment 
effect estimates for fat free mass at 7 years corrected age were similar regardless 
of how MI was implemented, whether performed overall, separately by 
randomised group, in combination with IPW, or restricted to children who 
provided outcome data during the extended follow-up phase of the trial. Further, 
despite the inclusion of auxiliary variables in the imputation model, treatment 
effect estimates did not substantially differ between MI and a simple adjusted 
CCA. Although in one sense it was reassuring to note that treatment effect 
estimates were consistent across approaches, it would be informative to consider 
case studies where results are more sensitive to the choice of approach for 
handling missing outcome data. 
 
8.3. Concluding remarks 
 
As highlighted at the beginning of this thesis, MI is a flexible and increasingly 
popular statistical approach for handling missing data. Despite a growing 
evidence base for its use, implementation in practical settings remains 
challenging, and in many cases there is no consensus in the literature to guide 
decisions around how to best generate imputed datasets for analysis. This thesis 
has focused on knowledge gaps in the application of MI for handling missing 
outcome data, which is a common problem in medical research. In particular, this 
thesis has explored the use of MI for handling missing outcome data in the 
presence of auxiliary variables for the outcome, when estimating relative risks, 
and in RCTs and extended follow-up studies based on RCTs. The research has 
demonstrated the benefits of retaining imputed outcomes for analysis, the 
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shortcomings of standard model-based methods of MI for estimating the relative 
risk, and the limited utility of MI in some RCT settings. In addition, this thesis has 
offered guidance on how imputation models should be specified in the context of 
RCTs and extended follow-up studies. Findings and recommendations from this 
work will enable researchers to make more informed decisions about the 
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